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ABSTRACT 
The primary aetiologic factor for vocal fold nodules has been proposed to be cumulative 
perpendicular impact stress between the vocal folds over time, which increases with voice use 
(Titze, 1994). Many people with vocal fold nodules work in high vocal demand occupations, 
therefore, it is essential that they recover vocal function so that their ability to perform their jobs is 
not compromised (Karkos & McCormick, 2009).
  
A number of studies have reported positive 
improvements in vocal fold nodules following various types of behavioural voice therapy, and as 
such, voice therapy is recommended as a first-line treatment (Blood, 1994; Holmberg, Hillman, 
Hammarberg, Sodersten, & Doyle 2001; Holmberg et al, 2003; Hogikyan, Appel, Guinn, & Haxer, 
1999; Hufnagle & Hufnagle, 1984; Lancer, Syder, Jones, & Le Boutillier, 1988; Lockhart, Paton, & 
Pearson, 1997; Murry & Woodson, 1992; Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 
1995). 
 The majority of the intervention studies for patients with vocal fold nodules have examined 
treatment outcomes following traditional voice therapy models, typically delivered once a week 
over a period of multiple weeks. To date, no studies have systematically examined the impact of 
using an intensive, massed practice therapy approach. In that the rehabilitation process for vocal 
fold nodules requires the learning, maintenance and transfer of new behaviours, it is possible that a 
more condensed voice therapy protocol may yield equal or even greater benefit. Therefore, the 
primary aim of this thesis was to explore the efficacy of intensive voice therapy (eight sessions 
within 3 weeks) as compared with traditional voice therapy (one session per week for 8 weeks). 
Both the short and long term effects of the different treatments on perceptual, acoustic, and 
physiological outcomes were examined. 
Although it has been established that voice therapy is often effective, in many caseloads, 
rates of therapy completion are poor and this creates a challenge for clinicians (Portone-Maira, 
Wise, Johns, & Hapner, 2011). Traditional, face-to-face (FTF) voice therapy has shown dropout 
rates as high as 65% (Hapner, Portone-Maira, & Johns, 2009). Various factors contributing to non-
attendance include travel time, inflexible work conditions, and inability to access due to physical 
barriers. Non-attendance not only affects treatment success, but also results in unnecessary 
extensions to treatment, and repeated examinations without sufficient behavioural change to effect 
improvement. Ultimately, there may be a loss of revenue or even employment if patients are unable 
to meet the vocal requirements of their occupations (Portone, et al., 2008; Portone-Maira et al., 
2011). Consequently, there is a need to explore ways to help maximise attendance and ultimately 
enhance outcomes for people with vocal fold nodules. To this end, the secondary aim of this thesis 
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was to examine the feasibility and outcomes of delivering intensive voice therapy via telepractice, 
as an alternative service delivery model for patients with vocal fold nodules.  
To address aim one, 53 female patients (56% professional voice users) with bilateral vocal 
fold nodules were recruited. Participants were matched in pairs according to their age, occupation, 
and severity of dysphonia and assigned to either of two treatment groups: traditional therapy of 
eight sessions delivered once a week for 8 weeks (n = 29) or intensive therapy of eight sessions 
delivered over 3 weeks (n = 24). All participants underwent physiological, acoustic and perceptual 
voice assessments pre-treatment, then again immediately post, and 6 months post therapy. Three 
investigations were reported from this initial study including: the perceptual, vocal fold functions 
and lesion outcomes following intensive voice treatment compared to traditional voice therapy 
(Chapter 2); the acoustic and physiological changes observed in cohorts treated via either traditional 
or intensive voice treatment (Chapter 3); and the long-term effects of intensive voice treatment 
compared with traditional voice therapy (Chapter 4). To explore the secondary aim, 10 participants 
with vocal fold nodules were recruited and completed intensive voice therapy via telepractice. 
Perceptual, physiological, acoustic and aerodynamic assessments of vocal function, as well as the 
Voice Handicap Index and a telepractice satisfaction questionnaire were completed both before and 
after treatment. This data is reported as Chapter 5. 
Analysis revealed significant improvements in vocal fold condition, voice quality and 
acoustic parameters following FTF delivery of intensive voice therapy. Short- and long-term results 
were comparable to a traditional voice therapy model. For those who completed intensive therapy 
via telepractice, patient perceptions were positive and significant improvements were found in 
perceptual, physiological, acoustic and aerodynamic parameters as well as patient perceptions of 
vocal function post treatment. Overall, the present thesis provides evidence which supports the 
implementation of intensive voice therapy via both conventional FTF and telepractice service 
delivery modalities. The series of investigations in this thesis demonstrate compelling evidence that 
intensive voice therapy can facilitate behavioural change for long-term maintenance. The outcomes 
of the current thesis provide valuable information for speech-language pathologists regarding 
evidence-based treatment for individuals with vocal fold nodules.  
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CHAPTER ONE 
1 Introduction 
Vocal fold nodules are common, benign laryngeal pathologies and their presence can result 
in significant voice deterioration (Colton, Casper, & Leonard, 2006; Kunduk & McWhorter, 2009; 
Pannbacker, 1999). This voice disorder occurs more frequently in women than men, possibly due to 
hormone- mediated effects (Chodara, Krausert, & Jiang, 2012; Colton et al., 2006; Dejonkere, 
2001). Vocal fold nodules are clinically defined as small protuberances located between the anterior 
and middle third of the vocal fold. They are described as being gray, white, or pearl in colour and 
bilateral, and can impede complete closure of the glottis leading to breathy voice production (Stepp, 
Heaton, Stadelman-Cohen, Braden, Jetté, & Hillman, 2011). These nodules are the result of the 
traumatic and constant collision of the vocal folds, caused by the overcontraction of the laryngeal 
intrinsic muscles (Martins et al., 2010). Individuals with vocal fold nodules constitute a large part of 
the client population at voice clinics and their incidence appears to be related to occupations 
involving high voice use, excessive work hours and time spent in the occupation (Fritzell, 1996; 
Goldman, Hargrave, Hillman, Holmberg, & Gress, 1996; Holmberg, Doyle, Perkell, Hammarberg, 
& Hillman, 2003; Martins et al., 2010).  
 It is known that vocal fold nodules are not uncommon in professional voice users who have 
vocally demanding professions. There is evidence of an increased incidence of vocal fold nodules in 
occupations such as homemakers, teachers, singers, lawyers, salespeople, preachers, and 
telemarketers (Pannbacker, 1999). The voice disorder associated with vocal fold nodules is 
commonly classified as a functional voice disorder, and the role of psychological precursors and 
predisposing personality factors is well recognised (Boone & McFarlane, 1988; Stemple, 1993). A 
range of personality (e.g., socially dominant, aggressive and impulsive), psychosocial factors (e.g., 
psychological stress, anxiety, and voice use) and somatic status (e.g., trouble sleeping, headache, 
and heartburns), have been deemed to be associated with vocal fold nodules (Goldman et al., 1996; 
Karkos & McCormick, 2009; Roy, Bless, & Heisey, 2000). Nodules are also frequently observed in 
individuals with velopharyngeal dysfunction and hearing loss; those who consistently use glottal 
stop substitutions; and children with attention deficit hyperactivity disorder (D’Alatri et al., 2015; 
Verdolini, Rosen, & Branski, 2006).  
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The cause of vocal fold nodules is believed to be repetitive mucosal injury leading to 
histological changes and concomitant voice mutation (Kent & Ball, 2000). They are generally 
localised masses, bilateral, although not always symmetrical, and located within the lamina propria 
typically at the midpoint of the membranous vocal folds (i.e., at the junction of the anterior third 
and posterior two thirds of the full length of the vocal fold) (Verdolini et al., 2006). The lesions 
often or typically interfere with the vibratory behaviour of the vocal folds, creating increased 
aperiodicity which results in symptoms of mild to moderate dysphonia characterised by hoarseness, 
breathiness, low pitch, and laryngeal hyperfunction; with hoarseness being the most common 
symptom (Pannbacker, 1999; Verdolini et al., 2006). It has been reported that a key stroboscopic 
diagnostic feature for vocal fold nodules is normal or minimal impairment of the vibratory 
properties of the mucosa (Rosen et al., 2012). Also, vocal fold nodules respond favorably to voice 
therapy and reduced voice demands with either complete resolution or substantive diminution of the 
size of the lesions. Thus, any lesions that do not respond to voice therapy, cannot be vocal fold 
nodules (Rosen et al., 2012). Vocal fold nodules cause voice difficulties that often lead to lost time 
at work, reduced productivity and impaired quality of life (Kunduk & McWhorter, 2009). The 
symptoms of dysphonia can adversely affect an individual’s professional life, often leading to 
disability as voice and speech functions are essential for effective communication, the power of 
self-assertion and persuasion, and therefore professional success (Fischera, Gutenbrunner, & Ptok, 
2009). Hence, various treatments for vocal fold nodules have been implemented to help improve 
vocal production; maximize vocal effectiveness relative to the existing laryngeal disorder; reduce 
handicapping effect of the voice problem; and to facilitate return of the best possible voice.  
To date, treatment options include either voice therapy from a speech-language pathologist 
(SLP) only, or a combination of voice therapy and laryngeal microsurgery by an otolaryngologist. 
However, most authors endorse voice therapy as the primary treatment, with surgery as a secondary 
alternative should vocal limitations and laryngeal pathology remain after behavioural management 
(Hogikyan, Appel, Guim, & Haxer, 1999). The success rate of voice treatment depends on many 
factors including: chronicity, nature of aetiology, medical history, presence or absence of secondary 
gains, variability of treatment techniques, treatment duration, clinician’s skill and knowledge, 
clinician’s personality, client motivation and confidence in treatment, client adherence, client’s 
perception of voice therapy, the need to take time off work to attend therapy and to practice target 
voice behaviours, and the time required to travel to therapy (Patel, Bless, & Thibeault, 2011).  
Furthermore, it is recognised clinically that effective voice therapy needs to involve both 
new motor learning and creating changes to cognitive processes for successful maintenance and 
transfer of the new vocal behaviour. Specifically researchers have stated that voice therapy requires 
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elements that address physiology, learning and compliance (Verdolini-Marston, Burke, Lessac, 
Glaze, & Caldwell, 1995). Unfortunately, despite such statements, very little is known about the 
principles and factors responsible for behaviour change in voice therapy in general. Equally there is 
minimal data on the efficacy and long term maintenance of voice therapy (for nodules or other types 
of vocal impairment). One exception to this is the Lee Silverman Voice Treatment (LSVT
®
LOUD) 
for individuals with Parkinson’s disease which has consistent and well-documented outcomes on 
the effectiveness of such intensive voice treatment (Ramig, Bonitati, Lemke, & Horii, 1994).  
Although voice therapy alone has been reported to minimise, eliminate and prevent the 
recurrence of vocal fold nodules, to date no research has been conducted which provides evidence 
or clear guidelines as to the optimal intensity or duration of voice therapy for clients with vocal fold 
nodules. Hence, the primary aim of the current thesis is to compare the effectiveness of two 
different intensities of voice treatment in the management of vocal fold nodules. The secondary aim 
is to examine the feasibility and efficacy of telepractice when delivering intensive voice therapy to 
individuals with vocal fold nodules. These two main aims are explored in a series of four 
investigations presented in Chapters 2 to 5. The present chapter provides a background to this 
research and provides an overview of the current literature regarding the causes, risk factors, 
clinical features, and treatment efficacy in the management of vocal fold nodules. Secondly, it will 
provide a comprehensive review of the variables which determine the effectiveness of vocal 
rehabilitation. Thirdly, the importance of treatment attendance and adherence which is associated 
with efficacy of voice treatment will be discussed. Finally, the use of telepractice as a potential 
alternative method of service delivery for treating vocal fold nodules will be introduced.  
 
1.1 Aetiology of Vocal Fold Nodules 
The primary aetiologic factor for vocal fold nodules is proposed to be cumulative 
perpendicular impact stress between the vocal folds over time, which increases with voice use. 
Especially certain forms of voice use, such as pressed voice, appear to increase the risk of this 
injury (Titze, 1994). The formation of a vocal fold nodule is a tissue reaction to frictional trauma 
between the vocal folds, and is the growth of hyperkeratotic epithelium with underlying fibrosis. It 
may begin as a submucous haemorrhage and may develop from the fibrosis of an organising 
hematoma. Under light microscopy, vocal fold nodules are seen as a predominance of epithelial 
hyperplasia, basal membrane thickening, fibrosis, and lamina propria oedema (Martins et al., 2010). 
Immunohistochemical analyses have revealed that there is a marked immunoexpression of 
fibronectin on the basal membrane and on the lamina propria (Martins et al., 2010).  
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Vocal fold nodules are benign, occur mostly at the mid-membranous portion of the vocal 
fold (as this is the point of maximum impact stress, or trauma, to the vocal fold) and are typically 
located bilaterally (Aronson & Bless, 2009; Johnson & Jacobson, 2007; Leonard, 2009). Repeated 
contact at the mid-portion of the membranous vocal folds causes thickening and often incomplete 
keratinisation of the mucosa (Johnson & Jacobson, 2007). The junction between the epithelium and 
submucosa, the basement membrane zone, is often damaged (Johnson & Jacobson, 2007). Pontes et 
al. (2002) hypothesised that the presence of a medium-posterior triangular chink that is associated 
with tension in the thyroarytenoid muscle concentrates the vocal emission energy in the middle one-
third of the vocal folds, leading to tissue trauma and subsequently, the formation of nodules. In turn, 
the nodules cause the occurrence of a small anterior chink, because of the mechanical hindering of 
vocal fold approximation. In order to achieve voicing, subglottal pressure is increased and vocal 
fold collision forces are heightened, thereby triggering a “vicious cycle” adding to the vocal trauma 
(Hillman, Holmberg, Perkell, Walsh, & Vaughan, 1989). Other characteristics of the larynx that can 
theoretically influence the formation of nodules are the smaller and thinner vocal folds and a higher 
pitch in women (Pontes et al., 2002).  
In addition, it is generally held that an underlying component in vocal fold nodules is vocal 
hyperfunction (Holmberg et al., 2003). Vocal hyperfunction is assumed to be a result of increased 
and poorly regulated laryngeal muscle tension. The imbalance and increase in muscle tension 
produces abnormally stiff vocal folds and/or incomplete closure of the membranous glottis 
(Holmberg et al., 2003). As a result, vocal fatigue is common with vocal fold nodules (Verdolini et 
al., 2006). Furthermore, the presence of dehydration, respiratory infection and/or inflammatory 
factors (e.g., allergies, tobacco and alcohol use, drug effects, environmental influences, mouth 
breathing, and laryngopharyngeal reflux) may be predisposing or aggravating factors (Verdolini et 
al., 2006). 
 
1.2 Clinical Features of Vocal Fold Nodules 
After the vocal fold nodule has been formed, the resultant dysphonia is perceived as breathy 
with various degrees of turbulent noise, strained vocal quality, roughness, instability, vocal 
fry/creak and a tendency towards a low pitch (Aronson & Bless, 2009; Aronsson, Bohman, 
Ternstrom, & Soderten, 2007; Colton et al., 2006). The combination of breathiness and hoarseness 
contributes to the perception of lower pitch. The dysphonia results from the change in the vibratory 
pattern caused by an increase in vocal fold mass. A breathy voice is often weak and ineffective, 
which may lead to compensatory vocal behaviour in terms of increased subglottal pressure and 
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hyperfunction, especially in a loud voice. As patients with vocal fold nodules represent a group of 
speakers with breathy, hyperfunctional, and dysphonic voices that are hard to hear in noisy 
environment, they may subsequently resort to additional vocal hyperfunction in order to make 
themselves understood. As the vocal fold nodules project into the glottis, they prevent the vocal 
folds from adducting anteriorly and posteriorly to the lesion and cause air-stream turbulence 
(Aronson & Bless, 2009). Consequently, the breathy or husky voice quality associated with the 
presence of vocal fold nodules is the effect of insufficient closure of vocal folds in the non-adducted 
areas around the vocal fold nodules (Aronson & Bless, 2009; Franco & Andrus, 2007). Vocal fold 
nodules that are small and immature may have little effect on acoustic, aerodynamic or vibratory 
characteristics associated with voice. With increasing size and firmness, however, complete closure 
of the folds during vibration is not easily achieved.  
Mucosal and vibratory displacement characteristics, viewed stroboscopically, may be 
diminished at the site of thickening and transglottal airflows may be increased (Leonard, 2009). 
Also, periodicity of vibration is often reduced (Leonard, 2009). Wuyts et al (2000) stated that, when 
extra mass are heterogeneously distributed along the cords, the higher vibratory rates hampers. The 
minimum glottal area (a parameter that reflects the degree of the glottis closure during phonation) in 
female patients with vocal fold nodules has also been shown to be significantly larger than 
individuals without vocal fold nodules (Hussein Gaber, Liang, Yang, Wang, & Zheng, 2014). A 
recent study has shown that vocal folds with nodules have a significant increase in lateral phase 
symmetry in an anterior to posterior direction when compared with those without vocal fold nodules 
(Chodara et al., 2012). The lesions cause similar effects on the right and left sides, leading to a 
higher degree of symmetry across the length of the vocal folds. The increase in phase symmetry 
toward the posterior end of the vocal folds in nodules may be explained by the presence of an 
hourglass vocal fold closure pattern and the effect of mucus on vibration (Chodara et al., 2012). It 
has also been reported that patients with nodules display a mucus layer on their vocal fold during 
vibration (Hsiung, 2004). 
Early or recent vocal fold nodules are soft and reddish, whereas established or chronic vocal 
fold nodules, which have been present for months or years, are large and fibrotic (Pannbacker, 
1991). The description of vocal fold nodules in the literature remains diverse with no apparent 
common terminology (e.g., small, soft, and early nodules). Under stroboscopic examination vocal 
fold nodules typically present with an incomplete vocal fold closure pattern (hourglass 
configuration) and may result in breathiness (Johns, 2003). However, small vocal fold nodules that 
compress on closure often result in complete closure of the vocal folds without the more typical 
hourglass configuration (Verdolini et al., 2006). If the lesions impair vocal fold closure, average 
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phonatory flow is predicted to increase from speaker’s normal range, but may still fall within upper 
limits of normal range (Verdolini et al., 2006). Perpendicular impact stress to the vocal folds, which 
cause the development of vocal fold nodules, leads to high subglottic pressures, vocal fold 
hyperadduction and vocal fold elongation (high pitch) within a given register (Verdoliniet al., 
2006). Fundamental frequency (F0) and intensity are often normal in adults with vocal fold nodules, 
however the frequency and intensity ranges may be reduced (Verdolini et al., 2006).  
It was demonstrated by Sapienza, Stathopoulos, and Brown (1997) that a greater amount of 
lung volume was used by women with vocal fold nodules than women without vocal fold nodules 
during syllable train production. The women with vocal fold nodules demonstrated distinctive 
speech breathing patterns during reading compared with women with normal voice. Larger volumes 
were expended per syllable and per utterance. The larger lung volume excursions appeared to be 
related to a tendency to initiate utterances at higher lung volumes and also to terminate utterances at 
lower lung volume. This speech breathing pattern likely reflects a compensatory strategy to 
maintain a constant subglottal pressure in the presence of a higher than normal glottal airflow 
(Sapienza et al., 1997).  
Benign lesions of the lamina propria such as vocal fold nodules and their symptoms may be 
an acute reaction to an intense period of phonotraumatic behaviour (Verdolini et al., 2006). 
Alternatively, lesions and symptoms may have a gradual course of development. Lesions which 
result from acute phonotrauma may resolve with reduced voice use while those that have developed 
gradually may then persist and require treatment. Patients may complain of pain lateral to the larynx 
that may result from increased effort used in producing voice, or sometimes they may report a 
feeling of a lump in the throat (Verdolini et al., 2006). Vocal fatigue may be severe enough to 
impact occupational and social functioning and general quality of life. Hence, the treatment of vocal 
fold nodules has been designed to resolve the vocal fold nodules, minimize the risk of damage to 
the delicate vocal fold structure improve vocal quality and ultimately improve quality of life. 
 
1.3 Treatment of Vocal Fold Nodules 
There are several treatment options for vocal fold nodules which typically include either 
voice therapy from an SLP, or a combination of voice therapy and laryngeal microsurgery by an 
otolaryngologist. Most authors recommend voice therapy as the primary treatment, with surgery as 
a secondary alternative (Hogikyan et al., 1999). Sulica and Behrman (2003) reported 91% of 
otolaryngologists who were active US members of the American Academy of Otolaryngology – 
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Head and Neck Surgery recommended voice therapy as a first line of treatment for vocal fold 
nodules, and that 89% would not recommend surgical excision. Sataloff (1991) suggested that for 
longer lasting lesions, voice therapy is the primary treatment and surgery should be reserved for 
those patients whose dysphonia persisted after 3 to 6 months of intense therapy. Treatment 
decisions may also be based on several factors, including age, duration of vocal fold nodules, extent 
of dysphonia, and what treatment options are available (Pannbacker, 1999). Furthermore, treatment 
should be collaborative between the otolaryngologist, the SLP, and the client (Pannbacker, 1999). 
Ideally, otolaryngologists and SLPs cooperate to provide comprehensive assessment and treatment 
for individuals with vocal fold nodules (Allen, Pettit, & Sherblom, 1991).  
If surgery is necessary, very conservative excision of only the abnormal tissue is typically 
performed. All normal mucosa should be preserved and extreme care taken to avoid trauma to the 
vocal ligaments, which are not typically abnormal with vocal fold nodules (Johnson & Jacobson, 
2007). Surgical therapies include microsurgery or laser excision and newer techniques such as 
radiosurgical removal (Benninger & Jacobson, 1995; Ragab, 2009). The risk in these approaches is 
that the nodule involves the free margin of the vocal fold at the region of maximal motion. It has 
been reported that scarring can result from surgical removal, either with cold steel or laser 
techniques, and may cause permanent and irreparable damage at this site (Allen & Belafsky, 2009). 
Anaesthetic complications have also been reported with surgical removal (Pannbacker et al., 1999). 
Although surgical treatment is an option for the management of vocal fold nodules, it has also been 
reported to be associated with high recurrence rate.  
Lancer, Syder, Jones, and Le Boutillier (1988) and Bequignon et al (2013) reported a high 
rate (56 – 62%) of recurrence of vocal fold nodules if patients received surgery alone. In contrast, 
no recurrence was reported by Lancer et al. (1988) in a group of patients who received combined 
surgery and voice therapy. The authors reported that the long-term outcome for patients treated by 
surgery alone was poorer than those treated only with voice treatment or with a combination of 
surgery and voice treatment. This finding was later supported by Zeitels, Hillman, Desloge, Mauri, 
and Doyle (2002) who also reported a low rate (4.2%) of second recurrence of vocal fold nodules 
when patients received a combination of surgery and voice therapy. Similarly, Murry and Woodson 
(1992) found that when three methods of treatment for vocal fold nodules in adults were studied, 
the least amount of voice improvement was found in the group that had nodules surgically removed 
before voice treatment.  
Voice treatment is often more cost effective than surgery, requires less time away from 
work, and is less traumatic (Pannbacker, 1999). In addition, although surgery is an effective 
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treatment for vocal fold nodules, the patients have to be treated in combination with postoperative 
voice therapy to reduce the risk of recurrence (Bequignon et al., 2013). Furthermore, it has been 
suggested that voice therapy (with or without surgery) reduces the incidence of recurrence of vocal 
fold nodules in adults (Lancer et al., 1988). The impact of voice therapy on vocal fold nodules was 
further demonstrated by McCrory (2001) who audited clinical files of patients with bilateral or 
unilateral vocal fold nodules retrospectively over 6-year period. After voice therapy, in over 70% of 
the clinical files audited, elimination and/or reduction of vocal fold nodules were demonstrated and 
over 90% of the participants presented either a normal voice quality or a mild degree of dysphonia. 
Moreover, 86% of participants had mean speaking F0 within normal limits and 80% of participants 
rated their voice as normal or mild in severity post therapy. The author concluded voice therapy was 
effective in the elimination and the reduction of vocal fold nodules, in restoring normal voice and 
improving voice quality in the majority of participants, thus obviating the need for surgical 
intervention.   
In a recent Cochrane review comparing surgical and non-surgical interventions for vocal 
fold nodules, the authors found that there is evidence from non-randomised intervention studies that 
both voice therapy techniques and surgery are effective (Pedersen & McGlashan, 2012). However 
there is uncertainty as to how patients should be selected for primary voice therapy and which 
would benefit from surgery. In addition, although voice therapy is first-line treatment, there is no 
consensus as to which of the techniques used are most effective nor the duration they should be 
used. Pedersen and McGlashan (2012) concluded there is no evidence from randomised controlled 
trials on which to base reliable conclusions about the comparative effectiveness of surgical versus 
non-surgical interventions for the management of patients with vocal fold nodules. 
 
1.3.1 Behavioural Voice Therapy for Vocal Fold Nodules 
There is a variety of behavioural therapy approaches used to treat vocal fold nodules. These 
interventions vary across clinicians and are tailored to individual clients, depending on their specific 
needs and demands, motivation and tissue characteristics. The different approaches are often used 
in combination, with the intent to improve vocal communication; maximize vocal effectiveness 
relative to the existing laryngeal disorder; reduce the handicapping effect of the voice problem; and 
to facilitate return of the best possible voice (Ramig & Verdolini, 1998; Stemple, 2000; van der 
Merwe, 2004). Appropriate and adequate treatment of voice may play a key role in restoring and 
preserving the individual’s quality of life, and possibly economic situation (Ramig & Verdolini, 
1998). It is recognised that an effective behavioural voice therapy program should be developed 
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with at least three important perspectives taken into account: physiology, learning and compliance 
(Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 1995). That is, the method must incorporate 
a physiological effect that has the potential for reversing pathogenic voice patterns; must be 
“learnable”; and must be one that patients are likely to utilise outside the clinical situation 
(Verdolini-Marston et al., 1995).  
Voice therapy is a behavioural intervention that primarily aims to resolve the behavioural 
component of a voice disorder; it depends inherently on active client involvement (van Leer, 
Hapner, & Connor, 2008). Most treatment approaches for vocal fold nodules will include at least 
three basic components: education of the patient regarding behaviours and practices that produce, 
maintain and/or exacerbate mid-membranous thickenings; elimination of maladaptive behaviours 
that result from the vocal fold nodules and further exacerbate pathology and voice; and modification 
of relevant speaker-specific and situation-specific behaviours implicated in development of the 
tissue changes (Leonard, 2009). However, in order to reinforce the behavioural change, structured 
treatment sessions and follow-up practice outside the therapy session are required (Portone, Johns & 
Hapner, 2008).  
1.3.1.1 Effectiveness of voice therapy for vocal fold nodules. 
A recent review by Leonard (2009) concluded that available evidence suggests voice 
therapy can improve tissue health and voice but complete resolution of pathology may not be 
possible in all patients, in particular, if the basement membrane of the vocal fold cover is 
permanently altered. Therefore, voice therapy, independently, or in combination with other 
treatment is essential in clients with vocal fold nodules. The current literature relating to the 
efficacy of voice therapy has been summarised in Table 1.1. As evidenced in the table, the existing 
studies vary in nature and design, and can be classified as predominantly Phase I studies. According 
to Robey (2004), a Phase I study identifies treatment protocols, often comprising of case studies, 
discovery-oriented single-subject studies, small group pre-post studies, and retrospective studies, 
while Phase II studies make all of the preliminary tests and preparations necessary for testing the 
protocol in a clinical trials, comprising of small-group within-effect studies, case-control studies, 
and small-group cohort-control studies. In contrast, a Phase III study conducts a clinical trial to test 
efficacy, using large sample sizes and parallel-groups design; a Phase IV study tests the 
effectiveness of efficacious treatments, comprising pre-versus post-studies, parallel-groups studies 
and hypothesis-driven single-subject studies; and a Phase V study tests the worth of a treatment, 
i.e., does the obtained value justify the cost of achieving that value, assessed through cost 
effectiveness studies and cost-benefit analyses. Currently, within the available research articles for 
vocal fold nodules there is a paucity of Phase II-V studies.  
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Table 1.1  
Studies of Voice Treatment for Vocal Fold Nodules 
Level of 
evidence/ Study 
Number of 
participants 
Type of treatment Duration of 
treatment 
Intensity of 
treatment 
Measures Findings 
Phase I       
Blood (1994) 2 women with 
vocal fold nodules 
Computer-
assisted voice 
treatment; 
relaxation 
17-21 sessions Unspecified 1. subjective (perceptual) 
2. objective [F0, MPT, 
perturbation factor 
percentage, breathing, air 
volume) 
3. laryngoscopy 
1. Voice treatment 
protocol appeared to 
be an effective 
technique for 
reduction of 
hyperfunctional voice 
disorders: improved 
voice, elimination of 
nodules, ratings of 
clients, and social 
validation measures. 
2. Relaxation 
component used was 
not associated with 
clinically significant 
improvements in 
patients’ voice. 
Chernobelsky 1 male and 27 Ultrasound 3-4 months Not specified 1. Acoustic measures  1. No differences in 
11 
(2007) women 
(professional 
classical singers) 
therapy & singing 
lessons combined 
2. mirror laryngoscopy/ 
microlaryngoscopy 
speaking F0 pre- and 
post-therapy.  
2. Decrease values of 
magnitudes of jitter 
and shimmer and 
increase of signal 
noise ratio post 
therapy.  
3. Vocal fold nodules 
having occurred once, 
tends to reoccur 
despite vocal rest, 
medical treatment and 
elimination of 
inappropriate use of 
the voice. 
Drudge & 
Philips (1976) 
3 college students 
with vocal fold 
nodules 
31-step voice 
therapy program 
8 weeks; 16 
sessions of half-
hours each 
Unspecified Percentages of correct 
responses  
All students demonstrated 
improvements in 
behavioural responses 
after therapy. 
Fisher & 
Logemann 
(1970) 
1 woman with 
vocal fold nodules 
Habituation of 
higher pitch 
Unspecified Unspecified Laryngoscopy with 
photographs 
1. Increased open 
quotient and reduced 
speed quotient. 
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2. Marked reduction in 
vocal fold nodules. 
Hogikyan, 
Appel, Guinn 
& Haxer 
(1999) 
Questionnaire 
study: survey 
distributed around 
States of 
Michigan, Ohio & 
Indiana for those 
who have been 
involved with 
care of singers 
with vocal fold 
nodules 
Voice training by 
teacher of singing 
alone or with 
voice therapy by 
speech pathologist 
and vice versa 
 
Surgery alone or 
followed by voice 
therapy and/or 
voice training 
Unspecified Unspecified Questionnaire 1. Majority preferred 
voice therapy alone 
and not voice training 
alone. 
2. Surgery was not 
considered first-line 
treatment.  
3. Majority of each 
professional group 
did agree or strongly 
agree that surgery is 
appropriate if 
behavioural 
management fails, 
disagreed with the 
statement that surgery 
should never be 
performed. 
Holmberg, 
Hillman, 
Hammarberg, 
11 women with 
vocal fold nodules 
5 phases: vocal 
hygiene, direct 
facilitation, 
4-6 months  One 
session/week. 
Three 
1. Auditory perceptual 
rating of vocal quality by 
SLPs 
1. Nodules did not 
disappear but did 
decrease in size for 9 
13 
Sodersten, & 
Doyle (2001) 
respiration, 
relaxation, 
carryover 
sessions of 
each approach 
2. Acoustic analysis (F0 and 
SPL) 
clients. 
2. No change in SPL 
(loudness), increase 
in F0. 
3. Some improvement in 
voice quality. 
Holmberg, 
Doyle, Perkell, 
Hammarberg, 
& Hillman 
(2003) 
10 women with 
vocal fold nodules 
5 phases: vocal 
hygiene, direct 
facilitation, 
respiration, 
relaxation, and 
carry over 
Varied between 
4 and 6 months 
One 
session/week 
1. Laryngeal examination 
2. Aerodynamic & acoustic 
measures  
1. Laryngoscopic 
examinations showed 
that the nodules had 
decreased in size and 
surrounding oedema 
had dissipated post 
voice therapy. 
2. Nodules did not 
completely resolve 
after therapy.  
3. Neither the acoustic 
nor the aerodynamic 
parameters changed 
significantly across 
the voice therapy. 
Hufnagle & 
Hufnagle 
8 women with 
vocal fold nodules 
Voice 
modification 
Unspecified Unspecified 
 
1. perceptual rating 
2. Speaking F0 
1. No significant 
differences between 
14 
(1984) program measurements pre- and post-therapy 
speaking F0. 
2. Changes in voice 
following therapy are 
not related to changes 
in the speaking F0. 
Lancer, Syder, 
Jones, & Le 
Boutillier 
(1988) 
13 women & 7 
men with vocal 
fold nodules 
Retrospective 
study: Surgery 
alone, speech 
therapy & surgery 
(in any 
combination), 
speech therapy 
alone 
Unspecified Unspecified 1. Voice symptom score 
2. Laryngoscopy 
3. Case history 
questionnaire 
1. No recurrences have 
been diagnosed in 
patients who had had 
speech therapy, alone 
or with surgery.  
2. Significant positive 
relationship between 
smoking and 
recurrence.  
Lockhart, 
Paton, & 
Pearson (1997) 
25 female/male 
with vocal fold 
nodules 
Unspecified type 
of voice therapy 
2 to 16 sessions Unspecified 1. ST1 computer assisted 
airflow measurement 
2. EGG 
3. Visispeech histogram 
4. videostroboscopy 
1. Larger nodules 
required a longer care 
period. 
2. Improvement was 
found in vital 
capacity, mean/peak 
airflow ratio, % 
voicing time in 
15 
reading, as well as the 
EGG results of 
closure time and 
opening fraction, 
indicating more 
adequate vocal cord 
adduction. 
Murry & 
Woodson 
(1992) 
59 adults (48 
women, 11 men) 
with vocal fold 
nodules 
Group 1:voice 
therapy 
Group 2: surgery 
followed by voice 
therapy,  
Group 3: voice 
therapy combined 
with 
videoendoscopic 
examination on 
every visit 
Average number 
of visits: 
Group 1 = not 
reported 
Group 2 = 11.2 
Group 3 = 7.5 
Unspecified  1. perceptual analysis 
2. videoendoscopic 
examination 
1. Group 3 had the 
highest overall 
improvement. 
2. Group 3 required the 
least number of visits. 
3. Group 1 &2 
demonstrated 
improvement in the 
post-treatment 
condition, but less 
than that of group 3. 
McFarlane & 
Watterson 
(1990) 
44 patients (11 
children, 33 
adults) with vocal 
fold nodules 
Voice therapy 
consisting of 
general vocal 
hygiene, abuse 
reduction & vocal 
Ranging from 5 
to 50 sessions, 
each session 
lasting for 30 
minutes 
Twice weekly 1. VisiPitch 
2. Phonatory Function 
Analyzer 
3. Video endoscopy 
1. Voice normalizes 
and vocal fold 
nodules are 
completely 
eliminated. 
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retraining 2. No scarring of vocal 
folds after therapy 
and nodules do not 
return. 
3. Less than 1% of 
patients have return 
of nodules one year 
later. 
Schneider 
(1993) 
1 woman with 
vocal fold nodules 
Vocal hygiene 
counselling 
12 weeks; 7 
assessments 
over two years 
One 
session/week 
1. voice quality ranking 
2. vocal fold photographs 
3. acoustic measures 
1. Voice quality 
judgments tended to 
relate to the changes 
in degree of vocal 
fold pathology and 
patient report of vocal 
function.  
2. Significant 
improvement in voice 
was reported by 
patient post treatment. 
3. No vocal fold nodules 
were visible at the 
end of the 7
th
 visit. 
Treole & 13 women with Retrospective 6 to 26 sessions Unspecified 1. perceptual-acoustic Did not demonstrate 
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Trudeau 
(1997) 
vocal fold nodules study: Tension 
identification, 
vocal abuse 
identification & 
elimination, 
laryngeal 
strengthening 
analysis 
2. Sustained phonation 
change over course of 
treatment. 
Trullinger, 
Emanuel, 
Skenes, & 
Malpass 
(1998) 
1 woman with 
vocal fold nodules 
Relaxation, vocal 
hygiene 
3 weeks Unspecified 1. auditory-perceptual 
analysis  
2. acoustic analysis 
3. laryngoscopy 
Perceived voice quality 
improved, reduction in 
vowel SNL increase in 
vowel F0, reduction in 
vocal fold nodules. 
van der Merwe 
(2004) 
1 woman with 
vocal fold nodules 
Voice use 
reduction program 
10 weeks One 
session/week 
1. Laryngoscopy  
2. auditory perceptual 
analyses 
3. acoustic voice analyses  
1. Nodules were no 
longer visible after 6 
weeks of the 
program. 
2. Acoustic parameters 
had improved or were 
within the normal 
range after 2 weeks 
into the program. 
3. Perceptually, the 
voice quality 
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improved across time. 
Client also reported a 
decrease in vocal 
fatigue and vocal 
effort. 
Verdolini-
Marston, 
Burke, Lessac, 
Glaze & 
Caldwell 
(1995) 
13 women: 
control & 
experimental 
Confidential vs. 
resonant voice 
therapy 
Nine sessions 
over 12 days. 1 
hour/session 
Intensive 1. Auditory-perceptual 
ratings of voice 
2. phonatory effect ratings 
3. visual-perceptual ratings 
of larynx 
4. acoustic & aerodynamic 
measures 
5. client impression 
1. Compliance factors 
appear to affect the 
outcome of therapy 
and there was little 
evidence that either 
treatment 
(confidential vs 
resonant voice 
therapy) produced a 
greater likelihood of a 
benefit for any 
measure. 
2. Both types of therapy 
provided 
improvements. 
Verdolini-
Marston, 
Sandage & 
6 women with 
vocal fold nodules 
or polyps  
Double-blind: 
hydration 
treatment & 
Two sets of 5 
consecutive 
days over 2 
Daily 
(intensive) 
1. Perceptual analyses 
2. acoustic measures 
3. laryngeal examination 
General benefits 
following both 
placebo/control & 
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Titze (1994) placebo/control 
treatment 
weeks hydration but 
significantly greater 
benefits were obtained 
from hydration treatment. 
Phase II       
Niebudek-
Bogusz, 
Kotylo, 
Politanski & 
Sliwinska-
Kowalska 
(2008a) 
46 female 
teachers with 
functional voice 
disorders (vocal 
fold nodules, 
glottal 
insufficiency, 
hyperfunctional 
dysphonia & 
others) 
Vocal training 
(group 1) & vocal 
hygiene (group 2) 
Over 3 months, 
each session 
lasting for 45 
minutes 
One 
session/week  
1. VHI 
2. laryngologic-phoniatric 
examination 
3. laryngovideostroboscopy 
4. voice acoustic analyses 
1. Aerodynamic 
parameter of MPT 
increased 
significantly in group 
1, but not in group 2. 
2. Videostroboscopic 
parameters (regularity 
of vocal fold 
vibration, amplitude 
of vocal fold 
movement & quality 
of mucosal wave) 
revealed significant 
post-therapy 
improvement in 
group.  
3. Videostroboscopic 
parameters 
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(amplitude & 
mucosal wave) 
revealed significant 
post-therapy 
improvement in 
group.  
4. Significant increase in 
the mean F0 noted in 
group 1 only. 
5. Other acoustic 
parameters of both 
groups were 
improved post 
treatment. 
Niebudek-
Bogusz, 
Sznurowska- 
Przygocka, 
Fiszer, Kotylo, 
Sinkiewicz, 
Modrzewska 
& Sliwinska-
Kowalska 
186 female 
teachers 
Voice trained 
group & non-
voice-trained 
group 
Ranging from 2 
to 4 months, 
each session 
lasting for 45 to 
60 minutes 
Once to 
twice/week 
1. Videostroboscopic 
examination 
2. MPT 
3. mean F0 
4. mean vocal intensity 
5. voice frequency range 
1. Videostroboscopic 
parameters (regularity 
and amplitude of 
vocal fold vibration, 
mucosal wave, & 
vocal fold closure) 
were found to have 
improved with voice-
trained group only. 
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(2008b) 2. MPT, mean F0, mean 
vocal intensity and 
voice frequency range 
were increased in 
voice-trained group 
only indicating 
improvement. 
Phase III       
Sellars, 
Carding, 
Deary, 
MacKenzie, & 
Wilson (2002) 
204 with either 
functional 
dysphonia, mild 
laryngitis, small 
nodules or muscle 
tension dysphonia 
Randomly 
allocated: 
treatment group 
or control group 
Maximum of six 
sessions, 50 
minutes/session 
Unspecified 1. Carding Vocal 
Performance 
Questionnaire 
2. Bufallo III Voice Profile 
3. voice measures 
Significant improvement 
in voice quality following 
a general program of 
voice therapy relying 
heavily on indirect 
therapy strategies. 
 Note. VHE = vocal hygiene education; VP = voice production; F0 = fundamental frequency; MPT = maximum phonation time; SLP = Speech-Language 
pathologist; SPL = speech pressure level; EGG = electroglottography; VHI = Voice Handicap Index; SNL = spectral noise level.
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1.3.1.1.1 Phase I efficacy studies. 
Several Phase I studies including single case and small group studies (without control group 
comparison) have reported perceptual, physiological, and acoustic improvements post voice 
treatment using various combinations of therapy techniques (Drudge & Philips, 1976; Fisher & 
Logemann, 1970; Holmberg et al., 2001; Holmberg et al., 2003; Schneider, 1993; Trullinger, 
Emanuel, Skenes, & Malpass, 1988). One of the earliest single case studies of an actress with 
bilateral soft vocal fold nodules reported that the overall vocal fold conditions were improved and 
there was a marked reduction in the nodules (Fisher & Logemann, 1970). The patient was able to 
resume her acting career before the termination of voice therapy. While positive changes were 
found following voice therapy, the authors did not report on the details of voice therapy (i.e., the 
content of the program, duration and frequency of the program). This lack of information does not 
allow for replication of the study to confirm the effects of treatment.  
Later in 1993, Schneider conducted a single case study in which the participant received 12 
sessions of vocal hygiene counselling, provided once weekly. The participant reported significant 
improvement in voice production following five sessions of voice therapy with her vocal range 
returning by the sixth session of voice therapy to what it was prior to the 3-year period of 
dysphonia. The self-report correlated with the improved voice quality ratings by the SLPs and the 
laryngologist’s finding that the vocal fold nodules were not visible at the final session. However, no 
acoustic changes were observed. These results were similar to those reported by Trullinger et al. 
(1998) in a case study of an individual with bilateral vocal fold nodules who underwent three weeks 
of voice therapy. It was found that after treatment, only slight erythema of the true vocal folds 
remained, and there was improvement in perceived voice quality, as well as a measured reduction in 
vowel spectral noise level. In addition, the participant had an increase in vowel F0. The participant 
was able to maintain these improvements over an extended time after discharge from therapy. 
Unfortunately, the intensity of treatment and the total number of sessions were not reported. 
Another early study reported on three participants with vocal fold nodules using a 31-step voice 
therapy program. Simlarly, they demonstrated that two of the participants had eliminated the 
nodules and one had reduction of the nodule formation post intervention (Drudge & Philips, 1976). 
Even though this study reported the therapy program took a total of 16 sessions over an 8 week 
period, the distribution of the sessions was not documented.  
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In addition to single case and case series data, many of the studies to date have conducted 
small group cohort studies. Hufnagle and Hugfagle (1984) investigated the relationship between 
improved vocal quality and speaking F0 in eight women with vocal fold nodules following voice 
therapy. It was found there were no significant differences between the before and after speaking F0 
although the listeners who rated the voice preferred the vocal quality following therapy. It was 
concluded that the change in voice following therapy is not related to the changes in the speaking 
F0.  Holmberg et al. (2001) examined the efficacy of a behaviourally based voice therapy for vocal 
fold nodules on 11 women provided on once a weekly basis. The voice therapy consisted of five 
basic phases: vocal hygiene, direct facilitation, respiration, relaxation, and carryover. The total 
therapy period varied between 4 and 6 months, depending on the attendance of the clients. Overall, 
dysphonia was found to have decreased significantly after therapy. However, although almost all 
participants’ vocal fold nodules had decreased in size, none of the vocal fold nodules had resolved 
after completion of the therapy. The outcomes suggested that the voice therapy had a positive effect 
for a majority of patients (Holmberg et al., 2001). Similar results were yielded in a later study by 
Holmberg et al. (2003) involving 10 women with bilateral vocal fold nodules. The same voice 
therapy techniques were used within the duration of 4 to 6 months and were also provided on a 
weekly basis. Laryngoscopic examinations showed that the vocal fold nodules had decreased in size 
and surrounding oedema had dissipated after completion of voice therapy, which suggested that the 
trauma to the vocal folds had indeed decreased after the therapy. However, it was found the 
improved vocal fold appearances were not reflected in the acquired aerodynamic and acoustic 
measures. Unlike other small group studies, none of the participants had resolved nodules. 
Explanation for the inconsistency could be that the severity of nodules may be different, thus the 
time needed for resolution of vocal fold nodules may be extended.  
In a larger group study of 25 participants with vocal fold nodules, Lockhart, Paton, and 
Pearson (1997) demonstrated that after voice therapy participants had improvement in the vital 
capacity, mean/peak airflow ratio, percentage voicing time in reading, as well as the 
electroglottography results. These results indicated a more adequate vocal cord closure. The therapy 
sessions provided for this study ranged from 2 to 16 with treatment duration ranging from 16 to 24 
weeks. The authors further commented that despite the differences in the number of therapy 
sessions and the duration of therapy given, their study provided some indication as to the length of 
care period for different degrees of severity (i.e., larger vocal fold nodules required a longer care 
period). McFarlane and Watterson (1990) also reported success in 44 individuals with vocal fold 
nodules. Their voice therapy ranged from 5 to 50 sessions, with each session being a half an hour 
long, conducted twice weekly. The vocal fold nodules were reported to have completely resolved 
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after voice treatment using a combination of vocal hygiene, vocal abuse reduction, and vocal re-
education. The authors found there was no scarring of the vocal folds post voice therapy, and the 
nodules did not return. Less than 1% of their patients experienced a return of nodules one year later, 
whereas if a patient had a nodule removed by surgery, the nodule had nearly always returned in as 
little as three weeks or less (McFarlane & Watterson, 1990). 
The support for behavioural treatment has also been noted in survey and retrospective 
studies (Hogikyan et al., 1999; Lancer et al., 1988; Murry & Woodson, 1992). A questionnaire 
survey showed majority of professionals involved in the care of singers with vocal fold nodules 
preferred voice therapy alone provided by SLPs and not voice training alone provided by teachers 
of singing (Hogikyan et al., 1999). In addition, the majority of the surveys showed surgery is 
appropriate only if behavioural management fails. Therefore, coordinated voice therapy and voice 
training would be considered as first line treatment. Despite the valuable insights into the opinions 
of professionals about treating singers with vocal fold nodules provided, the study did not represent 
outcomes research (Hogikyan et al., 1999). 
 Lancer et al. (1988) conducted a retrospective study on 34 participants diagnosed as having 
either unilateral or bilateral vocal fold nodules. The authors compared the results of three 
management programs for vocal fold nodules: surgery, voice therapy, or a combination of the two. 
It was found that voice treatment (with or without surgery) reduced the incidence of recurrence of 
vocal fold nodules. No recurrence was diagnosed in participants who had speech therapy, alone or 
with surgery. In addition, significant positive relationship between smoking and recurrence was 
reported. Murry and Woodson (1992) reached similar conclusions after their study of 59 
participants with vocal fold nodules. It was found that participants who were treated with an 
integrated approach involving both an SLP and otolaryngologist demonstrated greater progress than 
those who underwent therapy after surgery and those who underwent therapy alone. However, all 
participants demonstrated progress. The authors also concluded that because the results of treatment 
with or without surgery may be comparable, voice therapy should be considered as the first 
recommendation for treatment of vocal fold nodules. In addition, it was suggested that because of 
potential complications of surgery, such as postoperative scarring, the removal of vocal fold 
nodules is indicated only after other approaches fail to produce the desired results. Furthermore, the 
findings suggested that combined management from the otolaryngologist and SLP expedited 
recovery.  
 
 
25 
 
1.3.1.1.2  Phase II efficacy studies. 
The positive findings of the majority of the Phase I studies are supported by Phase II studies 
which have investigated the effectiveness of various forms of voice treatment using a range of 
group comparison designs. The effect of receiving vocal hygiene instructions with additional vocal 
training versus vocal hygiene instruction alone was examined in 46 female teachers with a 
functional voice disorder, consisting of vocal fold nodules, glottal insufficiency, hyperfunction 
dysphonia and others (Niebudek-Bogusz, Kotylo, Politanski, & Sliwinska-Kowalska, 2008a). 
Thirty participants received both vocal training and vocal hygiene instructions and the remaining 16 
received only vocal hygiene instructions. The voice training sessions were conducted once a week, 
45 minutes each session and lasted for an average of three months. It was found that those who 
underwent additional vocal training gained improvement in aerodynamic parameters of maximum 
phonation time and F0, whilst no changes were observed for those who underwent vocal hygiene 
sessions only. Niebudek-Bogusz et al. (2008a) interpreted the significant increase in F0 as a sign of 
voice quality improvement. Laryngo-videostroscopic parameters also revealed significant post-
therapy improvement in the group with additional vocal training. Other acoustic parameters such as 
jitter, relative average perturbation and amplitude perturbation quotient were found to have 
improved following both treatments. In addition, it was found the objective measures correlated 
with the subjective assessment. The authors concluded that the voice stability improvement may be 
the effect of vocal training. Hence, vocal training may play a role in protecting the laryngeal organ 
against undesirable changes related to vocal loading for professional voice users.  
In a larger group study, Niebudek-Bogusz et al. (2008b) examined the effectiveness of voice 
therapy on 186 female teachers with hyperfunctional dysphonia, chronic laryngitis, vocal fold 
nodules, minor polypoid hypertrophy, or slight vocal fold abnormalities. The participants were also 
divided into two groups: voice-trained group and non-voice-trained group. Both groups received 
advice on vocal hygiene. The vocal training program comprised of: breathing and relaxation 
exercises, vocal function exercises, resonant improvement exercises, and carry over exercises. The 
duration of the voice training varied between two to four months, the number of sessions ranging 
from 9 to 18, with each session of 45 to 60 minutes given once or twice a week. The results 
indicated the voice-trained teachers had improved voice quality whereas the non-voice-trained 
teachers had no improvements, on the following parameters: maximum phonation time, mean F0, 
voice intensity, and voice frequency range during speaking. Niebudek-Bogusz et al. (2008b) 
concluded voice therapy should be promoted as the major method used to enhance the efficiency of 
professional voice use. 
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1.3.1.1.3 Phase III efficacy studies. 
Further to these Phase I and Phase II efficacy studies, one higher evidence study (Phase III) 
has also been conducted which confirmed the benefits of voice therapy for vocal fold nodules. 
Sellars, Carding, Deary, MacKenzie, and Wilson (2002) conducted a randomised controlled trial 
(RCT) with 204 participants who presented with functional dysphonia, mild laryngitis, small 
nodules, or muscle tension dysphonia. Patients were randomly allocated to voice treatment group or 
control group, however, they were not blind to the type of treatment received. The treatment group 
received a maximum of six sessions, with each session lasting around 50 minutes. It was reported 
that significant improvement in voice quality following general voice therapy relying heavily on 
indirect strategies was achieved. This study further confirmed the effectiveness of voice therapy 
when treatment patients with dysphonia including those with vocal fold nodules.  
 
1.3.1.1.4  Long Term Benefits of Therapy 
As evidenced from the sections above, there is a relatively large body of evidence which has 
demonstrated, through various types of study design, that there a positive treatment effect post 
behavioural therapy for vocal fold nodules. However, of these, the vast majority have only reported 
the immediate benefits of treatment. Considering that incorrect voice use and vocally damaging 
behaviours are often the primary cause of vocal fold nodules, it is critical that therapy leads to long 
term changes in voice use to help prevent nodules from re-occurring. 
Koufman and Blalock (1989) conducted a retrospective study over a 10 year period on 127 
patients with various vocal fold lesions including vocal fold nodules and underwent vocal fold 
surgery. The authors found that for patients with vocal fold nodules, behavioural modification 
through patient education provides the principal long-term therapeutic benefit. Without such 
changes in motivation and subsequent behaviour, nodules will recur (Koufman & Blalock, 1989). 
Pre-operative voice therapy delivered by a trained SLP has also been shown to be associated with a 
low incidence of prolonged post-operative dysphonia. Lancer et al. (1988) also conducted a 
retrospective long-term follow up on patients who have received voice therapy with or without 
surgery and patients who were treated by surgery alone. The study data was obtained from patients’ 
speech therapy notes, the patients’ medical records, and a questionnaire obtained by return post 
from the patients. It was found that 3 to 5 years post treatment termination, those who received 
voice therapy with or without surgery had a reduced incidence of recurrence.  
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Studies which have examined outcomes at 3 months post therapy have also found that 
treatment benefits have been maintained in the short-term (Blood, 1994; Speyer, Wieneke, van 
Wijck-Warnaar, & Dejonckere, 2003). Blood (1993) reported that their investigated dependent 
variables, including F0, perturbation factor percentage, production of easy onset of air volume, level 
of tension and stress, and self perception of voice, maintained over a 3 months follow-up. It was 
further demonstrated by Speyer et al. (2003) that there were still significant changes 3 months after 
completion of therapy in the voice range profile, characterised by increased improvement at higher 
frequencies and intensities. 
In a recent study, Wenke et al. (2014) compared intensive versus traditional voice therapy in 
the treatment of clients with functional dysphonia, including vocal fold nodules. All of the 
participants were provided a total of 8 hours of treatment, with the intensity of treatment delivery 
varying depending on group allocation. Participants were randomly assigned to either an intensive 
treatment group (four 1-hour treatment sessions per week for 2 weeks) or standard treatment group 
(one 1-hour treatment session per week for 8 weeks). Wenke et al. (2014) found while the intensive 
group showed a greater improvement at 4 weeks follow up when compared with post-treatment on 
the voice handicap and well-being, this was not evident in the standard group.    
Ensuring that behavioural therapy implemented for vocal fold nodules achieves maintenance 
of treatment effects beyond the immediate post treatment period is an area that requires further 
exploration. To assist clinicians to select optimal treatment models for their patients, it is essential 
that both immediate and long term outcomes are available for consideration.  
 
1.3.1.1.5 Absence of Treatment Response 
In contrast to the majority of studies which reported success following behavioural voice 
therapy, a few have failed to demonstrate significant changes in specific parameters following voice 
therapy. Treole and Trudeau (1997) recorded maximum phonation duration for musical notes and 
vowels and the s/z ratio to examine differences before and after voice therapy in a group of women 
with bilateral vocal fold nodules in a retrospective study. After therapy no significant differences 
were found with the s/z ratio or maximum phonation duration. However, the authors also noted that 
most of the participants began with durational measurements near or within normal limits. 
Therefore, it is reasonable to conclude that these values would not have changed drastically over the 
course of treatment.  
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More recently Chernobelsky (2007) performed a retrospective investigation on the treatment 
and results of voice therapy amongst 28 professional classical singers with vocal fold nodules. It 
was stated by the author that they did not share the optimism of most of the people involved in the 
care of singers with vocal fold nodules concerning the responsiveness of appropriate non-surgical 
treatment and voice therapy. They reported that their participants began the treatment with 2 weeks 
of vocal rest followed by ultrasound therapy with corticosteroid ointment in the region of the 
larynx. After the ultrasound treatment, singing lessons for the correction of their vocal technique 
were provided for a period of 2 to 3 months. Their results specifically found no differences in 
speaking F0 pre- and post-therapy. However, there was decrease in values of magnitudes of jitter 
and shimmer and a considerable increase in s/z ratio, which reflected a diminishing in size of the 
nodules and indicated a reduction in the vocal noise. The authors concluded that vocal fold nodules, 
having occurred once, tend to reoccur despite non-surgical treatment and voice therapy. These 
inconsistencies in findings may be a result of variations in the amount and intensity of voice 
treatment selected by investigators. 
 
1.3.1.2 Range of voice programs used to manage vocal fold nodules. 
Even though positive outcomes have been confirmed following voice therapy across a 
diverse phase of studies, there is a great discrepancy in the components of the therapy programs 
administered. In many studies the actual nature of tasks and structure of the therapy program are 
only briefly or even incompletely described. Furthermore, specific information about the intensity 
(e.g., weekly), duration (length of session) and duration of therapy (weeks, months) are not detailed. 
As such, it can be problematic for clinicians to implement many of the programs described into 
their clinical settings for patients with vocal fold nodules. 
 
1.3.1.2.1 Nature of therapy programs.  
In the evidence reported to date, a wide range of different types of therapy programs have 
been used. Van der Merwe (2004) described the use of a voice use reduction (VUR) program, used 
as part of a holistic treatment approach, for clients with small bilateral vocal fold nodules. The 
treatment involved identification and elimination of vocal hyperfunction, avoidance of high risk 
factors, description of problem behaviour in quantitative terms with quantifiable goals set, and then 
application of these self-control were instructed. It progresses through three stages (starting with a 
period of severe voice use reduction, and as the voice improves, progress is made to a period of 
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moderate and then low voice use reduction), with duration of each stage reportedly determined by 
improvement in the condition of the vocal folds, in voice quality, and/or in the subjective 
experience of vocal fatigue, vocal effort, and laryngeal pain by the client. It was found that after 6 
weeks of moderate VUR and during all follow-up examinations, their participant’s vocal fold 
nodules were no longer visible. Acoustic voice analysis showed all parameters had improved or 
were within the normal range. Perceptually, the voice quality improved across time as judged by the 
clinician and participant also reported a decrease in vocal fatigue and vocal effort. An additional 
questionnaire survey was performed by the author to determine how other clients perceived the 
VUR program. Ten women with vocal fold nodules participated in this study. It was concluded that 
all participants agreed to a large extent or completely that the VUR program was an important part 
of their voice treatment. As the study reported on only one case of patient with vocal fold nodules, 
this weekly VUR program requires further research on a larger group study to assess its 
contribution in voice treatment for this population.   
A voice treatment protocol using a computer-assisted biofeedback device was evaluated in 
two women with bilateral vocal fold nodules by Blood (1994). The biofeedback device was a 
Computer-Aided Fluency Establishment Trainer (CAFET) which consisted of respiratory sensor, 
pressure transducer, clip-type microphone, printed circuit board, and plugs into a compatible 
microcomputer. The software provided coloured computer graphics for visual feedback and 
functions in real time. Their voice treatment package (12 sessions of treatment) involved seven 
components: review of anatomy and physiology of laryngeal musculature, with normal and 
pathologic vocal folds voice production and education; identification of misuses and abuses of the 
voice; establishment of a monitoring program for abuse and misuse reduction; transfer of the “new 
voice” to daily living activities; establishment of correct respiratory and supportive breathing habits 
using CAFET; establishment of easy onset of air volume using CAFET; and  relaxation training 
(Blood, 1994). It was found the voice treatment was effective in improving the voice, as 
demonstrated by elimination of the vocal fold nodules, subjective data (ratings of the voice by 
subjects and naïve listeners), and objective data (changes in F0, maximum phonation time, 
perturbation factor percentages, breathing errors, and slow rise in volume). Both patients were 
examined via indirect mirror laryngoscopy following voice treatment and it was reported both had 
normal vocal folds. This treatment protocol using CAFET however, does not seem to be reported in 
the recent literature and may not be commonly used. Whilst it has potential as a part of the voice 
treatment for vocal fold nodules, it is unknown if CAFET continues to be in use by clinicians. 
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Verdolini-Marston, Sandage, and Titze (1994) investigated on the effect of hydration 
treatment on six patients with either vocal fold nodules or vocal polyp. The hydration and 
placebo/control treatment was given on an intensive daily basis (5 consecutive days during 
consecutive weeks). For the hydration treatment, participants were instructed to drink eight or more 
glasses of water per day and take one teaspoon of a hydration medication (Robitussin expectorant, a 
mucolytic) three times per day at about six hour intervals, and were exposed to high humidity 
environments in the clinic. For the placebo/control treatment, participants were instructed to 
perform eight or more sets of 20 bilateral forefinger flexion per day and take one spoon of an herbal 
medication (actually cherry syrup) three times per day at approximately six hour intervals and were 
exposed to a room with commercial air filters and scented candles for 2 hour daily in the clinic. In 
addition to the tasks given, participants had to observe general voice conservation and hygiene 
measures by limiting heavy voice use, as well as alcohol and caffeine intake and exposure to smoke. 
It was found general benefits were obtained from both the placebo/control and hydration treatments, 
but overall significantly greater benefits were obtained from the hydration treatment.  
Later, Verdolini-Marston et al. (1995) compared two methods of treatment (confidential 
voice therapy and resonant voice therapy) on 13 women with vocal fold nodules using 
measurements of phonatory effort, auditory-perceptual status of voice and laryngeal appearance. 
Confidential voice therapy involved the production of a minimal intensity, low effort, and 
somewhat breathy phonation mode, similar to speaking confidentially at close distance. In contrast, 
resonant voice therapy involved the patients to feel the vibratory sensations on the alveolar ridge 
and other facial plates during phonation, but this approach does not necessarily require quiet voice 
output. The authors found following 2 consecutive weeks of intensive treatment (i.e., nine sessions 
of 1 hour each over 12 days) that both types of voice treatment showed improvements. However, 
the benefits directly co-varied with estimates of ongoing compliance (extra-clinical utilization of the 
therapy technique following therapy discontinuation), but not with therapy type.  
    
1.3.1.2.2 Variability in duration and intensity of treatment. 
Whilst various voice therapy approaches have been found to be effective for individuals 
with vocal fold nodules, to date no studies have provided evidence or clear guidelines as to the 
optimal intensity or duration of voice therapy for clients with vocal fold nodules. Across the 
treatment studies conducted, there is considerable variation in the duration of the therapy provided. 
Some studies on various voice disorders claim significant (short-term) improvement after one single 
treatment session, whereas others describe the need for a long series of sessions (e.g., 4 to 6 
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months) (Speyer, 2008). It was suggested through a survey by Mueller and Larson (1992) that voice 
treatment time depends on diagnosis and it is usually less than 15 hours (i.e., 6 to 10 hours). 
Similarly, Colton et al. (2006) have suggested that at least 6 to 8 weeks of once a week voice 
therapy is necessary for improvement in vocal behaviour. In contrast, Verdolini Abbott (2008) 
suggested that once to twice weekly, for 4 to 8 weeks is a preferable level of treatment intensity to 
effect vocal change. Consequently, the optimal intensity of voice therapy for vocal fold nodules 
remains unresolved.  
In some studies of vocal fold nodules, the number of sessions or duration of voice treatment 
was reported in days, weeks, or years (Pannbacker, 1999). McCrory (2001) stated in over 90% of 
clinical records audited, participants required a range of 2 to 12 sessions of therapy. Lockhart et al. 
(1988) investigated the time scales for treatment for various laryngeal pathology and they cited a 
range of 2 to 16 sessions of voice therapy for vocal fold nodules in the two centres evaluated. A 
review of the studies of voice therapy for vocal fold nodules showed duration of voice treatment 
varied from 10 consecutive days (Verdolini-Marston et al., 1994) to more than 2 years (Schneider, 
1993) while the intensity of voice treatment varied from daily intensive sessions (Verdolini-Marston 
et al., 1994; Verdolini-Marston et al., 1995) to the most commonly reported weekly sessions 
(Behrman, Rutledge, Hembree, & Sheridan, 2008; Holmberg et al., 2001; Holmberg et al., 2003; 
Niebudek-Bogusz et al., 2008b; Niebudek-Bogusz et al., 2008a; Schneider, 1993; van der Merwe, 
2004). However, several of the earlier studies did not provide any information about the duration 
and intensity of treatment delivered (Fisher & Logeman, 1970; Hufnagle & Hufnagle, 1984; Murry 
& Woodson, 1992).  
Traditionally, the model of voice therapy delivery typically involves one or two 40 to 45 
minute sessions per week for a course of 8 weeks (Patel et al., 2011). However, high dropout rates 
coupled with reduced success rates of traditional voice therapy have been reported (Hapner, 
Portone-Maira, & Johns, 2009; MacKenzie, Millar, Wilson, Sellars, & Deary, 2001; Portone et al., 
2008; Roy et al., 2003; Sellars et al., 2002; Smith, Kempster, & Sims, 2010) and will be discussed 
later in this chapter. Therefore, the need for the development of new approaches to voice therapy 
delivery to improve treatment success is evident. A novel approach for intensive short-term voice 
therapy (provided 1 to 4 days with 4 to 7 hours of therapy per day), also known as “boot camp” 
voice therapy was developed at the University of Wisconsin (Patel et al., 2011). Thibeault, Zelazny, 
and Cohen (2009) claimed that the “boot camp” voice therapy which involves a multi-clinician, 
intensive approach appears to yield improvements in a short period of time. The benefits of the 
“boot camp” include: increased patient confidence in the ability to effect change; voice 
improvements in a short period of time; multiple perspectives from several clinicians and specialists 
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in decision making for complex clients; and clients enhanced knowledge of tasks for home practice. 
This treatment follows theories of motor learning (Thibeault et al., 2009). Patel et al. (2011) stated 
that high-intensity training may better mimic cognitive, motor, and physiological requirements of 
activities of daily living than traditional therapy. Potential advantages of intensive treatment are 
that: rigorous practice (overload) is possible; simultaneous interventions can be conducted for 
multiple components involved in voice production; opportunities for specificity and individuality 
and facilitating transfer of learned skills, which may influence patient compliance all readily 
available. However, the drawback of this novel approach is that this type of high-intensity training 
may not be available in all types of facilities due to inadequate resources. For example, the number 
of trained professionals and equipment. Currently, more studies are needed to determine whether 
intensive short-term voice therapy is efficacious and cost-effective, compared with traditional voice 
therapy, for chronic dysphonia (Patel et al., 2011). In addition, it is important to further explore 
treatment schedules based on the principles of motor learning in order to determine optimal 
treatment dosage. 
 
1.4 Principles of Motor Learning 
Speech production is a motor skill, thus the physical aspects of vocal rehabilitation programs 
are also dependent on the principles of motor learning (Rammage, Morrison, Nichol, & Pullan, 
2001). Therefore, efficacy of vocal rehabilitation is likely to be influenced by principles of motor 
learning. According to Schmidt and Lee (2005), motor learning is a set of processes associated with 
practice or experience leading to relatively permanent changes in the capability for movement. 
Principles of motor learning can inform clinicians and researchers about training factors that may 
facilitate the acquisition of novel motor patterns (Yiu, Verdolini, & Chow, 2005). Conditions which 
assist in motor learning are inclusive of an understanding of the purpose and expected sensory 
results of a simple movement pattern; observations of individuals producing the correct movement 
pattern; observations of individuals learning the movement pattern; repeated “rehearsals” of the 
movement pattern; and use of sensory feedback to correct inappropriate responses and confirm 
appropriate responses. Motor learning is also facilitated by a number of factors pertaining to the 
structure of practice, stimulus selection, and the nature of feedback. These factors are components 
of all behavioural treatment programs. Voice therapy involves learning new motor skills, relearning 
previously efficient patterns, eliminating mislearned patterns, adjusting and coordinating their voice 
mechanism through practice so that they can phonate effectively with minimal effort. As such, 
principles of motor learning can and should be applied to voice therapy (McIlwaine, Madill, & 
McCabe, 2010). 
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It is known that the practice of a skill, whether motor or perceptual, is equated with the 
learning of it. However, true learning as defined in the cognitive and motor learning domains 
requires both long-term retention and generalization of the skill (Bergan, 2010). Long-term 
retention refers to performance levels after completion of practice. An improved capability for 
skilled movement should not only be observable during practice but should be retained over time 
(Maas et al., 2008). Generalisation is the ability of that individual to transfer or carry over what has 
been trained into new but similar task (Bergan, 2010). It has been recognised that the primary goal 
is not to improve performance during the therapy session, per se, but rather to maximise learning 
(i.e., retention and/or transfer beyond the therapy session; Maas et al., 2008). There are three 
important principles of motor learning which relate to voice therapy. These include the prepractice 
phase, the amount of practice and the duration of practice. 
 
1.4.1 Prepractice 
Prior to learning a new skill, prepractice considerations should be taken into account. 
Prepractice is intended to prepare the learner for the upcoming practice session (Maas et al., 2008). 
That is, it is the phase where the client acquires a basic knowledge of what the task is and how to 
perform it through conscious and focused attention on the movement. The practice phase, however, 
allows the client to improve their proficiency, accuracy and speed of performing the targeted skill 
such that the movement is “learnt” (maintained and generalised) and produced without conscious 
attention to its execution (McIlwaine et al., 2010).  
It is important that a person is motivated to learn a motor task in order for maximally 
effective learning to occur (Schmidt & Lee, 2005). Motivation may be enhanced by understanding 
the relevance of the practice task for the overall goal, i.e., improved voice production. It is also 
important that the learner sees the task as one that is desirable to learn and why it would be useful to 
have a certain skill. In addition, in order to focus on the desired long-term change, the client and 
clinician may together identify a functional goal that allows them to determine when therapy has 
been successful (Verdolini Abbott, 2008). After the learner has become motivated to learn the task, 
it is important to give the person some information about the task to be learned before he or she 
actually physically practices the task (Schmidt & Lee, 2005). Ways of doing this may be with, for 
example, videotapes, verbal instructions, and demonstrations. McIlwaine et al. (2010) suggested 
that instructions given during the prepractice phase of voice therapy should be short, simple, and 
focused on the sound of the voice (i.e., voice clarity), or on the sensations associated with 
successful production, rather than contractions of laryngeal, respiratory, pharyngeal, or oral 
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musculature. However, instructions alone are known to be rather ineffective as aids to learning 
motor skills, but they can be used along with other techniques to greatly facilitate initial 
performance. One method of achieving this is to demonstrate the skill so that learners can directly 
observe the elements of the action. The learner can then model the action during initial practice.  
Moreover, feedback on the accuracy of initial movement attempts is essential as a client 
needs to be aware that they are performing a movement incorrectly in order to attempt new, more 
accurate movements (Hodges & Franks, 2002). The prepractice components may vary with 
additional motor requirements, learner characteristics and with the characteristics of the 
instructor/speech-language pathologist, including their skills, knowledge, attitudes, beliefs, and 
motivation (McIlwaine et al., 2010). In general, prepractice consideration may lead clinicians to 
greater learning condition for the patients and may in turn guide the patient to better compliance.  
Although there has been a general consensus that prepractice is an important phase for voice 
treatment, to date there has been limited literature describing this component of therapy as a major 
element in programs. An investigation by Behrman (2006) discussed the use of motivational 
interviewing (MI), which is a therapeutic approach may have the potential to facilitate the 
therapist’s ability to elicit adherence to behavioural change. MI should be applied through the use of 
expression of empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy 
throughout all aspects of patient–therapist dialogue and this appear to reflect a “spirit ” of 
interpersonal communication (Behrman, 2006). This is in-line with one of the prepractice 
components mentioned above, that is establishing motivation by having clients actively involved in 
setting goals (McIlwaine et al., 2010).  
 
1.4.2 Amount of Practice 
Another important principle of motor learning relates to the actual amount of practice 
required to learn a motor skill. A recent review of the principles of motor learning by Maas et al. 
(2008) indicated that increasing the amount of practice results in greater retention (maintenance). 
However, a larger number of trials in a constant practice condition may lead to learning highly 
specific aspects of a task (producing high accuracy during practice) but very limited transfer 
(generalization). Although many speech treatment programs recommend a large number of trials, 
there is no empirical data to guide this recommendation. For example, the LSVT
®
, a program 
developed to treat the voice and speech deficits associated with Parkinson’s disease, involves a 
large amount of practice as an integral component of treatment (Ramig et al., 1994). 
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As discussed in detail in section 1.3.1.1.6 above the amount of practice currently documents 
in treatment efficacy studies for vocal fold nodules varies greatly from hours to months. Mueller 
and Larson (1992) suggested through survey that that voice treatment time usually requires less than 
15 hours (i.e., 6 to 10 hours) depending on the diagnosis. Correspondingly Colton et al. (2006) have 
suggested in order to have improvement in vocal behaviour, at least 6 to 8 weeks of once a week 
voice therapy is necessary. Whilst most studies have claimed success with voice therapy on a once 
weekly basis, Verdolini Abbott (2008) suggested a more intensive approach of once to twice 
weekly, for 4 to 8 weeks is a preferable level of treatment intensity to effect vocal change.  
 
1.4.3 Distribution of Practice 
Another variable which may have an effect on learning the skill being practised is the 
distribution of practice. Distribution across several days is encountered frequently in clinical 
settings, and treatment intensity is often debated at individual therapy planning meetings. Thus, a 
predominant area of research in motor learning is concerned with determining the best way to 
distribute the time spent in work (or “training”) versus the time spent resting. Typically, researchers 
have described practice sessions as either massed or distributed, depending on the relative amounts 
of performance and rest that take place during practice (Schmidt & Wrisberg, 2008). In massed 
practice, all the practice periods occur very closely together with little or no rest time in between 
periods of practice. In a spaced practice schedule, the time interval between the practice periods is 
increased significantly, allowing periods of “x” number of hours, days, weeks, or months to go by 
before another practice period is scheduled (Bergan, 2010).  
Few empirical data exist on the effects of practice distribution in speech and voice motor 
learning. With the LSVT
®
 program, which involves relatively massed practice (four treatment 
sessions per week for 4 weeks; Ramig et al., 1994), long- term voice treatment benefits have been 
observed for patients with dysarthria associated with Parkinson’s disease. While the standard 
LSVT
®
 treatment involves 16 sessions of therapy delivered over a 4-week period, a study by 
Spielman, Ramig, Mahler, Halpern, and Gavin (2007) examined the effects of an extended (16 
sessions over 8-weeks) LSVT
®
 program in 12 individuals with dysarthria secondary to Parkinson’s 
disease. Although the number and duration of treatment sessions was the same as in the typical 4-
week LSVT
®
 program, they were simply delivered over an extended length of 8 weeks. The 
extended treatment program did result in participant improvement and results were similar to those 
obtained in a previous study using the more traditional 4-week LSVT
®
 (Ramig, Sapir, Fox, & 
Countryman, 2001). In other words, no differences were observed in the amount of learning 
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between traditional and extended LSVT
®
 versions, suggesting that the more distributed practice did 
not appear to enhance learning relative to more massed practice. However, Spielman et al. (2007) 
did comment that the extended LSVT
®
 program increased the time commitment for both client and 
clinician, in particular for unbillable preparation time. This is an important consideration, as issues 
such as longer time commitments may be a factor which could influence patient adherence with 
therapy (as discussed further in section 1.5 below). 
Research involving intensive voice treatment for functional dysphonia has been conducted 
using both massed and distributed practice (Fischer et al., 2009; Wenke et al., 2014). Fischer et al. 
(2009) conducted a study on the effectiveness of an intensified multimodal rehabilitation program, 
consisted of daily therapies provided by SLP, physician, physiotherapist, massage therapist and 
psychologist. Following 2 weeks of intensive voice treatment, individuals with functional 
dysphonia were found to have benefited from the voice therapy in terms of patients’ self-perception 
of voice handicap and well-being. However, the subjective restoration in patients seems to depend 
on the severity of the baseline overall voice handicap, i.e., patients with high handicap values may 
need longer rehabilitation phase owing to the influence of contextual factors. The authors 
considered their 2 week therapy approach to be more advantageous from the patients’ point of view 
as the treatment course is much shorter, more intensive and is holistic in nature compared with the 
usual functional treatment approach.  
Similar issues were noted in a recent investigation conducted by Wenke et al. (2014) in 
which a massed versus distributed practice schedule was compared in the treatment of clients with 
functional dysphonia. All of the participants were offered a total of 8 hours of treatment, with the 
intensity of treatment delivery varying depending on group allocation. Participants were randomly 
allocated to either an intensive treatment group (four 1-hour treatment sessions per week for 2 
weeks) or standard treatment group (one 1-hour treatment session per week for 8 weeks). Although 
some have cautioned against interventions ‘‘over-dosing’’ on voice therapy because of the potential 
risk of damage to laryngeal tissues (Roy, 2012), Wenke et al. (2014) found there were positive 
outcomes of the intensive treatment, with no adverse effects on vocal function being documented 
for their participants. It was reported by their treating clinicians that the standard group spent a 
greater amount of time spent in the prepractice phase of intervention (i.e., revising acquisition of 
basic vocal strategies from the previous week), whereas intensive group spent more time on the 
practice phase of intervention (i.e., maintenance and generalisation). The authors also found that 
although the two treatment groups showed comparable positive outcomes relating to voice handicap 
immediately after treatment, there was significantly higher attendance in the intensive group. In 
addition, while the intensive group showed a greater improvement at 4-weeks follow-up when 
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compared with post-treatment on the voice handicap and well-being, this was not evident in the 
standard group. This finding may indicate that the intensive treatment schedule potentially 
enhanced motor learning and provide greater opportunity for the individuals to consolidate the 
learnt vocal techniques and vocal hygiene behaviours day-to-day (Wenke et al., 2014).   
Schmidt and Lee (2005) suggested that although it is clear that practice-distribution effects 
have important implications for the design of training sessions for learning motor skills, the applied 
nature of this work seems to be insufficient to drive sustained research in this area. In a recent 
review on voice therapy and the principles of motor learning by McIlwaine et al. (2010), it was 
suggested that research needs to be conducted to clearly establish which combinations, parameters, 
and intensities of prepractice components are essential to optimise motor learning in order to 
determine a set of evidence based practice guidelines for the prepractice phase of voice therapy. To 
date, no study has been performed to discuss the practice-distribution effect specifically in the 
management of vocal fold nodules. 
 
1.5 Treatment Attendance and Adherence 
In order to achieve positive treatment outcomes, another important factor to consider is the 
need for consistent attendance and patient adherence to therapy. A large portion of voice therapy 
requires patients to play a highly active role in their own vocal improvement due to the demands of 
behaviour change and practice outside therapy. To reinforce behaviour change, patients must 
schedule and complete voice exercises; they must self-monitor and self-correct movements; must 
often change interaction or parenting style; and it has been noted that voice therapy patients must 
resist reverting to problematic behaviour in social settings (van Leer & Connor, 2010). Therefore, 
the efficacy of voice therapy can be limited by the degree to which clients attend voice therapy 
session and adhere to treatment recommendations (van Leer & Connor, 2010).  
Both non-attendance (dropout) and non-adherence to voice therapy can affect treatment 
success, as well as lead to unnecessary extended duration of treatment of treatment, and repeated 
examinations without sufficient behaviour change to effect improvement. In addition, there can 
potentially be greater personal and societal impacts if clients experience a loss of revenue or even a 
loss of employment due to being unable to meet the vocal requirements of their occupations 
(Portone et al., 2008; Portone-Maira, Wise, Johns, III & Hapner, 2011). Reduced client adherence 
and session cancellations not only lead to emotional frustration for clinicians but also reduced cost 
efficiency of public health services (Wenke et al., 2014). 
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1.5.1 Therapy Attendance and Non attendance (Dropout) 
Clinicians often complain of missed appointments and no shows in the population with 
voice disorders (Portone et al., 2008). Indeed, recent investigations have shown that lack of 
attendance and therapy dropout rates for clients are high in this population (Hapner et al., 2009; 
MacKenzie, et al., 2001; Portone et al., 2008; Roy et al., 2003; Sellars et al., 2002; Smith et al., 
2010). Roy et al. (2003) had 16% of their 81 participants dropout over 6 weeks in a clinical trial 
comparing three therapy approaches involving teachers with dysphonia. Sellars et al. (2002) found 
18% of 100 participants dropped out of therapy prior to completion of a pre-established six-session 
treatment. Similar findings were reported by MacKenzie et al. (2001) with a 25% therapy dropout 
rate of the 204 participants after 6 weeks, with an additional 10% failing to return for therapy at 12 
to 14 weeks. Portone et al. (2008) found 38% of their 125 participants did not adhere to the 
physician’s recommendation to attend voice therapy, and of those who initiated follow-through 
47% did not return after the initial speech-language pathology evaluation. Furthermore, Smith et al. 
(2010) reported 44% of 100 participants reviewed essentially failed to attend voice therapy. The 
highest dropout rate was reported by Hapner et al. (2009) where their retrospective review of 147 
participants revealed 65% of participants did not return for therapy.  
An investigation of voice therapy dropout in a group of participants with dysphonia by 
Hapner et al. (2009) found that there was no significant differences in the patient characteristics of 
their therapy completers and non-completers on a range of variables studied, which included 
general demographics (gender, age, and race/ethnicity), otolaryngology diagnosis, severity of 
quality-of-life handicap, and severity of dysphonia. However, those study findings were not 
supported by a more recent investigation by Smith et al. (2010) which examined the patient-related 
factors to positive voice therapy attendance and outcomes. They found clients with more complex 
laryngeal diagnoses, more perceived vocal severity, occupational issues, more health issues (e.g., 
smokers, higher reports of being under stress, and reports of taking more prescription medications), 
and higher VHI scores at the time of the initial voice valuation may be at greater risk for failing to 
attend voice therapy sessions (Smith et al., 2010). It has also been proposed that treatment 
attendance rate may be related to patient motivation for voice therapy. It has been indicated that the 
lack of motivation and availability for behaviour change may be the factors related to treatment 
adherence and the completion of voice therapy (Duarte de Almeida, Santos, Bassi, Teixeira, & 
Côrtes Gama, 2013).  
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In a retrospective review by Portone-Maira et al. (2011) difference in variables between 
voice therapy completers and dropouts was explored and the strongest predictor of completing 
therapy was the number of sessions attended. For each additional session attended, after the initial 
voice evaluation, a patient was 1.6 times more likely to complete therapy. The second significant 
predictor variable found was the waiting period between otolaryngology referral and speech-
language pathology evaluation. For each week of delay in referral to therapy, the individual was 0.1 
times less likely to complete therapy. Authors suggested that clients are more likely to follow 
through with a referral when they are educated regarding the purpose and likely outcome of that 
referral.  
In addition to patient factors, there may be a number of other variables which could 
influence non-attendance and failure to complete therapy programs such as the frequency, timing, 
and duration of voice therapy (Portone-Maira et al., 2011). In research and clinical practice, the 
duration of voice therapy varies widely as discussed in earlier sections of this chapter. To date, there 
has been limited investigation on the optimal duration and its relationship with client 
attendance/adherence for voice therapy. In an investigation of voice therapy of individuals with 
hyperfunctional disorder, Andrews, Warner, and Stewart (1986) reported their therapy was 
delivered once weekly from as few as 4 weeks up to as many as 36 weeks. Attendance ranged from 
42% to 100% of the sessions offered. The authors failed to find a strong relationship between 
duration of rehabilitation and attendance, noting that participants who had better attendance records 
did not consistently require fewer sessions than others. However this area requires further 
exploration, as it is conceivable that if patients know they can complete therapy in an intensive and 
time efficient manner (i.e., in 3 weeks), rather than spread out over months, it is possible that there 
may be greater motivations to complete treatment. 
 
1.5.2 Therapy Adherence and Non-adherence 
Apart from to treatment attendance, treatment adherence is also another important factor 
than can impact treatment outcomes. Adherence may be defined as the extent to which people 
follow through with agreed-upon or prescribed actions, or do what the clinicians expect them to do, 
where treatment is concerned (Zweben & Zuckoff, 2002). It has been acknowledged as a potentially 
significant variable in voice therapy outcome in overview of treatment practices (Behrman, 2006; 
Pannbacker, 1998; Portone et al., 2008; Smith et al., 2010). Adherence with voice therapy involves 
regular attendance at voice therapy sessions and consistent practice of vocal behavioural changes 
within communicative activities of daily living (Behrman, 2006). However, as with every other 
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behaviour change therapies, there are problems of resistance to change, therapy dropout and lack of 
follow-through outside the therapy session (Behrman, 2006; Hapner et al., 2009; Portone et al., 
2008).  
Several reasons a client may or may not follow through with the voice therapy include: 
client specific issues, clinic-related factors, and economic issues (See Table 1.2). It is possible that 
perceived commitment to long term therapy may also influence therapy attendance and adherence. 
In 2010, van Leer and Connor investigated the patient perceptions of voice therapy process and 
suggested that self-regulatory behaviour, sensory-motor learning, and therapeutic alliance all play a 
role in voice therapy adherence. The study also found that adherence with behavioural voice 
therapy is a process that requires motivation, commitment, learning, self-regulation, and a good 
relationship with the therapist (van Leer & Connor, 2010).  
It is also postulated that strong physician support may add urgency and importance to the 
voice therapy endeavour (van Leer & Connor, 2010). Patients are less likely to see an 
otolaryngologist if they are unable to discuss the need for referral to a specialist with their primary 
care physician (Portone et al., 2008). A study conducted by Buck, Drinnan, Wilson, and Barnard 
(2007) found that although all participants perceived that treatment was likely to help, they believed 
that the dysphonia would be less amendable to recovery as time went on. Hence, decreased 
motivation and poor adherence to treatment are often related to patient misconceptions about 
treatment and concerns regarding potential adverse effects (Duarte de Almeida et al., 2013). 
According to Duarte de Almeida et al. (2013) patient’s self-perception of quality of life is also 
related to the adherence to voice therapy. It was found patients with improved quality of life were 
most adherent to the therapy compared with those subjects with poorer quality of life (i.e., patients 
with higher self-perception of dysphonia and greater negative impact on quality of life related to 
daily and work activities, adhered less to therapy). The relationship of adherence to treatment 
outcome was studied by Verdolini-Marston et al. (1995) in a group of 13 women with vocal fold 
nodules randomized to two weeks of confidential voice therapy, resonant voice therapy, or to a no-
treatment control condition. It was found that adherence had a greater effect on outcome than did 
the type of treatment.  
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Table 1.2  
Summary of Factors Related to Treatment Adherence 
Categories   Factors 
Client specific issues Perception of disease severity 
Client-clinician rapport 
Cultural norms 
Family support 
Self-efficacy 
Certain patient characteristics 
Lack of clinician empathy 
Loss of interest in the therapeutic process 
Lack of significant change  
Lack of provision of adequate client education  
Unawareness of patient readiness of change 
Lack of follow up support 
Lack of communication between speech-language pathologist and  
physician 
Distance to the clinic. 
Clinic-related factors Inflexible scheduling 
Long wait time from making an appointment to being seen 
Lack of reminder calls 
Difficulty in accessibility of clinic location. 
Economic issues Difficulty arranging transportation to and from sessions 
Insurance denial 
Inability to secure time off from work to attend sessions 
Note. Compiled from Murry and Woodson, 1992; Portone et al., 2008; Sharp and Hamilton, 2001; Smith et 
al., 2010; van Leer et al., 2008. 
 
 
Some studies have been conducted in attempt to facilitate patient’s adherence to voice 
therapy. These have explored changes to the nature and delivery of therapy. A number of these 
studies have found that not only is direct voice production therapy more effective, patients also find 
it easier to adhere to the direct therapy than to the vocal hygiene education (indirect voice therapy) 
(Behrman, Rutledge, Hembree, & Sheridan, 2008; Ziegler, Dastolfo, Hersan, Rosen, & Gartner-
Schmidt, 2014). This finding is support by the motor learning theory, which states that repetitive 
practice (direct therapy) facilitates learning more than explanation of ‘‘how’’ the voice works (a 
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component of indirect therapy; Behrman et al., 2008). Furthermore, Behrman et al. (2008) found on 
average, participants in the direct voice production group maintained their adherence during the 
self-study period, whereas those in vocal hygiene education did not. Therefore, to increase 
treatment adherence clinicians should spend more time on teaching direct voice production 
techniques during therapy sessions. In addition, current literature has shown attending to 
conversational speech tasks earlier in therapy may potentially engage patients in the therapeutic 
process by starting with relevant tasks, thereby reducing therapy attendance (Ziegler et al., 2014). 
In a recent study, investigators assessed whether portable video examples of voice-therapy 
exercises result in more frequent practice and greater motivation for practice than written 
homework descriptions outside of therapy sessions (van Leer & Connor, 2012). The study results 
demonstrated a statistically significant positive effect of portable video therapy examples on 
practice frequency and motivation when compared with a standard of care written condition. It was 
found patient adherence to voice therapy was increased without changing the treatment 
components. As a result clinicians may be able to improve their patients’ adherence through a 
feasible method that does not require increased time from the patient or the clinician (van Leer & 
Connor, 2012).  
Motivational interviewing, which is a style of interpersonal communication in which 
resistance is minimized through the use of skilful listening in a directive, constructive discussion 
about behaviour change, has also been claimed to enhance treatment adherence. The MI framework 
considers patient motivation as a dynamic state of readiness to change. Within this framework, the 
patient’s hesitation to change is normal and even expected. Hesitation and resistance are related to 
interaction style. Therefore, SLP shares in the responsibility for eliciting adherence to therapy 
(Behrman, 2006).  
 
1.5.3 Attendance and Adherence data Specific to Vocal Fold Nodule Therapy 
To date, only one study has been published on voice treatment adherence of individuals with 
vocal fold nodules, while none has reported on the treatment attendance. Furthermore, no 
investigation has explored the impact of barriers to access service has on the treatment adherence 
and attendance with individuals with vocal fold nodules. The only study reported to date examined 
the adherence to instructions about general voice hygiene practices and the ongoing adherence 
following therapy termination, i.e., of the relative continued utilization of the therapy technique 
after therapy was discontinued (Verdolini-Marston et al., 1995). The authors found participants, 
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regardless of the type of treatment groups, all appeared to follow instructions on general voice 
hygiene practices to about the same degree. They also indicated that adherence following 
discontinuation of therapy appeared to be a predictor of longer term improvements in phonatory 
effort and in auditory perceptual ratings with therapy, and is not related to the type of voice therapy 
received. 
 As one of the obstacles to begin voice therapy is the challenges of making time to attend 
sessions, one way to address this may be to propose a change in service delivery model, 
telepractice. In this way, voice therapy may become more convenient and accessible to people with 
vocal fold nodules. In turn, it is postulated that this change in service may enhance treatment 
attendance and adherence. 
 
1.6 Alternative Method of Service Delivery: Telepractice 
In addition to the need for further evidence to support intensive vice therapy, there is also a 
need to explore new models of service delivery. Although there is evidence to support the efficacy 
of voice therapy for vocal fold nodules, access to services remains a potential factor which can limit 
patients from both seeking and receiving services. Hence, in order for more patients to benefit from 
voice therapy, there is a need to explore ways to facilitate greater access to voice therapy to 
potentially help maximise attendance and ultimately enhance outcomes for people with vocal fold 
nodules. To date the majority of service models examined has focused on therapy delivered via 
traditional face-to-face (FTF) delivery modes. However, the FTF clinical model may not be 
possible for many patients due to multiple factors such as inflexible work conditions, absence of 
locally available services and travel distances. Therefore, there has been increasing interest in the 
development of alternative models of service delivery for managing patients with vocal fold 
nodules. One potential solution is the use of telepractice. 
A growing body of evidence is available in speech-language pathology to support the use of 
telepractice, in which therapy services are provided at a distance (Keck & Doarn, 2014; Theodoros, 
2008). Speech pathology services in general appear to be well-suited to telepractice delivery due to 
the audio-visual nature of the patient-clinician interaction in most consultations. Studies have 
compared the accuracy of online assessment and the effectiveness of online treatment with FTF 
service across a range of areas of speech pathology practice. To date the finding have been very 
positive with no significant differences found between traditional and FTF methods of service 
delivery across populations with various speech, language and swallowing disorders (Brennan, 
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Georgeadis, Baron, & Barker, 2004; Carey et al., 2010; Constantinescu, Theodoros, Russell, Ward, 
Wilson, & Wootton, 2010; Duffy, Werven & Aronson, 1997; Georgeadis, Brenna, Barker, & Baron, 
2004; Lasker, Stierwalt, Spence, & Calvin-Root, 2010; Mashima et al., 2003; Theodoros & Russell, 
2008, Tindall, Huebner, Stemple, & Kleinert, 2008; Ward & Burns, 2014; Ward, Burns, Theodoros, 
& Russell, 2013; Ward, Burns, Theodoros, & Russell, 2014).  
Specifically with respect to voice therapy, a small number of studies have explored the use 
of telepractice with neurogenic and functional voice disorders. The majority of the current evidence 
relates to the feasibility and validity of the online assessment and treatment of the voice disorder in 
Parkinson’s disease using the LSVT®  (Constantinescu et al., 2010; Constantinescu, Theodoros, 
Russell, Ward, Wilson, & Wootton, 2011; Howell, Tripoliti, & Pring, 2009; Tindall et al., 2008; 
Theodoros et al., 2006). It has been shown that online assessment of the speech and voice disorders 
associated with Parkinson’s disease was generally reliable and valid and the results are comparable 
to the FTF assessment (Constantinescu et al., 2010). Further support for the use of telepractice has 
been shown in studies comparing the outcomes of LSVT
®
 delivered remotely to the outcomes of 
traditional treatment delivered FTF. Investigators have reported post-treatment improvements 
achieved following remote LSVT
®
 and a similar magnitude of treatment effects was shown when 
compared with the FTF group (Constantinescu et al., 2011; Tindall et al., 2008; Theodoros et al., 
2006). The benefits for such remote intensive voice treatment were that it may assist in reducing the 
effects of physical disability, and eliminates the need to travel to a hospital or clinic when transport 
and travel difficulties are encountered (Constantinescu et al., 2011; Tindall et al., 2008). 
Currently, only one investigation has explored the use of telepractice with a group of 
patients with functional voice disorders, including some patients with vocal fold nodules (Mashima 
et al., 2003). In the study, participants were treated via either conventional therapy or telepractice. 
All of the therapy sessions for the remote group were delivered in adjacent rooms via a real-time 
audio-video monitoring system. The system consisted of Sony Hi-8 video cameras with remote 
lapel microphone and colour monitors. In addition, FTF contact between patient and clinician was 
minimised as much as possible during the course of the conventional treatment protocol. The results 
revealed improvements in voice quality, acoustic and physiological parameters after voice treatment 
in both the conventional group and telepractice group. The investigators reported that no significant 
differences were found between groups, indicating that voice therapy delivered remotely was as 
effective as therapy delivered conventionally (Mashima et al., 2003). The authors suggested that the 
use of telepractice would be helpful in overcoming the barrier of geographic distance and 
eliminating the commute time to the clinics, which interfered with work schedule. It was also 
suggested the use of telepractice would overcome physical and structural barriers of needing the 
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patients and healthcare provider to be in the same location. In a later discussion article about this 
service, Mashima and Holtel
 
(2005)
 
commented on the potential of telepractice service model to 
increase accessibility and availability for patients with voice disorders.  
Although there is evidence supporting the use of telepractice when treating patients with 
voice disorders, no investigation has been conducted to determine the validity of this mode of 
service delivery specifically for people with vocal fold nodules. Furthermore, no studies have 
explored the possibility of providing intensive voice therapy for vocal fold nodules via telepractice 
which may assist with resolving the adherence and attendance issues. Finally, in the absence of 
multiple studies, further exploration of different telehealth service delivery models is needed to 
examine possible options for therapy delivery via telepractice.  
 
1.7 Aims of the Present Thesis 
Despite considerable research into the efficacy of voice therapy for vocal fold nodules, 
treatment parameters remain poorly defined. In particular, temporal treatment factors such as 
intensity and duration of treatment have not been rigorously investigated despite the importance of 
these factors in underpinning motor learning and directing treatment protocols. To date, the optimal 
dosage of treatment for vocal fold nodules remains unknown. Furthermore, the long term outcome 
of treatment efficacy needs further investigation. The literature also indicates a need for 
investigation of alternate modes of delivery of voice therapy, such as telepractice, in order to 
facilitate client access to effective treatment protocols. 
Hence, the primary aim of the initial series of investigations (Chapters 2-4) described in this 
thesis is to investigate the relative efficacy of therapy programs which differ in duration and 
intensity of voice therapy. The secondary aim explores an alternative method of service delivery for 
clients with vocal fold nodules using telepractice (Chapter 5). The objective of this body of work is 
to ultimately help inform clinical practice and lead to improved service delivery and enhanced 
patient perceptions and functional outcomes.  
The specific sub-aims and hypotheses (all assuming a null hypothesis) relating to the four 
chapters of this PhD thesis are: 
Sub-Aim 1: Investigate the immediate perceptual, vocal fold functions and lesions 
outcomes of patients with vocal fold nodules following intensive voice treatment when 
compared to traditional voice therapy (Chapter 2). 
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Hypothesis 1: Comparable outcomes in perceptual parameters and vocal 
functions and lesions ratings will occur following intensive voice treatment for 
vocal fold nodules compared to traditional voice therapy. 
 
Sub-Aim 2: Explore the immediate acoustic and physiological changes observed in 
cohorts treated via either traditional or intensive voice treatment (Chapter 3). 
Hypothesis 2: Comparable improvement in acoustic and physiological 
parameters of voice will occur following intensive voice treatment for vocal 
fold nodules compared to traditional voice therapy. 
 
Sub-Aim 3: Examine the maintenance of perceptual, acoustic and physiological changes 
observed in patients treated via either traditional or intensive voice treatment (Chapter 4). 
Hypothesis 3: Intensive voice treatment would provide at least comparable 
maintenance of vocal function, voice quality, and patients’ perception of quality 
of life at 6 months post treatment when compared with traditional voice 
treatment. 
 
Sub-Aim 4: Investigate the feasibility, efficacy and related patient satisfaction of a 
telepractice model for delivery of intensive voice therapy for individuals with vocal fold 
nodules (Chapter 5). 
Hypotheses 4: (1) Intensive voice treatment for vocal fold nodules will be 
feasible via telepractice. (2) Intensive voice therapy delivered via telepractice 
will result in in improvements in perceptual, acoustic, physiological outcomes, 
and vocal fold function (3) Participants will express satisfaction with use of 
telepractice as a method of service delivery. 
   
1.8 Overview of the Thesis 
This thesis comprises a total of six chapters with an introductory chapter (Chapter 1), four 
chapters (Chapters 2, 3, 4, and 5) reporting on treatment outcomes, and a final conclusion chapter 
(Chapter 6). Figure 1.1 below has been provided to assist the reader in identifying how each of the 
aims has been addressed in a series of four investigations which are covered in Chapters 2 – 5. As 
this thesis has been submitted under The University of Queensland’s definition of a “partial thesis 
by publication”, each subsequent chapter, with the exception of the first (Chapter 1) and final 
conclusions chapter (Chapter 6), stands as published (or in press) with some additional contextual 
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paragraphs added at the beginning of each chapter. Tables and figures have been embedded in the 
text and references are presented at the conclusion of the thesis. To maintain consistency throughout 
the thesis, Australian English has been used in each chapter. Figure and table numbers, headings, 
page numbers, and general stylistic specifications have been adjusted to align with the guidelines 
set out by the American Psychological Association.  
Chapters 2 to 5 outline a series of investigations examining the effectiveness of intensive 
voice therapy when treating individuals with vocal fold nodules, using either the FTF or telepractice 
service delivery methods. These chapters are presented in accordance with the research objectives 
and aims of the research investigations as per section 1.6 of this chapter. Chapter 2 presents the 
comparison of auditory perceptual and vocal fold functions changes between intensive and 
traditional voice treatment. In this study, 53 participants with vocal fold nodules will be involved, 
and introduces the effects of practice distribution (massed versus distributed practice) in the 
treatment of vocal fold nodules. Chapter 3 provides quantitative results of acoustic and 
physiological parameters using massed and distributed practice. It further supports the use of 
intensive voice therapy and highlights the benefits of massed practice. Although separate 
manuscripts were submitted, the Journal of Voice elected to publish the results of Chapters 2 and 3 
as a combined manuscript in February 2015 (Fu, Theodoros, & Ward, 2015). Chapter 4 examines 
the long-term effects of intensive voice therapy and confirms the potential clinical value of applying 
intensive voice treatment for individuals with vocal fold nodules. Chapter 4 was accepted for 
publication from the International Journal of Speech-Language Pathology in June 2015 (Fu, 
Theodoros, & Ward, in press). Chapter 5 describes an alternative service delivery method, 
telepractice, for providing intensive voice treatment. The objective and subjective measures are 
evaluated to inspect the feasibility and efficacy of this method in this chapter. Chapter 5 was 
accepted by Journal of Voice in December 2014 and published online in February 2015 (Fu, 
Theodoros, & Ward, in press). Finally, Chapter 6 concludes the thesis by summarising the key 
findings in relation to the research aims. In addition, Chapter 6 presents the clinical implications, 
limitations, and directions for future research. 
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Figure 1.1. Schematic flowchart of participants through study 
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1.9 Ethical Approval 
Prior to the commencement of this series of investigations, the project was granted ethical 
clearance by the Institutional Review Board at the Taipei Veterans General Hospital on 22 January, 
2010 (Appendix A) and by the Medical Research Ethics Committee at The University of 
Queensland on 11 October, 2011 (Appendix B). All participants provided written, informed consent 
prior to taking part in this project. 
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CHAPTER TWO 
2 Intensive Versus Traditional Voice Therapy for Vocal Fold Nodules: Perceptual and 
Physiological Changes 
Although the review of the literature presented in Chapter 1 supports the use of behavioral 
voice treatments for the remediation of vocal fold nodules, several problems exist with the available 
evidence and a number of treatment issues remain unanswered. In particular, research to date has 
poorly defined treatment duration and intensity. The vast majority of research into the efficacy of 
behavioural voice treatment suggests a pattern of one or two sessions a week, delivered over a 
course of a number of weeks, typically around 4-8 weeks (Colton, Casper, & Leonard, 2006; 
Verdolini Abbott, 2008) though longer has also been proposed (e.g., 4 to 6 months, Speyer, 2008). 
Consequently, the optimal intensity for voice therapy for vocal fold nodules remains unresolved. 
Furthermore, specific to management of vocal fold nodules, the issue of using a model of intensive 
voice treatment, i.e,. multiple sessions a week for a shorter time period, rather than a weekly sessional 
model, has not been explored. 
Chapter 2 uses quantitative methodology to explore the auditory perceptual and 
physiological effects after intensive voice therapy in comparison with traditional voice therapy. 
This chapter aims to describe the potential benefits of an intensive voice therapy model for patients 
with vocal fold nodules. The insights gained will provide speech-language pathologists and other 
professionals involved in the management of voice disorders with evidence to support practice and 
provide adequate education for patients, which could enhance the clinical needs of this population.  
The content of Chapter 2 has been incorporated in the manuscript entitled “Intensive Versus 
Traditional Voice Therapy for Vocal Fold Nodules” which was published by the Journal of Voice in 
February 2015. Despite submitting the contents of Chapter 2 and 3 as separate manuscripts, it was 
decided by the editor of the Journal of Voice to combine the contents of Chapter 2 and 3 into a 
single large paper for publication purposes. For the purposes of this thesis, the contents of Chapter 2 
and 3 were again separated, and are inserted here as originally submitted to the journal as 
independent papers. Content and formatting is as partially published in the larger manuscript, with 
the exception of formatting and referencing changes that have been made to align with the style 
guidelines of the American Psychological Association and to maintain consistency throughout the 
thesis. A copy of the full, combined published manuscript can be found in Appendix C. All 
references are listed at the end of the thesis. The references specific to this published paper have 
been included in the overall reference list of this thesis. 
52 
 
2.1 Abstract 
Summary: Objectives. To investigate the perceptual and physiological outcomes of patients with 
vocal fold nodules following intensive voice treatment compared to traditional voice treatment 
model.  
Study Design: Pragmatic randomised clinical trial 
Methods: Fifty-three women diagnosed with bilateral vocal fold nodules participated in the study.  
All participants completed one session of vocal hygiene and eight sessions of direct voice therapy in 
either a Traditional Voice Therapy (TVT) format of eight sessions over 8 weeks (n = 29) or in an 
Intensive Voice Therapy (IVT) format of eight sessions over 3 weeks (n = 24). Voice recordings and 
stroboscopic recordings were made prior to voice treatment, after vocal hygiene education, and 
immediately post voice treatment.  
Results: Perceptual and physiological parameters improved in both treatment groups immediately 
after treatment. There were physiological improvements after vocal hygiene while no perceptual 
changes were found in either group. No differences in outcomes between the IVT or TVT 
treatments were noted at any time point.  
Conclusions: The investigation provided initial evidence that individuals with vocal fold nodules 
are able to recover voice function and vocal health through an intensive voice treatment model. The 
results suggest comparable positive perceptual and physiological outcomes from IVT compared 
with the TVT model of delivery. 
 
Keywords: vocal fold nodules, vocal hygiene, voice treatment, perception, physiology  
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2.2 Introduction 
Vocal fold nodules are benign lesions of the vocal folds caused by repetitive mucosal injury 
leading to histological changes and concomitant voice mutation (Kent & Ball, 2000). Their 
presence causes dysphonia, which is perceived as breathy with various degrees of turbulent noise, 
strained vocal quality, roughness, instability and vocal fry/creak, with a tendency towards a low pitch 
(Aronson & Bless, 2009; Aronsson, Bohman, Ternstrom, & Soderten, 2007; Colton, Casper, & 
Leonard, 2006). The dysphonia results from the change in the vibratory pattern caused by an increase 
in vocal fold mass. As the vocal fold nodules project into the glottis, they prevent the vocal folds from 
adducting completely both anteriorly and posteriorly to the nodule, causing air-stream turbulence 
(Aronson & Bless, 2009). Consequently, the breathy or husky voice quality associated with the 
presence of vocal fold nodules is the effect of insufficient closure of the folds in the non-adducted areas 
around the nodules. With increasing size and firmness, complete closure of the folds during vibration is 
not easily achieved. Mucosal and vibratory displacement characteristics, viewed stroboscopically, may 
be diminished at the site of thickening, transglottal airflows may be increased, and periodicity of 
vibration is often reduced (Leonard, 2009). Individuals with vocal fold nodules constitute a large part 
of the client population at voice clinics (Holmberg, Doyle, Perkell, Hammarberg, & Hillman, 2003). 
The voice disturbances can cause personal problems and societal losses, as individuals with vocal 
fold nodules in professions with high voice demands are forced to take long periods of sick leave 
and sometimes may have to change careers (Holmberg et al., 2003; Verdolini & Ramig, 2001). 
As a consequence, extensive research has been conducted on the efficacy of treatment for 
vocal fold nodules, with voice therapy recommended as first-line treatment (Blood, 1994; 
Holmberg, Hillman, Hammarberg, Sodersten, & Doyle 2001; Holmberg et al, 2003; Hogikyan, 
Appel, Guinn, & Haxer, 1999; Hufnagle & Hufnagle, 1984; Lancer, Syder, Jones, & Le Boutillier, 
1988; Lockhart, Paton, & Pearson, 1997; Murry & Woodson, 1992; Verdolini-Marston, Burke, 
Lessac, Glaze, & Caldwell, 1995). It has been demonstrated by a number of studies that voice 
quality significantly improves post voice therapy (Blood, 1994; Holmberg et al., 2001; Hufnagle & 
Hufnagle, 1984; Sellars, Carding, Deary, MacKenzie, & Wilson, 2002; Trullinger, Emmanuel, 
Skenes, & Malpass, 1988). With regards to the physiological parameters, it has also been shown 
that following voice therapy there is either marked reduction or complete elimination of vocal fold 
nodules (Blood, 1994; Fisher & Logemann, 1970; Holmberg et al. 2001; Holmberg et al., 2003; 
Lancer et al., 1988; Niebudek-Bogusz, Kotylo, Politanski & Sliwinska-Kowalska, 2008a; 
Niebudek-Bogusz et al., 2008b; Schneider, 1993; Trullinger et al., 1988; van der Merwe, 2004).  
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Although the majority of research conducted to date has demonstrated the positive effects 
voice therapy has on vocal fold nodules, there is considerable variation in the duration and intensity 
of the therapy provided. In fact, no report has provided evidence or clear guidelines as to the 
optimal intensity or duration of voice therapy for clients with this vocal pathology (Holmberg, et al., 
2001; Holmberg, et al., 2003; Lancer, et al., 1988; Niebudek-Bogusz, et al., 2008b; Trullinger, et al, 
1988; Verdolini-Marston, et al., 1995). Standard voice therapy varies widely with respect to 
intensity and duration of intervention. Some studies on various voice disorders claim significant 
(short term) improvement after one single treatment session, whereas others describe a long series 
of sessions (e.g., 4 to 6 months; Speyer, 2008). It was suggested through a survey by Mueller and 
Larson (1992) that voice treatment time depends on diagnosis and it is usually less than 15 hours 
(i.e., 6 to 10 hours). In contrast, Colton et al. (2006) have suggested that voice therapy once per 
week for at least 6 to 8 weeks is necessary while Verdolini Abbott (2008) recommended once to 
twice weekly, for 4 to 8 weeks. Other treatment studies have reported the number of sessions or 
duration of voice treatment in days, weeks, or years (Pannbacker, 1999).  
For voice therapy to be effective, both motor learning and cognitive processes for 
maintenance and transfer of the new vocal behaviour should be considered. However, very little is 
known about the principles and factors responsible for behavioural change during and after voice 
therapy. According to Schmidt and Lee (2005), motor learning is a set of processes associated with 
practice or experience leading to relatively permanent changes in movement. Practice conditions 
include the following: amount and distribution of practice, the variability of practice, the scheduling 
of practice with several different tasks, and part versus whole practice. These independent variables 
affect the learning of motor skills. One variable which may have an effect on learning, and has not 
been widely investigated is the distribution of practice. Practice distribution refers to how a given 
amount of practice is distributed over time (Maas et al, 2008). In clinical settings, a course of 
treatment is frequently distributed across several days, but the intensity of treatment is often debated 
at individual therapy planning meetings. The practice distribution can be massed or spaced. In 
massed practice, all the practice periods occur very closely together with little or no rest time in 
between sessions. In a spaced practice schedule, the time interval between the practice periods is 
increased significantly (Bergan, 2010).  
Few empirical data exist on the effects of practice distribution in speech motor learning. The 
strongest evidence exists for massed practice. For example, the Lee Silverman Voice Treatment 
(LSVT®), which incorporates principles of multiple repetition, high intensity, and high frequency of 
practice (four treatment sessions per week for four weeks), has been shown to result in long-term 
vocal improvements in the speech and voice of people with Parkinson’s disease (Ramig, Bonitati, 
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Lemke, & Horii, 1994; Spielman, Ramig, Mahler, Halpern, & Gavin, 2007). It is postulated that this 
treatment facilitates intensive motor relearning, maximises motor output and effort, increases drive 
and goal directed activity, and enhances sensory awareness to promote internal cueing, self 
monitoring and upscaling of motor output (Ramig, Sapir, Fox, & Countryman, 2001).  
The benefits of massed, intensive practice were also found to be beneficial in the treatment 
of dysphonia (Patel, Bless, & Thibeault, 2011; Thibeault, Zelazny, & Cohen, 2009). In a concept 
article, the authors provided a framework and indications for delivery of intensive short-term voice 
therapy, referred to as “boot camp” (Patel et al., 2011). This involved concentrated practice, using a 
variety of voice therapy techniques, delivered in a concentrated time frame (1 to 4 days with 4 to 7 
hours of therapy per day). This type of therapy was reported to be tailored to the nature of the voice 
disturbance and individual specific needs, thereby maximising the individual’s ability to learn and 
carryover targets to non-clinical environments. The authors stated that this approach can be 
successfully used with various types of dysphonia, especially those who have not been successful 
with traditional voice treatment approach, and with clients living at geographical distances 
sufficiently far from voice centres (Patel et al., 2011). However, clinical trials have not yet been 
conducted on the “boot camp” treatment approach. It was noted by Patel et al. (2011) that high-
intensity training may better mimic cognitive, motor, and physiological requirements of activities of 
daily living than traditional therapy. The potential advantages are that it increases patient 
confidence in the ability to effect change, provides rigorous practice, opportunities for facilitating 
transfer of learned skills, voice improvement in a short period of time, and enhances patient 
knowledge of tasks for home practice (Patel et al., 2011; Thibeault et al., 2009). 
Whilst studies which have used intensive, massed practice therapy approaches have reported 
positive results, thus far, no study has explored the relative efficacy of intensive treatment 
specifically for individuals with vocal fold nodules. Considering that the rehabilitation process for 
vocal fold nodules requires the learning, maintenance and transfer of new behaviours, it is possible 
that a model of more intense voice treatment may yield greater benefit. Therefore, the aim of the 
present study was to investigate the perceptual and physiological outcomes of patients with vocal 
fold nodules following intensive voice treatment when compared to traditional voice therapy. It is 
hypothesised that greater improvement in perceptual and physiological parameters will occur 
following intensive voice treatment for vocal fold nodules compared to traditional voice therapy. 
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2.3 Methods 
Ethics approval for the study was obtained from the Taipei Veterans General Hospital and 
The University of Queensland Medical Research Ethics Committee.  
 
2.3.1 Participants 
Fifty-three women diagnosed with bilateral vocal fold nodules were included in the study. 
The diagnoses of vocal fold nodules were made by one of five otolaryngologists from 
videostroboscopic examination, while the severity of dysphonia was determined by one speech-
language pathologist (SLP) experienced in the area of voice and blind to the study purpose. Overall 
severity was rated using the “Grade” scale from the GRABS scale (Hirano, 1981) (where 0 = 
normal, 1 = mild, 1.5 = mild-to-moderate, 2 = moderate, 2.5 = moderate-to-severe, and 3 = severe) 
and was based on evaluation of a sample of reading (a standard Mandarin passage). All participants 
were referred from the outpatient clinic at the Department of Otorhinolaryngology, Taipei Veterans 
General Hospital, Taiwan. The participants ranged from 20 to 54 years of age, with a mean age of 
37.5 years. Participants were included in this study if they: 1) were aged between 18 years and 55 
years; 2) had normal articulation, resonance, and language ability; 3) had normal hearing as 
determined by a screening test at 20 dB HL at 3 frequencies 500, 1000, 2000 Hz; 4) had no previous 
professional singing or speaking training; and 5) had no previous voice therapy or laryngeal surgical 
treatment. Exclusion criteria included: 1) use of prescription medication which may cause changes 
in laryngeal function, mucosa or muscle activity (list provided by National Center for Voice and 
Speech [NCVS], retrieved 26 June, 2009 from http://www.ncvs.org/e-learning/rx2.html); 2) current 
psychiatric or neurologic conditions; or 3) a history of allergies, lung disease, or other concomitant 
vocal pathology (e.g., vocal polyp and vocal cyst).  
Participants were matched in pairs according to their age, occupation, and severity of 
dysphonia. The participants occupations were categorised into non-professional voice users (e.g., 
factory worker, students, catering, clerical worker, home carers, and unemployed) versus 
professional voice users (e.g., teachers, health professional, and sales personnel). All participants 
were diagnosed with bilateral broad-based nodules before treatment. Participants in each pair were 
then assigned to either of two treatment groups according to their availability: intensive voice 
therapy (IVT) or traditional voice therapy (TVT) groups. Thirty-one participants were recruited to 
the intensive voice program. Seven withdrew or failed to complete the full program (for health, 
work or personal reasons), leaving 24 participants who completed the IVT program. A total of 37 
participants were recruited to the traditional voice therapy program group. Eight withdrew or failed 
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to complete the entire program, leaving 29 participants who completed the entire TVT program. 
Demographic information of the 53 participants who completed both programs is detailed in Table 
2.1.  
 
 
Table 2.1  
Demographic Information of Participants 
Demographic variables TVT Group IVT Group 
Total number of participants 29 24 
Mean age (years) 37.52 37.54 
Severity of dysphonia     
      Mild 2 - 
      Mild-moderate 19 12 
      Moderate 8 12 
Occupations   
      Professional voice user 16 14 
      Non-professional voice user 13 10 
Note. TVT = traditional voice therapy; IVT = intensive voice therapy. 
 
 
Comparisons of baseline characteristics between the two groups were conducted using 
independent t-tests for parametric data (age) and chi-square tests and Mann-Whitney U tests for 
non-parametric data (occupation, severity of dysphonia, existence of vocal fold oedema and vocal 
nodule location).There were no statistical differences between the groups with regards to their age 
(t= -0.165, p = 0.871), severity of dysphonia (Z = -1.861, p = 0.063), and occupation (χ2 = 0.053, p 
= 0.817) at presentation. There were no significant differences between the groups with respect to 
vocal nodule location (Z = -0.195, p = 0.845) or surrounding oedema of the vocal folds (χ2 = 2.511, 
p = 0.113). In the TVT group, 27 (93%) had nodules located on the front 1/3 of the vocal folds 
while 2 (7%) were located mid-vocal folds. In the IVT group, 22 (92%) had nodules located on the 
front 1/3 of the vocal folds with 2 (8%) participants having nodules located mid-vocal fold. All of 
the participants from TVT group had surrounding oedema prior to treatment as did 92% (n = 22) of 
the IVT group.  
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2.3.2 Procedure 
Assessments for all participants were conducted across three time intervals relative to their 
therapy: 1) before the initial vocal hygiene session, 2) three weeks after the vocal hygiene session 
and immediately prior to IVT/TVT voice therapy, and 3) immediately following IVT or TVT. All 
assessments were performed by a SLP and otolaryngologists experienced in voice disorders who 
were independent to the study and blinded to group allocation. 
 
2.3.3 Auditory Perceptual Ratings 
At each assessment interval, the participants were asked to read a Mandarin passage 
consisting of five sentences. Voice samples were recorded with a Shure SM48-LC microphone and 
stored in the Computerised Speech Laboratory system (CSL; model 4500, Kay Elemetrics Co.) at a 
4.41 KHz sampling rate in a sound-treated room. The desktop microphone was positioned in front 
of each participant’s mouth at a mouth-to-microphone distance of 15 cm.  
Speech samples were subsequently analysed perceptually by one SLP with 15 years 
experience assessing voice disorders, blinded to the treatment group allocation and not involved in 
the treatment process. Voice quality was assessed using the GRBAS scale (Hirano, 1981). The 
GRBAS scale consists of five perceptual parameters: grade (G), roughness (R), breathiness (B), 
asthenicity (A) and strain (S). Ratings using the GRBAS parameters were conducted using paired 
comparisons, using the Comparison Mean Opinion Score (CMOS) process (ITU-P.800, 1996). This 
process allows the rater to detect even subtle changes in a patient’s voice or speech characteristic by 
allowing them to listen to, and compare an individual’s speech sample in pairs (e.g., pre and post 
therapy), and rate the second sample relative to the characteristics of the first sample. A clinician 
independent of the rating process created pairs of recorded speech samples for each participant 
relating to the assessment time points (i.e., pre vocal hygiene and post vocal hygiene; pre vocal 
hygiene and post voice therapy; post vocal hygiene and post voice therapy). The order of the two 
samples in each pair was randomized to reduce any potential expectation bias. After listening to 
each pair of speech samples, the clinician then rated sample 2 in relation to sample 1 on a scale of -
3 to +3, in which 0 indicates the samples are equal. If the value is negative, it indicates that sample 
2 is worse than sample 1 (-1 mildly worse; -2 worse and -3 severely worse). However, if the value 
is positive, it indicates that sample 2 is better than sample 1 (+1 mildly better; +2 better and +3 
much better). The SLP was able to listen and compare the speech samples as often as they wished. 
Once the paired samples were rated, the principle investigator revealed the order of the two samples 
and transposed the scores to ensure data accurately reflected perceptual differences relative to the 
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time of speech sample recording such that any positive score indicated an improvement and 
negative values a decline in function.  
To validate the rater reliability, of the primary rater, a second speech-language pathologist 
with eight years experience assessing voice disorders listened to and rated a random set of 33 
samples (20% of the total voice samples). Inter-rater reliability was calculated using intraclass 
correlation coefficient (ICC) as well as direct calculation of the Percent Exact Agreement (PEA) 
and the Percentage of Close Agreement (PCA - where raters differed by no more than 1 scale 
point). Findings revealed an overall inter-rater reliability for perceptual parameters of 0.637. 
Overall PEA was 73.6% and the PCA was 92.7%. Intra-rater reliability was calculated by having 
the primary rater re-rate 20% of the sample a second time, at no sooner than four weeks following 
initial assessment. The overall ICC calculated for intra-rater reliability was 0.853, while the mean 
PEA was 70.9% and PCA was 99.1%. See Table 2.2 for ICCs, PEA and PCA for individual 
perceptual parameters. 
 
 
Table 2.2  
Inter-Rater Reliability and Intra-Rater Reliability for Perceptual Parameters 
 Inter-rater reliability 
Parameters ICC PEA (%) PCA (%) 
Grade 0.689 72.7 90.9 
Roughness 0.811 77.3 95.5 
Breathiness 0.711 63.6 95.5 
Asthenia 0.474 72.7 90.9 
Strain 0.359 81.8 90.9 
 Intra-rater reliability 
Grade 0.877 65.2 91.3 
Roughness 0.865 69.6 95.7 
Breathiness 0.815 69.6 95.7 
Asthenia 0.813 65.2 95.7 
Strain 0.872 69.6 95.7 
Note. ICC = intraclass correlation coefficient; PEA = percent exact agreement; PCA = percentage of 
close agreement. 
 
 
60 
 
2.3.4 Videostroboscopic Evaluation – Physiological Ratings 
The videostroboscopic recordings were made during the sustained phonation of the vowel /i/ 
produced at a comfortable loudness and pitch. The process of passing the endoscope and making the 
recording was conducted by any one of five otolaryngologists at any assessment point. The 
recorded videostroboscopic samples were then subsequently rated by one primary otolaryngologist 
with seven years experience assessing voice disorders, blinded to the treatment group allocation and 
assessment time points.  
The videostroboscopic ratings were performed in two stages. The first stage was to complete 
ratings of physiological parameters including: the symmetry of vocal fold abduction and vibration; 
the regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; mucosal 
wave characteristics and glottal closure (0 = normal; 1 = mild; 2 = moderate; 3 = severe); nodule 
location (very front, front, mid, back of the vocal fold membranous portion), and; nodule shape 
(narrow-based, broad-based); surrounding oedema (yes/no). The 159 samples (53 participants by 
three samples per participant) were randomized prior to presentation to the otolaryngologists for 
rating in order to reduce any potential bias. The otolaryngologists were able to review each 
videostroboscopic sample for as long as they wished. The ratings were completed from visual 
impression only and the videos were presented without sound.  
The second stage of the videostroboscopic rating process, was to use the paired sample 
comparison process (as described previously) to rate paired samples (pre vocal hygiene and post 
vocal hygiene; pre vocal hygiene and post voice therapy; post vocal hygiene and post voice therapy) 
using a questionnaire adapted from Holmberg et al. (2001). Ratings of sample two compared to 
sample one were rated for changes in: (1) nodule size (difference between the two recordings, -1 
larger; 1 smaller; 0 no difference), and; (2) surrounding oedema (difference between the two 
recordings: -1 larger; 1 smaller; 0 no difference). Once the samples were rated, the principle 
investigator revealed the order of the samples and transposed the scores to ensure data accurately 
reflected differences relative to the time of videostroboscopic sample recording (pre-vocal hygiene, 
post-vocal hygiene and post-voice therapy). 
The reliability of the primary rater was determined using a second otolaryngologist with 
nine years experience assessing voice disorders who rated a random set of 33 samples (20% of the 
total videostroscopic samples). Inter-rater reliability was calculated using ICC as well as PEA and 
PCA. Findings revealed inter-rater reliability for videostroboscopic parameters revealed an ICC of 
0.879, while PEA was 73.8% and PCA was 99.6% respectively. Intra-rater reliability was calculated 
by having the primary rater re-rate 20% of the sample a second time, at no sooner than four weeks 
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following initial assessment. The ICC calculated for intra-rater reliability was 0.91, while PEA was 
91.5% and PCA was 97.4%. See table 2.3 for ICC, PEA, and PCA of individual physiological 
parameters. 
 
 
Table 2.3  
Inter-Rater Reliability and Intra-Rater Reliability for Physiological Parameters 
 Inter-rater reliability 
Parameters ICC PEA (%) PCA (%) 
Symmetry 0.78 65.5 100 
Amplitude 0.853 71.9 100 
Mucosal wave 0.705 59.4 100 
Regularity 0.792 81.2 100 
Vocal fold edge smoothness 0.849 71.9 96.8 
Glottal closure 0.804 75 100 
Vocal nodule size 0.976 90.9 95.4 
Surrounding oedema 1.00 95.4 95.4 
 Intra-rater reliability 
Symmetry 0.909 93.8 96.9 
Amplitude 0.910 84.4 100 
Mucosal wave 0.946 84.4 100 
Regularity 0.938 90.6 96.9 
Vocal fold edge smoothness 0.791 93.8 93.8 
Glottal closure 1.00 100 100 
Vocal nodule size 0.694 86.4 90.9 
Surrounding oedema 0.838 90.9 90.9 
Note. ICC = intraclass correlation coefficient; PEA = percent exact agreement; PCA = percentage of 
close agreement.  
 
 
2.3.5 Therapy Program 
The therapy programs for both treatment groups consisted of both indirect and direct therapy 
treatment strategies (described in detail in Appendix E). Both groups began voice therapy with 
62 
 
indirect treatment strategies in which all participants were asked to follow general voice hygiene 
measures (adapted from Weinrich, 2002, Verdolini Abbott, 2008, and NCVS, 2009). Participants in 
each group were then scheduled to return for eight-sessions of direct voice therapy three weeks 
later. The therapy program which was followed over the eight sessions in both groups was identical. 
Only the intensity of its delivery varied between the groups. The TVT (control) group received one 
session of direct therapy per week for 8 weeks (eight sessions of therapy). The IVT group received 
eight sessions delivered within a 3 week period (i.e., three times per week in the first two weeks and 
two times in the third week). All sessions, regardless of group, were 45 minutes in duration.  
The voice therapy was provided by the principle investigator who was not involved in 
assessment of the participants. The principle investigator was trained and certified to provide the 
therapy program which was adapted from the Lessac-Madsen Resonant Voice Therapy (LMRVT) 
developed by Verdolini Abbott (2008). Components of the Vocal Function Exercises (VFE) 
program developed by Stemple were also incorporated in the speech tasks (Stemple, Lee, D’Amico, 
& Pickup, 1994). LMRVT focuses on the production of resonant voice which has been defined as a 
vocal quality that projects well, is easy to produce; involves a sensation of vibration in the mask of 
the face; and is characterised by ample harmonic content (Smith, Finnegan, & Karnell, 2005). It is 
generally produced with relatively complete anteroposterior vocal fold closure during phonation 
(Verdolini-Marston et al., 1995). The focus of this therapy is: (1) the production of concentrated 
vibratory sensations on the anterior palate during phonation, using an “inverted megaphone” facial 
posture, and (2) upper body relaxation, using manual manipulations to reverse any obvious head, 
neck, or shoulder tensions and to obtain good head and neck alignment (Verdolini-Marston et al., 
1995). VFE represent a holistic approach to voice treatment designed to rebalance the three 
subsystems of voice, respiration, phonation, and resonance (Gillivan-Murphy, Drinnan, O’Dwyer, 
Ridha, & Carding, 2006). These exercises are designed to build strength and endurance in the 
laryngeal muscles and in doing so improve range and control for voice production (Aronson & 
Bless, 2009, Stemple et al., 1994). The exercises also facilitate better control over airway valving 
and in so doing reduce hyperfunctional laryngeal behaviours (Aronson & Bless, 2009).  
Therapy procedures began with stretches of shoulders and neck and relaxation of facial 
muscles followed by basic training gestures as described by Verdolini Abbott (2008) and Roy et al. 
(2001). Following the relaxation exercises, direct facilitation of speech tasks were taught which 
started with stretching (ascending pitch glide) and contracting exercises (descending pitch glide) on 
the word “knoll”, “whoop” or “boom”, all with “extreme forward focus”, then working on sounds in 
isolation (containing both consonants and vowels) while feeling the vibration along the anterior 
alveolar ridge, and maintaining easy phonation. The sessions proceeded in stages to a 
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conversational level and real-life applications outside the therapy room, based on the clinician’s 
impression that earlier levels in the therapy hierarchy have been satisfactorily mastered. All 
participants were asked to practice voice techniques worked on in the therapy session at home, in 
two 15-minutes sessions per day on non-therapy days, and once per day on therapy days. The 
techniques were provided in worksheets in the form of a daily checklist for participants to take 
home. 
 
2.3.6 Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., Chicago, IL) 
was used for all statistical analysis and level of significance was set at p < 0.05. Analysis involved 
both within group and between group analyses. For within group analysis, the paired comparison 
ratings (between baseline and post vocal hygiene, baseline and post treatment, and post vocal 
hygiene to post treatment) conducted for the perceptual parameters of grade; roughness; 
breathiness; asthenia; strain and also for the physiological parameters of nodule size and oedema 
were analysed using a series of one sample t-tests (2-tailed) where 0 was taken to indicate no 
difference between the sample pairs. 
For the physiological parameters of the symmetry of vocal fold abduction and vibration; the 
regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; mucosal wave; 
and glottal closure were analysed using Friedman’s tests to explore extent of within group change in 
each treatment group (IVT and TVT) across the three time points (baseline, post vocal hygiene, and 
post voice treatment). Any significant result was examined further using post-hoc Wilcoxon signed 
rank tests.  
Prior to conducting the between group analysis, data from the physiological ratings 
(symmetry of vocal fold abduction and vibration, the regularity and amplitude of the vocal fold 
movement, vocal fold edge smoothness, mucosal wave and glottal closure) were converted to 
change scores, calculated as the difference between the baseline and post vocal hygiene ratings, 
between baseline and post treatment ratings, and between post vocal hygiene and post treatment for 
each participant in each group. Mann-Whitney U tests were then used to determine any differences 
in the extent of change across the physiological parameters at baseline to post vocal hygiene, 
baseline to post treatment and post vocal hygiene to post treatment between the IVT and TVT 
groups.  
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To explore between group differences for the perceptual and physiological data from the 
paired comparisons ratings, the proportions of participants identified as either better, worse or no 
different at post vocal hygiene and post treatment were calculated then compared between the 
groups, using Chi-square tests. 
 
2.4 Results 
2.4.1 Perceptual Ratings – Comparison of Pairs 
Within group analysis 
The perceptual ratings (paired comparisons) between baseline and post vocal hygiene, 
baseline and post treatment, and post vocal hygiene to post treatment in both the TVT and IVT 
groups were analysed using a series of one sample t-tests (see Table 2.4). Between baseline and post 
vocal hygiene, there were no significant changes across any of the perceptual parameters except for 
strain, which improved significantly (p < 0.05) in the TVT group only (Table 2.4). Between 
baseline and post treatment, both the TVT and IVT groups were found to have significantly 
improved ratings of overall voice quality, roughness, breathiness, weakness of voice, and strain. 
Comparison between post vocal hygiene and post treatment also demonstrated significantly 
improved ratings of overall voice quality, roughness, and strain of voice in both groups, with IVT 
group showing additional significant improvement in breathiness and weakness of voice (Table 
2.4).  
 
Between group analysis 
Descriptive analysis was used to determine the proportion of patients in each group who had 
improved, declined or made no change across each of the perceptual rating parameters (Table 2.5). 
Chi-square tests were used to compare these proportions in each group post vocal hygiene, and 
post-treatment between the TVT and IVT groups. The results showed there were no differences in 
the proportions of patients making positive change between the groups at either baseline to post 
vocal hygiene, baseline to post voice treatment or post vocal hygiene to post voice treatment for all 
perceptual parameters (Table 2.5). 
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Table 2.4  
Results of the One Sample t-Tests for the Perceptual Parameters Over Time for the TVT and IVT Groups 
  TVT IVT 
Time Parameter Mean difference T p Mean difference t p 
Baseline to post VH Grade 0.310 1.877 0.071 0.042 0.196 0.846 
 Roughness 0.241 1.425 0.241 0.125 0.681 0.503 
 Breathiness 0.138 1.162 0.255 0.042 0.296 0.770 
 Asthenia 0.103 1.140 0.264 0.208 1.735 0.096 
 Strain 0.276 2.512 0.018* 0.250 1.543 0.137 
Post VH to post tx Grade 0.552 3.266 0.003* 0.625 3.498 0.002* 
 Roughness 0.517 2.824 0.009* 0.625 3.498 0.002* 
 Breathiness 0.241 1.885 0.070 0.292 2.290 0.032* 
 Asthenia 0.241 1.885 0.070 0.292 2.598 0.016* 
 Strain 0.241 2.045 0.050* 0.292 2.598 0.016* 
Baseline to post tx Grade 0.897 5.363 <0.001* 0.875 4.764 <0.001* 
 Roughness 0.828 5.255 <0.001* 0.750 3.892 0.001* 
 Breathiness 0.345 2.415 0.023* 0.458 2.696 0.013* 
 Asthenia 0.483 3.524 0.001* 0.458 3.114 0.005* 
 Strain 0.586 4.308 <0.001* 0.542 2.716 0.012* 
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; VH = vocal hygiene; tx = treatment. 
* indicates a statistically significant difference. 
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Table 2.5  
Analysis of the Proportion of Change in Perceptual Ratings at Each Time Point Observed Between the Two Groups 
Parameter/Time  TVT IVT χ2 p 
Grade       
  Baseline to post VH Post VH better 11 (38%) 6 (25%) 3.086 0.544 
 Post VH worse 5 (17%) 7 (29%)   
 No change 13 (45%) 11 (46%)   
  Post VH to post tx Post tx better 18 (62%) 13 (54%) 2.240 0.326 
 Post tx worse 5 (17%) 2 (8%)   
 No change 6 (21%) 9 (38%)   
 Baseline to post tx Post tx better 24 (83%) 17 (71%) 4.592 0.204 
 Post tx worse 4 (14%) 2 (8%)   
 No change 1 (3%) 5 (21%)   
Roughness      
  Baseline to post VH Post VH better 10 (34%) 5 (21%) 2.613 0.241 
 Post VH worse 6 (21%) 8 (33%)   
 No change 13 (45%) 11 (46%)   
  Post VH to post tx Post tx better 18 (62%) 13 (54%) 2.240 0.326 
 Post tx worse 5 (17%) 2 (8%)   
 No change 6 (21%) 9 (38%)   
  Baseline to post tx Post tx better 22 (76%) 17 (71%) 2.304 0.680 
 Post tx worse 3 (10%) 2 (8%)   
 No change 4 (14%) 5 (21%)   
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Breathiness      
  Baseline to post VH Post VH better 6 (21%) 5 (20%) 2.192 0.700 
 Post VH worse 3 (10%) 3 (13%)   
 No change 20 (69%) 16 (67%)   
  Post VH to post tx Post tx better 9 (31%) 7 (29%) 0.816 0.665 
 Post tx worse 3 (10%) 1 (4%)   
 No change 17 (59%) 16 (67%)   
  Baseline to post tx Post tx better 11 (38%) 10 (42%) 0.516 0.915 
 Post tx worse 3 (10%) 2 (8%)   
 No change 15 (52%) 12 (50%)   
Asthenia      
  Baseline to post VH Post VH better 5 (17%) 3 (12%) 2.274 0.518 
 Post VH worse 2 (7%) 0 (0%)   
 No change 22 (76%) 21 (88%)   
  Post VH to post tx Post tx better 9 (31%) 6 (25%) 3.185 0.203 
 Post tx worse 3 (10%) 0 (0%)   
 No change 17 (59%) 18 (75%)   
  Baseline to post tx Post tx better 14 (48%) 8 (33%) 4.965 0.174 
 Post tx worse 2 (7%) 0 (0%)   
Strain      
  Baseline to post VH Post VH better 8 (28%) 7 (29%) 2.274 0.518 
 Post VH worse 1 (3%) 3 (13%)   
 No change 20 (69%) 14 (58%)   
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  Post VH to post tx Post tx better 10 (35%) 6 (25%) 3.679 0.159 
 Post tx worse 3 (10%) 0 (0%)   
 No change 16 (55%) 18 (75%)   
  Baseline to post tx Post tx better 17 (59%) 11 (46%) 4.915 0.178 
 Post tx worse 2 (7%) 2 (12%)   
 No change 10 (34%) 10 (42%)   
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; VH = vocal hygiene; tx = treatment. 
* indicates a statistically significant difference.  
69 
 
2.4.2 Videostroboscopic Ratings – Physiological Parameters 
Within group 
Results of the physiological ratings over time for TVT and IVT groups are shown in Table 
2.6. Friedman tests revealed a significant (p < 0.05) difference across the three time points for the 
ratings of mucosal wave, vocal fold edge smoothness, regularity of vocal fold movement, and 
glottal closure in both the IVT and TVT groups. There were no significant differences observed for 
symmetry of vocal fold abduction or amplitude of vocal fold movement over time in either group 
(Table 2.6). 
 Post-hoc Wilcoxon signed rank tests revealed statistically significant improvements from 
baseline to post vocal hygiene for both the TVT and IVT groups for ratings of mucosal wave (TVT: 
Z = -2.738, p = 0.006; IVT: Z = -3.441, p = 0.001), vocal fold edge smoothness (TVT: Z = -3.317, p 
= 0.001; IVT: Z = -2.887, p = 0.004) and glottal closure (TVT: Z = -2.500, p = 0.012; IVT: Z = -
1.968, p = 0.049). No significant differences were found between baseline and post vocal hygiene 
for regularity of vocal folds (TVT: Z = -0.707, p = 0.480; IVT: Z = -1.667, p = 0.096) for either 
groups.  
Comparisons between post vocal hygiene to post treatment revealed further significant (p < 
0.05) improvements in mucosal wave (Z = -3.625, p < 0.001), vocal fold edge smoothness (Z = -
3.464, p = 0.001), regularity of vocal movement (Z = -2.530, p = 0.011) and glottal closure (Z = -
3.500, p < 0.001) for participants in TVT group. In the IVT group only, a significant improvement 
in mucosal wave (Z = -3.477, p = 0.001) was found between post vocal hygiene and post treatment.  
Between baseline and immediately post voice therapy significant (p < 0.05)  improvements 
had were observed in mucosal wave (TVT: Z = -4.567, p < 0.001; IVT: Z = -4.110, p < 0.001), 
vocal fold edge smoothness (TVT: Z = -4.347, p < 0.001; IVT: Z = -3.300, p = 0.001), regularity of 
vocal fold movement (TVT: Z = -2.517, p = 0.012; IVT: Z = -2.496, p = 0.013) and glottal closure 
(TVT: Z = -4.181, p < 0.001; IVT: Z = -2.982, p = 0.003) in both the TVT and IVT groups.  
Between group analysis 
 The Mann-Whitney U tests were conducted to determine whether any differences in the 
degree of change scores (baseline to post vocal hygiene, post vocal hygiene to post treatment, or 
baseline to post-treatment) existed between the groups. The results showed no significant difference 
in the extent of change between the groups at either baseline to post vocal hygiene, post vocal 
hygiene to post treatment, or baseline to post treatment for all parameters (Table 2.7). 
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Table 2.6  
Within Group Analysis of Physiological Parameters for Both TVT and IVT Groups 
Parameter/Group Pre VH mean (SD)           Post VH mean (SD) Post tx mean (SD) χ
2
 p 
Symmetry      
TVT 1.22 (0.506) 1.26 (0.447) 1.26 (0.447) 0.182 0.913 
IVT 1.28 (0.689) 1.17 (0.650) 1.04 (0.475) 1.200 0.549 
Amplitude      
TVT 1.07 (0.550) 0.89 (0.698) 1.00 (0.679) 2.150 0.341 
IVT 1.09 (0.733) 1.17 (0.576) 1.13 (0.694) 0.545 0.761 
Mucosal wave      
TVT 2.00 (0.48) 1.48 (0.802) 0.63 (0.688) 32.689 <0.001* 
IVT 1.83 (0.717) 1.22 (0.671) 0.39 (0.583) 32.747 <0.001* 
VF edge smoothness      
TVT 1.81 (0.483) 1.41 (0.501) 0.96 (0.437) 31.524 <0.001* 
IVT 1.74 (0.541) 1.30 (0.470) 1.13 (0.548) 16.423 <0.001* 
Regularity      
TVT 1.37 (0.492) 1.30 (0.454) 1.00 (0.555) 8.909 0.012* 
IVT 1.35 (0.573) 1.13 (0.548) 0.96 (0.475) 8.400 0.015* 
Glottal closure      
TVT 1.52 (0.509) 1.15 (0.602) 0.63 (0.565) 27.800 <0.001* 
IVT 1.65 (0.573) 1.26 (0.619) 1.09 (0.596) 10.793 0.005* 
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; VH = vocal hygiene; tx = treatment; VF = vocal fold; SD = standard deviation.  
* indicates a statistically significant difference. 
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Table 2.7  
Between Group Analysis of Extent of Change in Physiological Parameters in Both the TVT and IVT 
Groups 
Time/Parameter TVT  
Mean difference (SD) 
IVT  
Mean difference (SD) 
Z p 
Pre VH vs post VH     
   Symmetry -0.04 (0.518) 0.08 (0.584) -0.789 0.430 
   Amplitude 0.19 (0.622) -0.08 (0.584) -1.486 0.137 
   Mucosal wave 0.52 (0.849) 0.63 (0.647) -0.536 0.592 
   VF edge smoothness 0.41 (0.501) 0.42 (0.584) -0.185 0.853 
   Regularity 0.07 (0.550) 0.21 (0.558) -0.863 0.388 
   Glottal closure 0.37 (0.688) 0.38 (0.875) -0.061 0.951 
Pre tx vs post tx     
   Symmetry -0.07 (0.456) 0.22 (0.795) -1.375 0.169 
   Amplitude 0.07 (0.651) -0.04 (0.562) -0.667 0.505 
   Mucosal wave 1.38 (0.775) 1.43 (0.788) -0.300 0.976 
   VF edge smoothness 0.83 (0.602) 0.61 (0.656) -1.121 0.262 
   Regularity 0.38 (0.728) 0.39 (0.656) -0.114 0.909 
   Glottal closure 0.86 (0.693) 0.57 (0.728) -1.458 0.145 
Post VH vs post tx     
   Symmetry 0.00 (0.602) 0.13 (0.757) -0.371 0.711 
   Amplitude -0.11 (0.506) 0.04 (0.562) -1.013 0.311 
   Mucosal wave 0.85 (0.864) 0.83 (0.778) 0.020 0.841 
   VF edge smoothness 0.44 (0.506) 0.17 (0.576) -1.632 0.103 
   Regularity 0.30 (0.542) 0.17 (0.576) -1.080 0.280 
   Glottal closure 0.52 (0.580) 0.17 (0.778) -1.757 0.079 
Note. VH = vocal hygiene; tx = treatment; VF = vocal fold; IVT = intensive voice therapy; TVT = 
traditional voice therapy; SD = standard deviation. 
 
 
2.4.3 Videostroboscopic Ratings – Comparison of Pairs 
Within group analysis 
The paired comparison ratings for nodule size and oedema (baseline and post vocal hygiene, 
baseline and post treatment, and post vocal hygiene to post treatment) in the TVT and IVT groups 
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were analysed using a series of one sample t-tests. Both groups were found to have significantly 
improved ratings of vocal nodule size (TVT: t = 2.3, df = 26, p = 0.026, mean diff = 0.333; IVT: t = 
3.7, df = 23, p = 0.001, mean diff = 0.500) and vocal fold oedema (TVT: t = 2.6, df = 26, p = 0.015, 
mean diff = 0.370; IVT: t = 4.1, df = 23, p < 0.001, mean diff = 0.500) following vocal hygiene. 
Comparison between post vocal hygiene and post treatment revealed significantly improved ratings 
of vocal nodule size (TVT: t = 3.808, df = 27, p = 0.001, mean diff = 0.536; IVT: t = 2.865, df = 22, 
p < 0.001, mean diff = 0.435) and vocal fold oedema (TVT: t = 4.688, df = 27, p < 0.001, mean diff 
= 0.607; IVT: t = 4.447, df = 22, p < 0.001, mean diff = 0.609). Overall from baseline to post vocal 
therapy both groups demonstrated significantly improved ratings for vocal nodule size (TVT: t = 
4.03, df = 28, p = 0.001, mean diff = 0.552; IVT: t = 15.199, df = 22, p < 0.001, mean diff = 0.913) 
and vocal fold oedema (TVT: t = 4.04, df = 28, p < 0.001, mean diff = 0.586; IVT: t = 10.199, df = 
22, p < 0.001, mean diff = 0.826).  
 
Between group analysis 
Descriptive analysis was used to examine the proportion of patients in each group identified 
as having either reduced, no change or worsened ratings of nodule size and oedema at each of the 
three paired comparison time points (Table 2.8). These data revealed that in the TVT group 48% 
had reduced vocal fold nodules and 52% reduced oedema post vocal hygiene, while 69% had 
reduced nodule size and 76% reduced oedema by post treatment. In the IVT group, post vocal 
hygiene 58% and 54% had reduced nodule size and oedema respectively, however by end of 
treatment 91% had reduced nodule size and 83% had reduced oedema ratings. 
Chi-square tests were used to compare the proportion of patients who had improved, 
declined of, or had no change in their vocal nodule size or oedema (Table 2.8) both post vocal 
hygiene, and post treatment between the TVT and IVT groups. The results showed there were no 
differences between the groups at either baseline to post vocal hygiene, baseline to post voice 
treatment or post vocal hygiene to post voice treatment for all physiological paired comparisons 
(Table 2.8). 
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Table 2.8  
Physiological Paired Comparison Ratings 
Parameter/Time  TVT IVT χ2 p 
Vocal nodule size      
   Baseline to post VH Post-VH smaller 13 (48%) 14 (58%) 0.752 0.687 
 Post-VH larger 4 (15%) 2 (8%)   
 No change 10 (37%) 8 (33%)   
   Post VH to post tx Post-tx smaller 19 (68%) 13 (57%) 1.122 0.571 
 Post-tx larger 4 (14%) 3 (13%)   
 No change 5 (18%) 7 (30%)   
   Baseline to post tx Post-tx smaller 20 (69%) 21 (91%) 4.680 0.096 
 Post-tx larger 4 (14%) 0 (0%)   
 No change 5 (17%) 2 (9%)   
Surrounding oedema      
   Baseline to post VH Post-VH smaller 14 (52%) 13 (54%) 1.719 0.423 
 Post-VH larger 4 (15%) 1 (4 %)   
 No change 9 (33%) 10 (42%)   
   Post VH to post tx Post-tx smaller 20 (71%) 16 (69%) 0.156 0.925 
 Post-tx larger 3 (11%) 2 (9%)   
 No change 5 (18%) 5 (22%)   
   Baseline to post tx Post-tx smaller 22 (76%) 19 (83%) 5.264 0.072 
 Post-tx larger 5 (17%) 0 (0%)   
 No change 2 (7%) 4 (17%)   
Note. VH = vocal hygiene; tx = treatment; IVT = intensive voice therapy; TVT = traditional voice 
therapy. 
 
 
2.5 Discussion 
Extensive studies have been conducted to investigate the benefits of voice therapy on the 
management of vocal fold nodules, however there is large variation in the duration and intensity of 
the therapy reported. This study examined perceptual and physiological outcomes following the 
delivery of therapy in two types of treatment intensities for individuals with vocal fold nodules. The 
results of the current investigation provide initial support for comparable positive perceptual and 
physiological effects from intensive voice therapy compared with traditional voice therapy. 
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Although both treatments modalities contributed to significant improvements post treatment across 
most variables, the efficiency of intensive practice may be better suited for some patients. 
In the current study, no significant differences were noted post vocal hygiene perceptually in 
either group, except for a perception of reduced strain in the TVT group. Interestingly, unlike the 
results yielded for the perceptual data, ratings of individual physiological parameters showed there 
were significant changes post vocal hygiene, specifically in mucosal wave, vocal fold edge 
smoothness and glottal closure in both the TVT and IVT groups. It was also found that the 
participants from both groups had significantly reduced nodule size and surrounding oedema 
following the vocal hygiene program.  
A possible explanation for the lack of change in perceptual parameters post vocal hygiene 
could be that the subtle changes identified under videostroboscopic examination were not yet 
sufficient to result in perceptual change. This discrepancy in findings was also observed by 
Verdolini-Marston, Sandage, and Titze (1994) who found that although there was significant 
improvement on laryngeal appearance through vocal hygiene (i.e., hydration), auditory-perceptual 
ratings fell short of statistical significance. As observed in the current data, previous case study 
reports have documented positive changes in vocal fold morphology and function following vocal 
hygiene counselling alone (Schneider, 1993). A specific vocal hygiene target, hydration, has also 
been shown to have significant benefit on the laryngeal appearance on a group of participants with 
vocal fold nodules and polyps (Verdolini-Marston et a., 1994). These findings indicate that vocal 
hygiene, the indirect component of voice therapy, improves vocal fold conditions as observed in 
both the TVT and IVT groups. Several reviews of vocal hygiene training concluded that although it 
is beneficial to include vocal hygiene program, due to the lack of evidence to support the use of 
vocal hygiene as a primary mode of voice treatment, it should be considered only as a component of 
a comprehensive vocal rehabilitation program (Behlau & Oliveira, 2009; Thomas & Stemple, 2007).  
Previous investigators have reported that voice therapy is effective in restoring normal voice 
and improving voice quality in individuals with vocal fold nodules (Blood, 1994; Holmberg et al., 
2001; Hufnagle & Hufnagle, 1984; Sellars et al., 2002; Trullinger et al., 1988; van der Merwe, 
2004). Specifically, it has been reported that breathiness and pressed quality of voice is significantly 
reduced post therapy (Holmberg et al., 2001). Our study also yielded a similar result, in that 
participants from both TVT and IVT groups had significantly less rough, breathy, weak, and 
strained voices, and overall had a better voice quality immediately post therapy when compared 
with baseline. As implied by Holmberg et al. (2001) the decreased breathiness may reflect on 
reduction in nodules size, thus making possible more complete glottal closure. This is consistent 
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with our physiological findings in that our participants had significantly reduced nodule size and 
glottal closure post therapy.  
The reduction in strained voice identified post therapy in both groups may have indicated 
decreased muscle tension, and improved speech respiratory behaviour with better management of 
air supply and a more efficient relationship between subglottal pressure and glottal function 
(Holmberg et al., 2001). The decrease in strained voice may also be reflected through the improved 
regularity of vocal fold movement and mucosal wave. A combination of the improvement of all 
voice qualities can be seen as an indicator of efficacy of the voice therapy delivered in both groups.  
Physiologically, several researchers have found regularity of vocal fold vibration, quality of 
mucosal wave and vocal fold closure to have improved with voice training; and elimination or 
marked reductions in nodules and surrounding oedema to have been dissipated post voice therapy 
(Blood, 1884; Fisher & Logemann, 1970; Holmberg et al, 2001; Holmberg et al., 2003; Niebudek-
Bogusz et al., 2008a; Niebudek-Bogusz et al. 2008b; Schneider, 1993; van der Merwe, 2004). This 
was also demonstrated in our study. When comparing baseline to immediately post voice therapy, 
both the IVT and TVT groups had significant improvements in mucosal wave, vocal fold 
smoothness, regularity of vocal fold movement and glottal closure. In addition, there was 
significant reduction in nodules and surrounding oedema post treatment for both groups. The 
improvement in mucosal wave, vocal fold smoothness, regularity of vocal fold movement and 
glottal closure may reflect an increase in effective mass of the vocal fold and a reduction in the size 
of the vocal fold nodules. 
Although significant improvements were noted by the end of treatment, for the majority of 
the participants, their vocal fold nodules had not completely resolved. This finding has also been 
reported in other studies (Holmberg et al., 2001; Holmberg et al., 2003). It is postulated that 
although the trauma to the vocal folds may have decreased after therapy, the impact on the vocal 
fold physiology might not have been significant enough to allow complete amelioration of the 
nodular lesions (Holmberg et al., 2001; Holmberg et al., 2003). It is also suspected that those with 
larger nodules may require a longer care period (Lockhart et al., 1997). Direct treatment periods of 
three weeks and eight weeks may not be sufficient for vocal fold nodules to completely resolve. 
Therefore, further long-term observations should be conducted to determine whether or not the 
resolution of vocal fold nodules persists.  
Between the end of vocal hygiene and the end of direct therapy both groups showed further 
significant improvement in overall voice quality, roughness and strain. However, the IVT group 
exhibited additional improvement in breathiness and weakness of voice. This may indicate that the 
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IVT group was able to carryover learnt strategies to daily conversation more readily, providing the 
participants with a more resonant and better quality voice. On the contrary, for the physiological 
parameters, TVT group showed further significant improvements in more parameters (mucosal 
wave, vocal fold edge smoothness, regularity of vocal movement and glottal closure) than the IVT 
group which demonstrated significant improvement in mucosal wave only. In addition, participants 
from both groups showed continuous reduction in nodule sizes and surrounding oedema when 
comparing post vocal hygiene to immediately post treatment. This difference in extent of 
physiological change in the TVT group may be a factor of the duration of the treatment period, that 
is, the physiological change can only be detected after a longer period of time. Despite the 
difference in the number of improved physiological parameters shown from vocal hygiene to post 
voice therapy within groups, no treatment differences were found between IVT and TVT groups on 
all physiological parameters at all time points. Therefore, IVT could potentially be the better 
treatment option for some patients in that vocal cord function can be significantly improved within 
three weeks of direct voice therapy, thus enabling individuals to return to regular work conditions 
earlier. 
The overall outcome of this current investigation showed that both treatment approaches 
were able to provide improvements to vocal fold condition and vocal function. As such the data 
demonstrate that participants were able to improve voice and vocal fold health in the short period of 
time needed for the intensive therapy approach and were able to carryover vocal strategies into 
everyday life. Thus, the intensive model may be more time efficient and beneficial for people who 
have busy work schedules as they have the need to go back to work as soon as possible with a 
satisfactory voice. 
While the present study revealed the potential value of providing treatment to individuals 
with vocal fold nodules in an intensive approach, there are limitations which prevent conclusive 
statements about the effectiveness of the intensive program of voice therapy in this population. Due 
to the subjective nature of perceptual and physiological assessments, the data from more objective 
acoustic and aerodynamic evaluations would be useful to support these findings. Another limitation 
is that this study could not be conducted as a conventional randomised clinical trial (RCT) due to 
the work restrictions of participants. Workers in Taiwan have limited amount of sick leave and there 
are real financial concerns associated with being away from work for too many days. Hence a 
pragmatic RCT approach had to be adopted to allow more participants to be included in the study 
with less dropout. Future studies would also benefit from the use of standardised self-rating 
questionnaires to further monitor participants’ perception of the possible changes in quality of life 
and satisfaction with voice therapy. In addition, long-term follow-up of both treatments should 
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occur to determine whether or not there is continuous improvement or maintenance of vocal quality 
and vocal fold health.  
 
2.6 Conclusion 
In conclusion, the current study provided preliminary evidence that intensive voice therapy 
was equally as beneficial in treating vocal fold nodules as a traditional voice therapy model. 
Individuals with vocal fold nodules were able to regain improved vocal quality and vocal fold 
health in a much shorter period of time with the intensive voice therapy model. This research 
warrants further investigation of the effects of intensive voice treatment on other aspects of 
laryngeal function, as well as participant perception of the benefits of this treatment protocol. Such 
research will ultimately lead to better quality of life and service delivery for the many individuals 
with vocal fold nodules.  
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CHAPTER THREE 
3 Differential Acoustic and Aerodynamic Outcomes Following Intensive Versus 
Traditional Voice Therapy for Vocal Fold Nodules 
The results of Chapter 2 reported perceptual and physiological data which supported that 
behavioural therapy delivered in an intensive format was equally as beneficial in treating vocal fold 
nodules as a traditional voice therapy model. Through intensive voice therapy, individuals with 
vocal fold nodules were able to significantly improve their vocal quality and vocal fold health 
within a condensed period of time, in a manner comparable to those completing traditional voice 
therapy. Although the previous chapter has provided initial evidence of voice quality change 
through subjective perceptual parameters, whether or not these perceived changes also equate to 
change in more objective acoustic and aerodynamic measures is still required to further validate the 
impact of treatment.  
Chapter 3 explores the impact of traditional and intensive voice treatment on the more 
objective acoustic and aerodynamic measures that were collected. Comprehensive analyses were 
performed pre- and post-assessments across the two forms of voice therapy. The findings from this 
study will provide clinicians and other professionals with further evidence for the benefits of 
massed practice when compared with distributed practice. The information gained from this study 
could potentially assist the speech-language pathologists in treatment decision making and provide 
an enhanced service delivery to accelerate vocal recovery for individuals with vocal fold nodules. 
The following manuscript, entitled “Differential acoustic and aerodynamic outcomes 
following intensive versus traditional voice therapy for vocal fold nodules” was partially published 
as part of a larger manuscript, by the Journal of Voice in February 2015. As mentioned in the 
preface to Chapter 2, the contents of Chapter 2 and 3 were originally submitted as separate 
manuscripts to the Journal of Voice, however the editor chose to combine the contents of both 
papers into a single large paper for publication purposes. For the purposes of this thesis, the 
contents of Chapter 2 and 3 were again separated, and the contents of Chapter 3 are inserted here as 
originally submitted to the journal as an independent paper. Content and formatting is as partially 
published in the larger manuscript, with the exception of small wording formatting and referencing 
changes that have been made to assist flow between the content of Chapters 2 and 3 and to align 
with the style guidelines of the American Psychological Association and the formatting of the 
thesis. A copy of the full, combined published manuscript can be found in Appendix C. The 
80 
 
references specific to this published paper have been included in the overall reference list of this 
thesis. 
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3.1 Abstract 
Summary: Objectives. The present study examined the acoustic and aerodynamic effects of 
intensive voice therapy on individuals with vocal nodules compared to a traditional voice treatment 
model.  
Study Design: Pragmatic randomised clinical trial  
Methods: Fifty-three women diagnosed with bilateral vocal nodules were included in the study. All 
participants completed one session of vocal hygiene and eight sessions of direct voice therapy in 
either an Traditional Voice Therapy (TVT) format of eight sessions over 8 weeks (n = 29) or in an 
Intensive Voice Therapy (IVT) format of eight sessions over 3 weeks (n = 24). Acoustic and 
aerodynamic assessments were performed prior to any voice intervention, after vocal hygiene 
education, and immediately after voice treatment.  
Results: Significant increases in fundamental frequency and decrease in jitter and shimmer were 
found in both treatment groups immediately after voice treatment, while no aerodynamic changes 
were noted. No acoustic or aerodynamic changes were shown after vocal hygiene in both groups. 
There were no differences between outcomes achieved through IVT or TVT for any outcome 
measure.  
Conclusions: The study supports that individuals with vocal nodules benefit from intensive voice 
treatment and can demonstrate improved vocal communication within a concentrated treatment 
period. Results suggest comparable acoustic and aerodynamic improvements following either IVT 
or TVT. Further investigation is required to determine the long-term effects of intensive treatment. 
 
Keywords: Vocal nodules, treatment intensity, voice treatment, acoustics, aerodynamics  
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3.2 Introduction 
Vocal fold nodules are common, benign lesions of the vocal folds, known to be associated 
with voice overuse, vocal misuse or abuse (Abeida et al., 2013; Colton, Casper, & Leonard, 2006; 
Holmberg, Doyle, Perkell, Hammarberg, & Hillman, 2003). Ultimately, the presence of vocal fold 
nodules and changes to vocal behaviour can lead to lost time at work, reduced productivity and 
impaired quality of life (Kunduk & McWhorter, 2009). Consequently, there is a need for efficient 
and effective interventions for this clinical population. 
Voice therapy has been found to be effective in the treatment of vocal fold nodules with 
positive outcomes reported across a range of perceptual, physiological, and acoustic measures 
(Blood, 1994; Chernobelsky, 2007, Holmberg, Hillman, Hammarberg, Sodersten, & Doyle, 2001; 
Lockhart, Paton, & Pearson, 1997; Schneider, 1993; Trullinger, Emanuel, Skenes, & Malpass, 
1988). Acoustic and aerodynamic measures form core components of this research, but to date have 
demonstrated equivocal results pre- and post-voice therapy. It has been reported by a number of 
researchers that measurements of acoustic jitter, shimmer, signal-to-noise ratio, fundamental 
frequency (F0), maximum phonation time (MPT), and mean airflow rate, were positively correlated 
with voice improvement following treatment for vocal fold nodules (Blood, 1994; Chernobelsky, 
2007; Holmberg et al., 2001; Lockhart et al., 1997; Trullinger et al., 1988). Other investigations, 
however, have shown no significant changes in acoustic and aerodynamic parameters post treatment 
(Hufnagle & Hufnagle, 1984; Schneider, 1993; Holmberg et al., 2003; Chernobelsky, 2007; Treole 
& Trudeau, 1997). It is possible that the lack of consistent change in acoustic and aerodynamic 
parameters pre- and post-therapy across these studies may be due to the differences in treatment 
programs and measurement tools used across these studies. It may also be a consequence of the 
intensity of the treatment delivered in these studies The majority of the investigations did not 
specify the intensity of voice treatment, (Blood, 1994; Chernobelsky, 2007; Hufnagle & Hufnagle, 
1984; Lockhart, Paton & Pearson, 1997; Treole & Trudeau, 1997; Trullinger et al., 1988) while 
others reported that voice treatment was delivered only once per week (Holmbert et al., 2001; 
Holmbreg et al., 2003; Schneider, 1993). 
To date only the data presented here in this thesis as Chapter 2 has systematically reported 
on the effectiveness of intensive voice treatment for vocal fold nodules. This study examined 
perceptual and physiological outcomes following intensive and traditional voice treatments in 
individuals with vocal fold nodules. The results revealed comparable positive perceptual and 
physiological effects from intensive voice therapy administered over a three week period and 
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traditional voice therapy delivered once per week. Both treatments groups demonstrated significant 
improvements immediately after treatment for perceptual and physiological variables.  
Finding that intensive voice therapy was beneficial for patients, is consistent with prior 
research which has examined the efficacy of intensive voice treatment in other clinical populations. 
One such example is the Lee Silverman Voice Treatment (LSVT
®
) which currently provides the 
strongest evidence of benefit from intensive voice treatment (Fox et al., 2002). This program which 
involves relatively massed practise (four treatment sessions per week for 4 weeks), has been shown 
to result in long-term vocal improvements in the voice of people with Parkinson’s disease (Fox et 
al., 2002). Studies which have directly examined the issue of treatment intensity where a more 
distributed practise schedule for LSVT
®
 (extended to 8 weeks) was examined revealed that 
comparable  results to traditional LSVT
®
 could be achieved (Spielman, Ramig, Mahler, Halpern & 
Gavin, 2007). However, it was noted by the authors that the extended 8 week program increased the 
work load for both clinicians and clients in terms of efficiency, and potentially may result in more 
unbillable time or less clinical contact (Spielman et al., 2007).  
Other researchers have reported positive effects of intensive voice therapy for recalcitrant 
dysphonia (Patel, Bless, & Thibeault, 2011). Their program, referred to as “boot camp” voice 
therapy was developed at the University of Wisconsin (Patel et al., 2011; Thibeault, Zelazny, & 
Cohen, 2009). The treatment involved a multi-clinician, intensive approach which appears to yield 
improvements in a short period of time (1 – 4 days with 4 – 7 hours of therapy per day). However, 
clinical trials on this program have not yet been performed, therefore no final conclusion can be 
reported. Patel et al. (2011) speculated that the nature of the high-intensity training may better 
mimic cognitive, motor, and physiological requirements of activities of daily living than traditional 
therapy.  
Potential advantages of intensive treatment are that: rigorous practice (overload) is possible; 
simultaneous interventions can be conducted for multiple components involved in voice production; 
and opportunities for specificity, individuality, and facilitating transfer of learned skills which may 
influence patient compliance are readily available (Thibeault et al., 2009). Thus in translating this 
evidence to the management of vocal fold nodules, it is possible that intensive voice therapy may be 
more beneficial than traditional treatment protocols, and offer greater speed and efficiency in 
achieving improvement in vocal function. 
Whilst the study of Chapter 2 has shown that intensive voice treatment for vocal fold 
nodules had a positive impact on perceptual and physiological outcomes, thus far the impact of 
treatment on acoustic and aerodynamic data has not been examined. Therefore, the aim of the 
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current study is to explore the acoustic and aerodynamic changes observed in cohorts treated via 
either traditional or intensive voice treatment. Based on our previous perceptual and physiological 
findings, it is hypothesised that both intensive and traditional voice therapy will affect positive 
outcomes with a comparable level of acoustic and aerodynamic change observed between groups. 
 
3.3 Methods 
Ethics approval for the study was obtained from the Taipei Veterans General Hospital and 
The University of Queensland Medical Research Ethics Committee. 
 
3.3.1 Participants 
Fifty-three women, with bilateral vocal fold nodules, were recruited to the present study. 
Participants’ ages ranged from 20 to 54 years with a mean age of 37.5 years. The diagnosis of vocal 
fold nodules for each participant was made by one of five otolaryngologists using 
videostroboscopic examination. Severity of dysphonia at the time of the videostroboscopic 
examination was determined by one speech-language pathologist (SLP) experienced in the area of 
voice and blind to the study using the GRBAS scale (Hirano, 1981) while the participants read a 
standard Mandarin passage. Participants were eligible to be included in the study if they: 1) were 
aged between 18 years and 55 years; 2) had normal hearing as determined by a screening test at 20 
dB HL at 3 frequencies 500, 1000, 2000 Hz; 3) had normal articulation, resonance, and language 
ability; 4) had no previous professional singing or speaking training; and 5) had no previous voice 
therapy or laryngeal surgical treatment. Exclusion criteria for this study included: 1) use of 
prescription medication which may cause changes in laryngeal function, mucosa or muscle activity 
(list provided by National Center for Voice and Speech [NCVS], retrieved 26 June, 2009 from 
http://www.ncvs.org/e-learning/rx2.html); 2) psychiatric or neurologic illness; or 3) a history of 
allergies, lung disease, or other concomitant vocal pathology (e.g., vocal polyp and vocal cyst). All 
participants were referred by otolaryngologists from the outpatient clinic at the Department of 
Otorhinolaryngology, Taipei Veterans General Hospital, Taiwan upon diagnosis.  
Following recruitment, participants were matched in pairs according to age, occupation, and 
severity of dysphonia. The occupations were categorised into professional voice users (teachers, 
health professional, and sales personnel) versus non-professional voice users (factory worker, 
students, catering, clerical worker, home carers, and unemployed). Participants in each pair were 
then allocated to either of two treatment groups according to their availability: intensive voice 
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therapy (IVT) or traditional voice therapy (TVT) groups. Thirty-one participants were recruited to 
the IVT program. Seven withdrew or failed to complete the full program (for health, work or 
personal reasons), leaving 24 participants who completed the IVT program. A total of 37 
participants were recruited to the TVT program group. Eight withdrew or failed to complete the 
entire program, leaving 29 participants who completed the entire TVT program. Demographic 
information of the 53 participants who completed both programs is detailed in Table 3.1.  
To ensure the equivalence of groups on pre-treatment age, severity of dysphonia, acoustic 
and aerodynamic measurements, pre-treatment differences between groups for each parameter were 
tested using independent t-tests for parametric data (age, acoustic and aerodynamic measurements). 
For non-parametric data (occupation and severity of dyphonia) chi-square tests and Mann-Whitney 
U tests were used. With respect to age, pre-treatment severity of dysphonia, occupation and pre-
treatment acoustic and aerodynamic measurements, there were no significant differences (p > 0.05) 
between groups at baseline (see Table 3.1).  
 
 
Table 3.1 
Demographic Information of Participants 
Demographic variables TVT Group IVT Group p 
Total number of participants 29 24  
Mean age (years) 37.52 37.54 0.871 
Severity of dysphonia     0.063 
     Mild 2 -  
     Mild-moderate 19 12  
     Moderate 7 12  
     Moderate-severe 1 -  
Occupation   0.817 
     Professional voice user 16 14  
     Non-professional voice user 13 10  
Note. TVT = traditional voice therapy; IVT = intensive voice therapy. 
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3.3.2 Procedure 
Assessments were conducted with all participants across three time intervals relative to 
therapy: 1) before the initial vocal hygiene session, 2) 3 weeks after the vocal hygiene session and 
immediately prior to the voice therapy and 3) immediately following the program of voice therapy. 
All assessments were performed by an SLP experienced in voice disorders who was independent to 
the study and blinded to group allocation.  
 
3.3.2.1  Aerodynamic assessment. 
Aerodynamic assessment included measures of maximum phonation time (MPT), mean 
airflow rate (MFR) and subglottic pressure. MPT was measured with a stopwatch while participants 
were asked to produce the sustained vowel /a/ for as long as possible at a comfortable loudness and 
pitch level on a single breath, three times. The MFR and subglottic pressure were obtained and 
analysed using the Aerophone II (Model 6800, Kay Elemetrics Co., Lincoln Park, NJ). Each 
participant was asked to produce a sustained vowel /a/ for as long as possible at a comfortable 
intensity and pitch level with a face mask, sealed over the nose and mouth connected to a 
pneumotachograph- based flow system, three times. The subglottal pressure was measured 
indirectly using an intraoral pressure probe positioned behind the lips and resting on the tongue. The 
participants were asked to repeat /ipipip/ with the face mask and probe in place at a rate of 1.5 
syllables/second, three times. Results for each parameter were averaged to produce one single value 
which was used in the statistical analyses. 
 
3.3.2.2  Acoustic assessment. 
All acoustic recordings were conducted in a sound-proof room. The participants were asked 
to produce a sustained vowel /a/ on one breath at a comfortable pitch and loudness level, three 
times. Vowel productions were recorded via the desktop microphone of the Computerized Speech 
Lab (CSL) (Model 5105, Kay Elemetrics Co.). The microphone was positioned in front of the 
participant with a mouth-to-microphone distance of 15 cm. Each participant’s production of 
sustained /a/ was analysed using the Multi-Dimensional Voice Program (MDVP) software in the 
CSL. The middle 3-second segment from each of the sustained vowels was selected for acoustic 
analysis. Detailed voice stability measures included: vocal fundamental frequency (F0) (Hz), mean 
percentage vocal jitter and shimmer, and noise-to-harmonics ratio (NHR) (dB). Results across the 
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three vowel phonations were averaged to produce a single value for each measure. In addition, 
participants’ vocal intensity (VI) (dB) for the three prolonged vowels /a/ and additional 
conversational speech samples were simultaneously measured using Sound Level Meter (320 series, 
Center Technology Corp., Taiwan) which was also positioned in front of the participant with a 
mouth-to-microphone distance of 15 cm. Vocal intensity recorded for the prolonged vowel 
phonations and conversational speech samples were averaged to produce a single value for each 
measure. 
 
3.3.3 Therapy Program 
The therapy programs (IVT and TVT) consisted of both indirect (vocal hygiene instruction) 
and direct therapy treatment strategies (described in detail in Appendix E). Both groups began voice 
therapy with one vocal hygiene session in which all participants were asked to follow general voice 
hygiene measures (adapted from Weinrich, 2002, Verdolini Abbott, 2008, and NCVS, 2009). 
Participants in each group were then scheduled to return for eight-sessions of voice therapy three 
weeks later. The TVT (control) group received one session of direct therapy a week for 8 weeks 
(eight sessions of therapy). The IVT group received eight sessions delivered within a 3 week period 
(i.e., three times per week in the first two weeks and two times in the third week). All sessions, 
regardless of group, were 45 minutes in duration.   
The voice therapy was provided by the principle investigator who was not involved in 
assessment of the participants. The therapy program which was followed over the 8 sessions in both 
groups was identical. Only the intensity of its delivery varied between the groups. The principle 
investigator was trained and certified to provide the therapy program which was adapted from the 
Lessac-Madsen Resonant Voice Therapy (LMRVT) developed by Verdolini Abbott (2008). 
Specifically, therapy focused on the production of resonant voice which has been defined as a vocal 
quality that projects well, is easy to produce; involves a sensation of vibration in the mask of the 
face; and is characterised by ample harmonic content (Smith, Finnegan, & Karnell, 2005). Resonant 
voice is generally produced with relatively complete anteroposterior vocal fold closure during 
phonation (Verdolini-Marston et al., 1995). The focus of this therapy is: (a) the production of 
concentrated vibratory sensations on the anterior palate during phonation, using an “inverted 
megaphone” facial posture, and (b) upper body relaxation, using manual manipulations to reverse 
any obvious head, neck, or shoulder tensions and to obtain good head and neck alignment 
(Verdolini-Marston et al., 1995). Components of the Vocal Function Exercises (VFE) program 
developed by Stemple were also incorporated in the speech tasks (Stemple, Lee, D’Amico, & 
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Pickup, 1994). VFE represents a holistic approach to voice treatment designed to rebalance the 
three subsystems of voice, respiration, phonation, and resonance (Gillivan-Murphy, Drinnan, 
O’Dwyer, Ridha, & Carding, 2006). It is designed to build strength and endurance in the laryngeal 
muscles and in doing so improve range and control for voice production (Aronson & Bless, 2009, 
Stemple et al., 1994). The exercises also facilitate better control over airway valving and in doing so 
reduce hyperfunctional behaviours (Aronson & Bless, 2009).  
Therapy procedures began with stretches of shoulders and neck and relaxation of facial 
muscles followed by basic training gestures as described by Verdolini Abbott (2008) and Roy et al. 
(2001). The speech tasks began with stretching (ascending pitch glide) and contracting exercises 
(descending pitch glide) on the word “knoll”, “whoop” or “boom”, all with “extreme forward 
focus”, then working on sounds in isolation (containing both consonants and vowels) while feeling 
the vibration along the anterior alveolar ridge, and maintaining easy phonation. Participants 
proceeded by stages to a conversational level and real-life applications outside the therapy room, 
based on the clinician’s impression that earlier levels in the therapy hierarchy have been 
satisfactorily mastered. In addition participants in both groups were asked to practice voice 
techniques worked on in the therapy session at home, in two 15-minutes sessions per day on non-
therapy days, and once per day on therapy days. The techniques were provided in worksheets in the 
form of a daily checklist for participants to take home.  
 
3.3.4 Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 19 (SPSS, Inc., Chicago, IL) 
was used for statistical analysis. To identify differences between the two treatment groups (IVT and 
TVT) across time (pre-, post-vocal hygiene, and post-voice treatment) as well as any interaction 
occurring between treatment group and time, two-factor repeated measures analyses of variances 
(ANOVAs) were used. Where a significant (p < 0.05) effect for time was found, post-hoc 
procedures were performed to determine where the significant difference occurred (i.e., between pre 
and post vocal hygiene, post vocal hygiene and post treatment, or pre and post treatment) within 
each group.  
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3.4 Results 
3.4.1 Aerodynamic Measures 
A series of two-factor ANOVAs (group x time) conducted for each aerodynamic parameter 
revealed no significant interactions between group and time for any parameters (Table 3.2). There 
was also no main effect for time for any aerodynamic parameter. Furthermore, the between group 
effect was not significant for any aerodynamic parameters, suggesting no difference in the 
effectiveness of the two approaches regarding aerodynamic measures (Table 3.2).  
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Table 3.2 
Results – MPT, MFR, and Subglottic Pressure for TVT and IVT groups 
Task/Group Pre-VH              
mean (SD)           
Post-VH               
mean (SD) 
Post-tx              
mean (SD) 
Interaction effect Main effect Between group effect 
F p Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
MPT (seconds)             
     TVT 8.53 (3.59) 8.81 (3.14) 9.57 (3.64) 0.972 0.385 0.037 0.227 0.798 0.009 0.001 0.974 <0.005 
     IVT 9.04 (4.35) 9.07 (3.24) 8.72 (2.79)          
MFR (ml/sec)             
  TVT 139.60 (60.65) 143.65 (71.00) 140.34 (65.02) 0.634 0.530 0.005 0.165 0.848 0.007 0.959 0.332 0.018 
   IVT 163.35 (65.07) 150.68 (75.52) 159.09 (81.21)          
Subglottic 
pressure 
(cmH2O) 
            
   TVT 10.10 (3.08) 9.64 (2.92) 10.68 (3.04) 1.886 0.162 0.070 0.762 0.472 0.030 2.478 0.122 0.046 
   IVT 11.32 (2.80) 11.41 (3.09) 11.18 (3.37)          
Note. VH = vocal hygiene, tx = treatment, MPT = maximum phonation time, MFR = mean airflow rate, IVT = intensive voice therapy, TVT = 
traditional voice therapy, SD = standard deviation.  
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3.4.2 Acoustic Measures  
For the acoustic data, the two-factor ANOVAs conducted for each acoustic parameter 
showed no significant interaction between group and time (Table 3.3). There was however a 
significant main effect for time for F0, jitter, shimmer, NHR and VI of prolonged /a/, with both 
groups showing an increase in values across the three time periods for F0 and VI of prolonged /a/ 
and a reduction in values for jitter, NHR and shimmer. There was no main effect observed for VI in 
conversation. In addition, the between group effect was not significant across all acoustic 
parameters, suggesting no difference in the effects of the two interventions on acoustic measures 
(see Table 3.3).  
Post-hoc tests were performed on the acoustic parameters which demonstrated a significant 
main effect for time. Analysis revealed no significant differences between pre- and post-vocal 
hygiene across all acoustic parameters for both treatment groups, except for VI of prolonged /a/ (p = 
0.019) in IVT group. However, significant increases in mean F0 were found for participants in both 
the IVT and TVT groups between baseline and immediately post voice therapy. Both groups also 
experienced significant reductions in jitter (p < 0.001 and p = 0.012), and shimmer (p = 0.001 and p 
= 0.03) following treatment. Although there was a significant main effect for time for NHR, no 
significant differences were found in the post hoc analysis between time points in both groups, 
though a trend (p = 0.099 and p = 0.381, respectively) was observed for a reduction in NHR 
between baseline and post treatment for TVT and IVT groups. Results of VI of prolonged vowel 
/a/revealed a significant increase immediately post treatment in TVT group (p = 0.005) but not in 
IVT group (p = 0.069).
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Table 3.3  
Results – F0, jitter, shimmer, NHR, VI of Prolonged Vowel /a/ and VI of Conversational Speech Sample for TVT and IVT Groups 
Task/Group Pre-VH              
mean (SD)           
Post-VH               
mean (SD) 
Post-tx              
mean (SD) 
Interaction effect Main effect for time Between group effect 
F p Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
F0 (Hz)             
     TVT 205.75 (29.28) 205.03 (27.27) 233.92 (29.56) 0.637 0.533 0.025 60.303 <0.001* 0.707 0.342 0.561 0.007 
     IVT 197.88 (33.56) 203.79 (23.89) 230.67 (25.65)          
Jitter (%)             
   TVT 2.03 (1.18) 1.65 (0.96) 1.20 (0.92) 0.515 0.600 0.020 18.537 <0.001* 0.426 0.275 0.602 0.005 
   IVT 2.08 (1.06) 1.92 (0.89) 1.21 (0.84)          
Shimmer (%)             
   TVT 5.17 (1.90) 4.59 (1.82) 3.87 (2.10) 0.495 0.613 0.019 10.231 <0.001* 0.290 1.158 0.287 0.022 
   IVT 5.83 (2.43) 5.24 (2.21) 3.96 (1.83)          
NHR             
     TVT 0.16 (0.04) 0.15 (0.03) 0.14 (0.05) 0.089 0.915 0.004 3.508 0.038* 0.123 0.046 0.831 0.001 
     IVT 0.16 (0.04) 0.15 (0.03) 0.14 (0.04)          
VI of 
prolonged  
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/a/ (dB) 
   TVT 75.73 (5.53) 76.43 (5.34) 79.92 (6.51) 0.196 0.823 0.008 9.931 <0.001* 0.293 0.541 0.465 0.011 
   IVT 75.28 (5.79) 75.15 (4.33) 78.70 (6.97)          
VI of 
conversation 
(dB) 
            
   TVT 71.50 (3.81) 71.85 (2.75) 72.27 (3.79) 1.184 0.315 0.047 1.122 0.334 0.045 0.097 0.757 0.002 
   IVT 72.19 (3.52) 70.84 (3.11) 71.91 (3.99)          
Note. F0 = fundamental frequency, NHR = noise-to-harmonic ratio, VI = vocal intensity; IVT = intensive voice therapy; TVT = traditional voice 
therapy; SD = standard deviation, *= statistically significant difference.  
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3.5 Discussion 
The results of the current study found that both treatment groups (intensive or traditional) 
demonstrated improvements in acoustic voice parameters, and that there were no differences in 
outcomes between the two treatment groups. Hence, the results of the current investigation provided 
further evidence to show that a similar treatment effect can be achieved through a more intensive 
treatment model as opposed to traditional voice therapy. It is possible, therefore to assist patients in 
achieving improvements in vocal function in a much shorter period of time. These findings support 
the benefits of massed practise as reported by other investigations (Chapter 2; Fox, Morrison, 
Ramig, & Sapir, 2002; Patel et al., 2011; Spielman et al., 2007). 
In the present study, it was found that after three weeks of vocal hygiene no significant 
changes in either the acoustic or aerodynamic outcome measures were identified in either treatment 
group. This finding is consistent with the results reported previously in Chapter 2, that no 
significant change in perceptual voice rating was observed following vocal hygiene. The lack of 
change observed is also  consistent with recent studies which have revealed that vocal hygiene 
education alone is ineffective for treating individuals with existing voice problems and that voice 
therapy is required to optimise treatment benefits (Nanjundeswaran et al., 2012; Roy et al., 2001; 
Roy et al., 2002). In a study by Rodriguez-Parra, Adrian, and Casado (2011) comparing voice 
therapy and vocal hygiene treatment in dysphonia, it was observed that the direct voice therapy 
group achieved improvements on aerodynamic variables post treatment whilst the vocal hygiene 
group tended to decrease or show no change in their performance (Rodriguez-Parra et al., 2011).  
However, although there was no significant change noted in acoustic and aerodynamic 
parameters following vocal hygiene, our prior study reported in Chapter 2 of this thesis did find that 
significant improvements were found in physiological parameters following vocal hygiene. A 
possible explanation for these differing results between physiological parameters and the acoustic 
and aerodynamic data is that vocal hygiene facilitates improvements in vocal physiology but not to 
a sufficient degree that results in perceptual, acoustic, and aerodynamic changes. Therefore, the 
combined results of the studies reported here in Chapter 2 and 3 of this thesis suggest that although 
some benefit in physiological characteristics may be observed following vocal hygiene alone, direct 
intervention is needed to effect changes in at perceptual, and acoustic dimensions of voice for 
patients with vocal fold nodules.   
The results of the acoustic analyses revealed there were significant increases in F0, and a 
decrease in jitter, and shimmer, immediately after voice treatment for both groups which is 
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consistent with previous research findings (Fex, Fex, Shiromoto, & Hirano, 1994; van der Merwe, 
2004; McCrory, 2001). The increase in F0 may have resulted from a reduction in size of the vocal 
fold nodules and a decrease in surrounding oedema (Holmberg et al., 2001). Also, it has been 
suggested that once the vocal fold nodules have been eliminated with voice therapy, the F0 will 
increase due to a reduction in the mass loading effects on the vibratory characteristics of the vocal 
folds (Aronson & Bless, 2009; Mueller, 1975). It was also noted there was a significant increase in 
vocal intensity for TVT group but not the IVT group. This increased vocal intensity may be 
attributed to the extended time provided for the TVT group to familiarise themselves with the use of 
vocal projection, which is a treatment component of LMRVT. As a result, participants developed a 
louder voice. The overall acoustic improvements found in both groups reflected increases in 
effective mass of the vocal fold, reduction in the vocal noise, and possibly a diminishing in size of 
the vocal fold nodules (Chernobelsky, 2007; Holmberg et al., 2001). This is confirmed by our 
previous study (Chapter 2) which showed significant improvement in mucosal wave, vocal fold 
edge smoothness, regularity of vocal fold movement, glottal closure, and significant reduction in 
vocal nodule size and vocal fold oedema immediately post treatment. In addition, the acoustic 
improvement also positively correlates with participants' perceptual ratings observed in which 
overall voice quality, roughness, breathiness, weakness, and strain of voice were significantly 
improved (Chapter 2). These changes indicate that the intensive and traditional treatment dosages 
used in this study were effective in the management of vocal fold nodules. As no statistical 
differences were found between the treatment groups, it is suggested that intensive intervention over 
a 3 week period is of sufficient duration to improve voice outcome for individuals with vocal fold 
nodules. 
Similar to the aerodynamic findings yielded by Holmberg et al. (2003) and Treole and 
Trudeau (1997), the current study found no significant changes in aerodynamic parameters post 
treatment. It may be that as the participants’ aerodynamic measures were already in the normal 
range before voice treatment, significant changes were unable to be detected immediately following 
therapy (Kent, Kent, & Rosenbek, 1987). It may also be the case that as the smoothness of the vocal 
fold edges (data found in Chapter 2) in the majority of the participants was only mildly or 
moderately affected at baseline as observed in our preliminary study, this did not impact on 
aerodynamic function through the therapy period. 
Overall, the results of this study provide evidence to support the positive effects of intensive 
voice therapy on acoustic parameters of voice in individuals with vocal fold nodules. Although 
comparable outcomes were yielded in both traditional and intensive groups, the therapy duration 
differences were large (i.e., 3 weeks vs. 8 weeks). It is known that majority of the individuals with 
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vocal fold nodules work in professions which are high in voice demand, therefore, it is essential that 
they return to workforce as soon as possible with an adequate voice. Therefore, intensive voice 
therapy may be a preferable service delivery model as these individuals would be able to return to 
work with an improved voice within a shorter period of time. The benefits of such an intensive 
voice treatment include: voice improvement in a short period of time, increased patient compliance 
and understanding of home practice, more time efficient for both clinician and client, decreased 
time between sessions, and increased ability to carryover learned strategies into everyday life. 
Individuals are able to accelerate learning regulated by increasing therapy rate, therapy phase 
duration, and variability of practice, and decreasing the rest phase duration (Patel et al., 2011). 
Intensive contact with the clinician allows individuals with vocal fold nodules to resolve any 
queries and be provided with clinician’s feedback regarding their use of voice in a shorter time 
frame. This process can assist patients to consolidate their awareness and facilitates generalisation 
of treatment effects to daily living (Thibeault et al., 2009). In contrast, prolonged voice therapy as 
noted by Spielman et al. (2007) extends the time commitment for both client and clinician, with no 
additional gains to be made. 
One of the limitations of the current research, however was that a conventional randomised 
clinical trial (RCT) could not be conducted. The pragmatic allocation of participants to treatment 
groups was necessary to facilitate recruitment in the research setting of Taiwan where there is high 
work demands and minimal support for sick leave. The typical workforce in cultures such as 
Taiwan face considerable issues when seeking therapy, as people rarely take sick leave and are 
encouraged not to, for fear of job loss and reduced pay. Therefore, not all individuals were able to 
attend intensive treatment, even if it was their preferred treatment method. This study instead used 
pragmatic RCT, in which participants were able to enter the study according to their availability. 
Although a conventional RCT would have provided stronger internal validity, a pragmatic RCT 
reflects the “real world” scenario which provides good external validity (Hotopf, 2002). Another 
limitation is that no follow-up of participants has been conducted to examine participant quality of 
life, client satisfaction with intensive treatment and long-term maintenance of treatment effects. 
Such information should be examined in future research.  
 
3.6 Conclusion 
In conclusion, the positive improvements in acoustic parameters of voice identified in this 
study provide further evidence that intensive voice treatment is beneficial in the treatment vocal 
fold nodules. Intensive voice therapy should be considered as an option when providing clinical 
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management to individuals with vocal fold nodules. Consequently this population would be able to 
regain better vocal communication and return to the workforce in a shorter period of time. 
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CHAPTER FOUR 
4 Long-term Effects of an Intensive Voice Treatment for Vocal Fold Nodules 
The findings from Chapter 2 and Chapter 3 support that intensive voice therapy resulted in 
positive, immediate functional change on both subjective and objective parameters, comparable to 
traditional therapy. Although the outcomes were comparable, intensive therapy was delivered in a 
more time efficient manner (3 weeks versus 2 months) which may be a potential benefit for some 
individuals. However, whether or not this type of short term, intensive therapy model can ensure 
equally beneficial long term outcomes is not yet known. Studies have identified that contact with 
clinicians assists patients with vocal fold nodules to consolidate their awareness and facilitates 
generalisation of treatment effects to daily living (Verdolini-Marston, Burke, Lessac, Glaze, & 
Caldwell, 1995; Wenke et al., 2014). Whether or not a short term intensive therapy model also can 
achieve this is unknown. Therefore, the study presented in Chapter 4 of this thesis used quantitative 
research methods to elucidate the outcomes of treatment at 6 months using a range of perceptual, 
physiological and acoustic parameters, as well as a measure of the patients’ perception of functional 
voice impact. 
The manuscript contained in Chapter 4 entitled “Long-term Effects of an Intensive Voice 
Treatment for Vocal Fold Nodules” was accepted for publication in International Journal of Speech-
Language Pathology in June 2015 and was in-press at the time of thesis submission. It is inserted as 
published, with the exception of formatting and referencing changes that have been made to align 
with the style guidelines of the American Psychological Association and to maintain consistency 
throughout the thesis. An exception has been made for all references to the chapters of the thesis 
that have been published. In these cases, to assist the examiner, the reference has been modified to 
clarify which particular chapter of the thesis is cited in relation to the publication cited in this 
published paper (e.g., Fu et al., 2015 = Chapters 2 and 3). The references specific to this published 
paper have been included in the overall reference list of this thesis. 
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4.1 Abstract 
Purpose: The purpose of the current study was to examine the long-term effects of intensive voice 
treatment for vocal fold nodules, compared to outcomes for patients treated with traditional voice 
therapy. It was hypothesised that intensive treatment would provide comparable maintenance of 
vocal function, voice quality, and patients’ perception of quality of life when compared with 
traditional treatment at 6 month follow-up.  
Method: Thirty-six women diagnosed with bilateral vocal fold nodules who were treated with either 
traditional (n = 20; once a week for 8 weeks) or intensive (n = 16; eight sessions within 3 weeks) 
therapy. Each participant completed voice, stroboscopic, and acoustic assessments and the Voice 
Handicap Index before, immediately post, and 6 months post treatment.  
Result: Results revealed most improved perceptual, stroboscopic and acoustic parameters were 
maintained in both groups at 6 months post treatment, with no significant differences between the 
two groups. In addition, both groups maintained satisfaction on their perception of vocal function, 
with no significant difference between the two groups.  
Conclusion: The investigation provided further evidence that individuals with vocal fold nodules 
are able to maintain improved voice quality and vocal health following intensive voice treatment to 
a similar degree to traditional voice treatment.  
 
Keywords: Vocal fold nodules, treatment intensity, auditory perception, stroboscopy, acoustic, 
quality of life. 
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4.2 Introduction 
A number of studies have demonstrated the efficacy of treatment for vocal fold nodules, 
with voice therapy recommended as the first-line treatment (Blood, 1994; Holmberg, Doyle, 
Perkell, Hammarberg, & Hillman, 2003; Holmberg, Hillman, Hammarberg, Sodersten, & Doyle 
2001; Hogikyan, Appel, Guinn, & Haxer, 1999; Hufnagle & Hufnagle, 1984; Lancer, Syder, Jones, 
& Le Boutillier, 1988; Lockhart, Paton, & Pearson, 1997; Murry & Woodson, 1992; Verdolini-
Marston, Burke, Lessac, Glaze, & Caldwell, 1995). This body of existing research has shown that 
post behavioural therapy, voice quality significantly improves (Blood, 1994; Holmberg et al., 2001; 
Hufnagle & Hufnagle, 1984; Sellars, Carding, Deary, MacKenzie, & Wilson, 2002; Trullinger, 
Emmanuel, Skenes, & Malpass, 1988). It has also been shown that following voice therapy, there is 
either marked reduction or complete elimination of vocal fold nodules (Blood, 1994; Fisher & 
Logemann, 1970; Holmberg et al. 2001; Holmberg et al., 2003; Lancer et al., 1988; Niebudek-
Bogusz, Kotylo, Politanski, & Sliwinska-Kowalska, 2008a; Niebudek-Bogusz et al., 2008b; 
Schneider, 1993; Trullinger et al., 1988; van der Merwe, 2004). Where acoustic and aerodynamic 
measures have been reported, positive improvements in these parameters have been noted post 
treatment (Blood, 1994; Chernobelsky, 2007, Holmberg et al., 2001; Lockhart et al., 1997; 
Schneider, 1993; Trullinger et al., 1988). Patient’s perception of changes in vocal function post 
treatment have also been reported to improve significantly post treatment (Behrman, Rutledge, 
Hembree, & Sheridan, 2008; Niebudek-Bogusz et al., 2008a).  
Whilst the existing evidence largely supports voice therapy as the primary treatment for 
patients with vocal fold nodules, significant variation exists between studies regarding the intensity 
of the voice treatment provided (Blood, 1994; Chernobelsky, 2007; Hufnagle & Hufnagle, 1984; 
Lockhart et al., 1997; Treole & Trudeau, 1997; Trullinger et al., 1988). To date, only one study has 
specifically discussed the issue of intensity of voice therapy for vocal fold nodules, with recent 
evidence suggesting that positive outcomes can be achieved with intensive treatment (Fu, 
Theodoros, & Ward, 2015 – Chapters 2 & 3). That study compared a traditional and an intensive 
model of voice therapy and found significant improvements in acoustic, auditory perceptual and 
physiological parameters immediately post treatment following both interventions. Although both 
treatments resulted in largely equivalent outcomes, the intensive voice treatment was viewed as 
more beneficial and time efficient for people with busy work schedules, allowing them to return to 
work sooner with an improved voice and vocal fold health (Fu et al., 2015 – Chapters 2 & 3). These 
results were consistent with Patel, Bless, and Thibeault (2011) who speculated that the nature of 
high-intensity training may better mimic cognitive, motor, and physiological requirements of 
102 
 
activities of daily living than traditional therapy. Similarly, research relating to intensity of 
treatment for functional dysphonia supports the benefits of this protocol with patients demonstrating 
improved self-perception of voice handicap and well-being following two weeks of intensive voice 
and other multidisciplinary intervention (Fischer, Gutenbrunner, & Ptok, 2009). In a study 
comparing intensive treatment (four x 1-hour sessions per week for 2 weeks) with standard 
treatment (one x 1-hour session per week for 8 weeks) in a group of patients with functional 
dysphonia, Wenke et al. (2014) reported positive voice outcomes for both groups. However, a 
greater proportion of therapy time was spent on maintenance and generalisation of vocal techniques 
for the intensive treatment group. In addition, higher attendance rates, and greater improvement in 
voice handicap and well-being at 4 weeks follow-up was evident for patients in the intensive 
treatment group compared to those who received standard treatment. Wenke et al. (2014) suggested 
that the intensive treatment schedule may have enhanced motor learning and provided greater 
opportunity for patients to consolidate vocal hygiene and vocal techniques day-to-day.   
Although behavioural treatment has been found to be effective for the treatment of vocal 
fold nodules, there is limited long-term data to confirm the maintenance of the benefits achieved 
through either traditional or intensive treatment. Most studies report efficacy data based on 
outcomes recorded either immediately post voice treatment (Fu et al., 2015 – Chapters 2 & 3) or 
after a short-term (3 month) follow-up period (Blood, 1994; Chernobelsky, 2007; Holmberg et al., 
2001; Holmberg et al, 2003; Hogikyan et al., 1999; Hufnagle & Hufnagle, 1984; Lockhart et al., 
1997; Treole & Trudeau, 1997; Trullinger et al., 1988). Such studies support the maintenance of 
treatment benefits at 3 months (Blood, 1994), or significant improvement (Speyer, Wieneke, van 
Wijck-Warnaar, & Dejonckere, 2003). However, limited evidence for longer term effects exists. 
Pre-operative voice therapy for vocal fold nodules provided by a trained Speech-Language 
Pathologist (SLP) has been reported to correlate with a low incidence of prolonged post-operative 
dysphonia (Koufman & Blalock, 1989). Furthermore, in a retrospective study, Lancer et al. (1988) 
found that patients with vocal fold nodules who had received voice therapy in addition to surgery 
had a reduced incidence of recurrence 3 to 5 years after treatment.   
Although intensive voice treatment has been found to be beneficial with positive outcomes 
immediately after treatment, there remains limited validation of the long-term effects of intensive 
therapy. The aim of the current research was to examine the 6 month outcomes following intensive 
voice treatment for vocal fold nodules, and compare these with the outcomes for patients treated 
with traditional voice therapy. Based on the efficacy data reported immediately post treatment (Fu 
et al., 2015 – Chapters 2 & 3) it was hypothesised that intensive voice treatment would provide 
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comparable maintenance of improved perceptual and stroboscopic ratings, and patients’ perception 
of quality of life when compared with traditional voice treatment. 
 
4.3 Methods 
4.3.1 Participants 
Fifty-three women diagnosed with bilateral vocal fold nodules were initially recruited from 
the outpatient clinic at the Department of Otorhinolaryngology, Taipei Veterans General Hospital, 
Taiwan. The study was approved by the ethics committee at the Taipei Veterans General Hospital 
and The University of Queensland. The inclusion criteria for participants were that they had to be 
aged between 18 years and 55 years; be judged as having normal articulation, resonance, and 
language ability; normal hearing as determined by a screening test at 20 dB HL at 3 frequencies 
500, 1000, 2000 Hz; no previous professional singing or speaking training; no previous voice 
therapy or laryngeal surgical treatment; no use of prescription medication which may cause changes 
in laryngeal function, mucosa or muscle activity (list provided by National Center for Voice and 
Speech [NCVS], retrieved 26 June, 2009 from http://www.ncvs.org/e-learning/rx2.html); no current 
psychiatric or neurologic conditions; and no history of allergies, lung disease, or other concomitant 
vocal pathology (e.g., vocal polyp and vocal cyst). Twenty-four participants were allocated to 
intensive voice treatment (IVT) and 29 to traditional voice treatment (TVT). Participants were 
matched in pairs before treatment according to their age, occupation, and severity of dysphonia. The 
duration of dysphonia prior to treatment was not taken into consideration. The participants’ 
occupations were categorised into non-professional voice users (e.g., factory worker, students, 
catering, clerical worker, home carers, and unemployed) versus professional voice users (e.g., 
teachers, health professional, and sales personnel). All participants were diagnosed with bilateral 
broad-based nodules before treatment. Following the pre treatment assessment, participants in each 
pair were then assigned to either of the two treatment groups according to their availability, i.e., the 
frequency of therapy which is appropriate for their schedule and lifestyle. Outcomes achieved 
immediately post treatment for this cohort of 53 participants have been reported elsewhere (Fu et 
al., 2015 – Chapters 2 & 3).  
Of the 24 participants in the IVT group, 8 failed to return for the 6 month follow-up, leaving 
16 participants available for long-term assessment. Of the 29 participants in the TVT group, 9 could 
not be contacted or failed to return for the 6 month follow-up. Mean age of the 36 participants who 
completed assessments at 6 months post treatment was 36.4 years in TVT and 38.5 years in IVT 
group. Mild-moderate or moderate dysphonia was present at baseline in 90% in TVT and 100% of 
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IVT participants and 80% and 69% were professional voice users in the TVT and IVT groups 
respectively. Full details are outlined in Supplementary Material (provided in published paper as 
supplementary material - provided here in thesis as Appendix D). Comparisons of baseline 
characteristics between the two groups were conducted using independent t-tests for parametric data 
(age) and chi-square tests and Mann-Whitney U tests for non-parametric data (occupation and 
severity of dysphonia). Statistical analysis confirmed there were no statistical differences between 
the groups with regards to their age (t = -0.664, p = 0.511) and occupation (χ2 = 0.000, p = 1.000) at 
presentation. However, there was significant difference in the extent of severity of dysphonia (Z = -
2.382, p = 0.017) at baseline, as the current study groups were subsets of the original population 
reported elsewhere (Fu et al., 2015 – Chapters 2 & 3) which had been matched for dysphonia 
severity at the time of recruitment. At baseline, the IVT group had fewer participants who had mild-
moderate dysphonia but more participants with moderate dysphonia relative to the TVT group. 
There was no difference (χ2 = 0.801, p = 0.371) in the proportion of patients with surrounding 
oedema of the vocal folds at baseline (100% in TVT group, 87.5% in IVT group). The mean 
duration to follow-up assessments was 7.25 months (range, 6 – 11) for TVT group and 6.56 months 
(range, 6 – 10) for IVT group which was not significantly different (t = 1.412, p = 0.167).  
 
4.3.2 Procedure 
Auditory perceptual ratings, stroboscopic assessments, acoustic measurements, aerodynamic 
data and patient perception questionnaires were collected pre- and post treatment and at 6 months 
post treatment as part of a larger outcomes study (Fu et al., 2015 – Chapters 2 & 3). For the 
purposes of this study, which is to determine the long-term maintenance of the improved parameters 
post treatment, only those parameters which were found to have made significant positive 
improvements immediately post treatment (Fu et al., 2015 – Chapters 2 & 3) have been included in 
this investigation. These parameters included perceptual, physiological and acoustic parameters 
detailed further below. All participants received a total of nine sessions of voice therapy as 
described previously in Fu et al. (2015 – Chapters 2 & 3) and provided in full in the Supplementary 
Material online (provided here in thesis as Appendix E). Only the intensity of its delivery varied 
between the groups. The TVT group received one session of direct therapy per week for 8 weeks 
(eight sessions of therapy). The IVT group received eight sessions delivered within a 3 week period 
(i.e., three times per week in the first two weeks and two times in the third week). The therapy 
program was implemented by the principal investigator with 8 years of experience in voice 
disorders and not involved in assessment of the participants. The principal investigator was trained 
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and certified to provide the therapy program which was adapted from the Lessac-Madsen Resonant 
Voice Therapy (LMRVT) program developed by Verdolini Abbott (2008a, 2008b). 
     
4.3.2.1  Auditory perceptual ratings. 
At all time points, participants were asked to read aloud a five-sentence Mandarin passage, 
in a normal voice, at each assessment interval. All voice samples were collected with a Shure 
SM48-LC microphone in a sound-treated room and stored in the Computerised Speech Laboratory 
system (CSL; model 4500, Kay Elemetrics Co.) at a 4.41 KHz sampling rate. The desktop 
microphone was placed in front of each participant’s mouth at a distance of 15 cm (Thompson-
Ward & Theodoros, 1998).  
All speech samples were subsequently analysed perceptually by one primary SLP with 15 
years experience assessing voice disorders and not involved in the treatment process; a second SLP 
with 8 years experience assessing voice disorders performed ratings of a subset of the voice samples 
for determining reliability. Voice quality was assessed using the GRBAS scale (Hirano, 1981) 
which consists of five perceptual parameters: grade (G), roughness (R), breathiness (B), asthenicity 
(A) and strain (S). GRBAS data was analysed using the Comparison Mean Opinion Score (CMOS) 
process (ITU-P.800, 1996). This process involved voice samples being sorted into pairs (pre-post, 
pre-6 months, post-6 months) and then the order of the two samples in each pair was randomised to 
avoid any prediction bias. This process was performed by a clinician independent of the rating 
process. The rater who was blinded to the assessment time points then compared and listened to 108 
paired speech samples (3 samples for each participant) rating. After listening to each pair, the rating 
clinician evaluated sample 2 in relation to sample 1 for each of the five GRBAS parameters. A 
rating scale of -3 to +3, in which 0 indicates the samples are equal for each GRBAS parameter. If 
the value was negative, it indicated that sample 2 was worse than sample 1 (-1 mildly worse; -2 
worse and -3 severely worse) and vice versa. Raters were allowed to listen to the paired samples 
multiple times. Once the paired samples were rated, the principle investigator revealed the order of 
the two samples and transposed the scores to reflect the temporal order of the speech samples, such 
that any positive score indicated an improvement over time and negative values indicated declining 
function. 
To validate the reliability of the primary rater, a second SLP listened to and rated a random 
set of 21 paired samples (20% of the total voice samples). Inter-rater reliability was calculated using 
intraclass correlation coefficient (ICC) as well as direct calculation of the Percent Exact Agreement 
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(PEA) and the Percentage of Close Agreement (PCA - where raters differed by no more than 1 scale 
point). Inter-rater reliability was high with an ICC of 0.83, PEA of 71.4% and PCA of 97.1%. Intra-
rater reliability was calculated by having the primary rater re-rate 20% of the sample a second time, 
at no sooner than four weeks following initial assessment. The overall ICC calculated for intra-rater 
reliability was 0.886, while PEA was 88.6% and PCA was 100%.  
 
4.3.2.2 Stroboscopic evaluation – physiological ratings. 
 The examination procedure was conducted by any one of five otolaryngologists at any 
assessment point. The stroboscopic recordings were performed during the sustained phonation of 
the vowel /i/ produced at a comfortable loudness and pitch. The recorded stroboscopic samples 
were then subsequently rated by one primary otolaryngologist with 10 years experience in assessing 
voice disorders. The stroboscopic ratings were performed in two stages which are described fully in 
Fu et al. (2015 – Chapter 2) and provided in Supplementary material online (provided here in thesis 
as Appendix F and G). A total of 108 samples (36 participants by three samples per participant) 
were randomised prior to presentation to the otolaryngologist for rating in order to reduce any 
potential bias, i.e., the rater was blinded to the assessment time points when rating samples. 
The reliability of the primary rater was determined using a second otolaryngologist with ten 
years experience assessing voice disorders who rated a random set of 21 paired samples (20% of the 
stroboscopic samples). Inter-rater reliability was calculated using ICC as well as PEA and PCA. 
Inter-rater reliability was adequate with ICC of 0.753, PEA of 69.1% and PCA of 94.1%. Intra-rater 
reliability was calculated by having the primary rater re-rate 20% of the sample a second time, at no 
sooner than four weeks following initial assessment. The overall ICC was 0.776. The PEA 
calculated for intra-rater reliability was 78.6%, while PCA was 94.5%.  
 
4.3.2.3 Acoustic assessment. 
Each participant was asked to produce a sustained vowel /a/ on one breath at a comfortable 
pitch and loudness level, three times. Vowel productions were recorded via the desktop microphone 
of the Computerized Speech Lab (CSL) (Model 5105, Kay Elemetrics Co.). All acoustic recordings 
were conducted in a sound-proof room with the microphone positioned in front of the participant at 
a mouth-to-microphone distance of 15 cm (Thompson-Ward & Theodoros, 1998). The recordings 
of each vowel production were subsequently analysed using the Multi-Dimensional Voice Program 
(MDVP) software in the CSL. The middle 3-second segment from each of the sustained vowels was 
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selected for analysis. Acoustic measures included: vocal fundamental frequency (F0) (Hz), mean 
vocal jitter (%) and shimmer (%), and noise-to-harmonics ratio (NHR) (dB). Results across the 
three vowel phonations were averaged to produce a single value for each measure. Participant vocal 
intensity (VI) (dB) for the three prolonged vowels /a/ and additional conversational speech samples 
were simultaneously measured using Sound Level Meter (320 series, Center Technology Corp., 
Taiwan) positioned in front of the participant with a mouth-to-microphone distance of 15 cm. Vocal 
intensity levels were averaged to produce a single value for each speaking task. 
 
4.3.2.4 Voice Handicap Index. 
The Chinese version of Voice Handicap Index (VHI) (Lam et al., 2006) was used to 
quantify self-assessment of voice-related quality of life. The VHI is a 30-item instrument consisting 
of three domains: emotional, physical, and functional aspects (each 10 questions). A total score 
(ranging from 0 to 120) was generated. A lower total score represents less self perceived voice-
related quality of life problems.  
 
4.3.3 Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., Chicago, IL) 
was used for statistical analysis with significance set at p < 0.05. Although multiple analyses were 
conducted, alpha level adjustment was not adopted. Only the acoustic data and the total score from 
the VHI questionnaire were parametric, allowing use of two-factor repeated measures analyses of 
variances (ANOVAs) analysis to identify differences between the two treatment groups (IVT and 
TVT) and across the three time points. Where a significant (p < 0.05) effect for time was found, 
post-hoc analyses were performed (i.e., between pre- and post treatment, pre- and 6 months post 
treatment, and post- and 6 months post treatment) within each group. For the other parameters 
analyses were performed both within group across time and then between groups. 
 
Within group analysis 
Paired comparison ratings conducted for the GRBAS parameters and for nodule size and 
oedema were analysed using a series of one sample t-tests (two-tailed) where 0 was taken to 
indicate no difference between the sample pairs. For the physiological parameters of symmetry of 
vocal fold abduction and vibration, the regularity and amplitude of the vocal fold movement, vocal 
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fold edge smoothness, mucosal wave, and glottal closure, Friedman’s tests were used to explore the 
extent of within group change in each treatment group (IVT and TVT) across time. Significant 
results were examined using post-hoc Wilcoxon signed rank tests.  
 
Between group analysis 
To explore differences between the two treatment groups (IVT and TVT) for the perceptual 
and physiological data from the paired comparisons ratings, the proportions of participants 
identified as either better, worse or no different at pre- to 6 months post treatment and post 
treatment to 6 months post treatment were calculated then compared between the groups, using Chi-
square tests.  
Prior to conducting the between group analysis, data from the physiological ratings of vocal 
fold structure and movement, were converted to change scores, calculated as the difference between 
pre- and post treatment, pre- and 6 months post treatment, and immediately post treatment and 6 
months post treatment for participants in each group. Mann-Whitney U tests were used to determine 
differences in the extent of change between the IVT and TVT groups pre- to immediately post 
treatment, pre- to 6 months post treatment, and immediately post treatment to 6 months post 
treatment. 
 
4.4 Results 
4.4.1 Auditory Perceptual Ratings 
Within group analysis 
Results of perceptual analyses for the TVT and IVT groups are provided in Table I. Between 
baseline and post treatment, both the TVT and IVT groups were found to have significantly 
improved ratings of overall voice quality, weakness of voice, and strain. The TVT group showed 
significant improvement on roughness. Between baseline and 6 months post treatment, both TVT 
and IVT groups showed a statistically significant improvement in ratings of overall voice quality, 
roughness, weakness and strain of voice (Table 4.1). No significant changes were observed on any 
parameter in either group between immediately post treatment and 6 months post treatment, 
indicating that post treatment improvements had been maintained at 6 months. 
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Between group analysis 
Results revealed no significant differences in the proportions of participants who 
demonstrated change between the groups at either baseline to post treatment, baseline to 6 months 
post treatment or post treatment to 6 months post treatment for all perceptual parameters (see Table 
4.2). Exploring patterns of change in both groups revealed that overall grade (severity of dysphonia) 
had improved in 80% of the TVT and 63% of the IVT group immediately post treatment. At 6 
months, compared to baseline in 60% of the TVT and 56% of the IVT group had improved overall 
voice severity.      
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Table 4.1  
Within Group Analysis of Perceptual Ratings for Both Traditional Voice Therapy (TVT) and Intensive Voice Therapy (IVT) Groups 
  TVT IVT 
Time Parameter Mean difference T p Mean difference t p 
Pre tx to post tx Grade 0.75 3.94 0.001* 0.69 2.91 0.011* 
 Roughness 0.71 4.27 <0.001* 0.50 2.07 0.06 
 Breathiness 0.25 1.75 0.096 0.87 1.43 0.17 
 Asthenia 0.55 3.24 0.004* 0.81 2.15 0.048* 
 Strain 0.50 3.68 0.002* 0.89 2.24 0.041* 
Pre tx to 6M post tx Grade 0.75 3.94 0.001* 0.81 3.90 0.001* 
 Roughness 0.75 3.94 0.001* 0.69 3.47 0.003* 
 Breathiness 0.30 2.04 0.055 0.31 2.08 0.06 
 Asthenia 0.30 2.85 0.010* 0.50 2.74 0.015* 
 Strain 0.45 2.44 0.025* 0.81 3.90 0.001* 
Post tx to 6M post tx Grade 0.05 0.44 0.666 0.06 0.44 0.67 
 Roughness 0.05 0.57 0.577 -0.06 -0.56 0.58 
 Breathiness 0.05 1.00 0.330 0.13 1.46 0.16 
 Asthenia -0.10 -1.45 0.163 -0.06 -1.00 0.33 
 Strain -0.06 -1.00 0.330 0.13 1.46 0.16 
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; tx = treatment; 6M = six months. 
* indicates a statistically significant difference. 
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Table 4.2  
Analysis of the Proportion of Change in Number of Participants in Perceptual Ratings Observed Between the Two Groups 
Parameter/Time  TVT  IVT  χ2 p 
Grade       
 Pre tx to post tx Post tx better 16 (80%) 10 (63%) 2.98 0.23 
 Post tx worse 3 (15%) 2 (12%)   
 No change 1 (5%) 4 (25%)   
 Pre tx to 6M post tx 6M post tx better 12 (60%) 9 (56%) 0.99 0.61 
 6M post tx worse 1 (5%) 0 (0%)   
 No change 7 (35%) 7 (44%)   
 Post tx to 6M post tx 6M post tx better 3 (15%) 3 (19%) 0.17 0.92 
 6M post tx worse 2 (10%) 2 (12%)   
 No change 15 (75%) 11 (69%)   
Roughness      
 Pre tx to post tx Post tx better 15 (75%) 10 (63%) 0.71 0.70 
 Post tx worse 2 (10%) 2 (12%)   
 No change 3 (15%) 4 (25%)   
 Pre tx to 6M post tx 6M post tx better 12 (60%) 8 (50%) 1.44 0.49 
 6M post tx worse 1 (5%) 0 (0%)   
 No change 7 (35%) 8 (50%)   
 Post tx to 6M post tx 6M post tx better 2 (10%) 1 (6%) 0.76 0.68 
 6M post tx worse 1 (5%) 2 (13%)   
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 No change 17 (85%) 13 (81%)   
Breathiness      
 Pre tx to post tx Post tx better 7 (35%) 5 (31%) 0.090 0.96 
 Post tx worse 2 (10%) 2 (13%)   
 No change 11 (55%) 9 (56%)   
 Pre tx to 6M post tx 6M post tx better 6 (30%) 4 (25%) 1.008 0.60 
 6M post tx worse 1 (5%) 0 (0%)   
 No change 13 (65%) 12 (75%)   
 Post tx to 6M post tx 6M post tx better 1 (5%) 2 (12%) 0.655 0.42 
 6M post tx worse 0 (0%) 0 (0%)   
 No change 19 (95%) 14 (88%)   
Asthenia      
 Pre tx to post tx Post tx better 10 (50%) 4 (25%) 3.600 0.17 
 Post tx worse 1 (5%) 0 (0%)   
 No change 9 (45%) 12 (75%)   
 Pre tx to 6M post tx 6M post tx better 6 (30%) 6 (37%) 0.225 0.64 
 6M post tx worse 0 (0%) 0 (0%)   
 No change 14 (70%) 10 (53%)   
 Post tx to 6M post tx 6M post tx better 0 (0%) 0 (0%) 0.164 0.69 
 6M post tx worse 2 (10%) 1 (6%)   
 No change 18 (90%) 15 (94%)   
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Strain 
 Pre tx to post tx Post tx better 11 (55%) 6 (38%) 1.099 0.58 
 Post tx worse 8 (40%) 1 (6%)   
 No change 1 (5%) 9 (56%)   
 Pre tx to 6M post tx 6M post tx better 9 (45%) 9 (56%) 1.828 0.40 
 6M post tx worse 2 (10%) 0 (0%)   
 No change 9 (45%) 7 (44%)   
 Post tx to 6M post tx 6M post tx better 0 (0%) 2 (12%) 3.355 0.19 
 6M post tx worse 1 (5%) 0 (0%)   
 No change 19 (95%) 14 (88%)   
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; 6M = six months; tx = treatment. 
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4.4.2 Videostroboscopic Ratings – Physiological Parameters 
Within group analysis 
Compared to baseline, vocal fold nodules remained in all participants immediately post 
treatment and with residual nodules at 6 months post treatment in both groups. In TVT group, 80% 
(n = 16) of the group had surrounding oedema of vocal folds immediately post treatment and all 
returned with oedema at 6 months post treatment. When compared with baseline, there was a 
significant change in the proportion of participants with persistent oedema at immediately post 
treatment (2 = 4.444, p = 0.035), but not at 6 months post treatment. In IVT group, 62.5% (n = 10) 
continued to have oedema immediately post treatment and 93.8% (n = 15) had oedema at 6 months 
post treatment. When compared with baseline, there were no apparent changes in the proportion of 
participants who continued to have oedema at immediately post treatment (2 = 2.667, p = 0.102) or 
6 months post treatment (2 = 0.368, p = 0.544). Results of the physiological ratings of symmetry of 
vocal fold abduction, amplitude of vocal fold movement, mucosal wave, vocal fold edge 
smoothness, regularity of vocal fold movement, and glottal closure in both the IVT and TVT groups 
are summarised in Table 4.3. Friedman’s test revealed a significant (p < 0.05) difference across the 
three time points for ratings of mucosal wave, vocal fold edge smoothness, and glottal closure in 
both the IVT and TVT groups (Table 4.3). There were no significant differences observed for 
symmetry of vocal fold abduction, amplitude of vocal fold movement, or regularity of vocal fold 
movement over time in either group (Table 4.3). 
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Table 4.3  
Within Group Analysis of Physiological Parameters for Both Traditional Voice Therapy (TVT) and 
Intensive Voice Therapy (IVT) Groups 
Parameter/Group Pre tx 
mean (SD) 
Post tx 
mean (SD) 
6M Post tx 
mean (SD) 
χ2 p 
Symmetry      
 TVT 1.05 (0.39) 1.20 (0.41) 1.35 (0.59) 4.57 0.10 
 IVT 1.25 (0.68) 1.13 (0.52) 1.00 (0.37) 2.25 0.32 
Amplitude      
 TVT 1.00 (0.69) 1.00 (0.56) 1.00 (0.56) 0.00 1.00 
 IVT  1.00 (0.82) 1.33 (0.62) 1.06 (0.68) 3.00 0.22 
Mucosal wave      
 TVT 2.00 (0.56) 0.60 (0.68) 1.85 (0.59) 27.37 <0.001* 
 IVT 1.75 (0.68) 0.27 (0.46) 1.75 (0.78) 24.27 <0.001* 
VF edge 
smoothness 
     
 TVT 1.80 (0.52) 1.05 (0.51) 1.30 (0.47) 20.59 <0.001* 
 IVT 1.56 (0.62) 1.13 (0.52) 1.19 (0.54) 8.19 0.017* 
Regularity      
 TVT 1.20 (0.52) 0.95 (0.51) 1.40 (0.50) 5.63 0.06 
 IVT 1.25 (0.58) 0.87 (0.52) 1.19 (0.40) 5.00 0.08 
Glottal closure      
 TVT 1.50 (0.51) 0.65 (0.67) 0.95 (0.69) 16.88 <0.001* 
 IVT 1.56 (0.51) 1.13 (0.64) 1.00 (0.57) 7.94 0.019* 
Note. IVT = intensive voice therapy; TVT = traditional voice therapy; 6M = six months; tx = 
treatment; VF = vocal fold; SD = standard deviation.  
* indicates a statistically significant difference. 
 
 
Post-hoc tests revealed there were significant (p < 0.05) improvement in mucosal wave 
(TVT: Z = -3.798, p < 0.001; IVT: Z = -3.502, p < 0.001), vocal fold edge smoothness (TVT: Z = -
3.638, p < 0.001; IVT: Z = -2.333, p = 0.020), and glottal closure (TVT: Z = -3.368, p = 0.001; 
IVT: Z = -2.333, p = 0.020) from pre- to post treatment in TVT and IVT groups. From pre to 6 
months post treatment there remained significant improvements in vocal fold edge smoothness (Z = 
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-2.887, p = 0.004) and glottal closure (Z = -2.668, p = 0.008) in TVT group. In comparison only 
glottal closure (Z = -2.271, p = 0.023) was significantly improved between pre and 6 months post in 
IVT group. No significant changes were evident in mucosal wave (TVT: Z = 0.905, p = 0.366; IVT: 
Z = -0.187, p = 0.852) between baseline to 6 months post treatment in either group, indicating that 
the mucosal wave changes observed post treatment had not been maintained. This finding was 
confirmed by a significant decline in mucosal wave observed between post treatment and 6 months 
in both groups (TVT: Z = -3.601, p < 0.001; IVT: Z = -3.391, p = 0.001). No significant differences 
were observed between post treatment and 6 months for vocal fold edge smoothness (TVT: Z = -
1.890, p = 0.059; IVT: Z = 0.000, p = 1.000) or glottal closure (TVT: Z = -1.732, p = 0.083; IVT: Z 
= -2.271, p = 0.023) indicating maintenance of these parameters from post treatment to 6 months. 
 
Between group analysis 
There were no apparent differences between the two groups between the proportion of 
individuals with persistent oedema at either post treatment (χ2 = 1.357, p = 0.244) or 6 months post 
treatment (χ2 = 1.286, p = 0.257). For the other parameters, Mann-Whitney U tests revealed only 
one parameter, symmetry, was found to have a greater degree of change in the TVT group (pre to 6 
months post treatment) compared to the IVT group (Table 4.4).  
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Table 4.4  
Between Group Analysis of Extent of Change in Physiological Parameters in Both the Traditional 
Voice Therapy (TVT) and Intensive Voice Therapy (IVT) Groups 
Time /Parameter TVT  
Mean difference (SD) 
IVT  
Mean difference (SD) 
Z p 
Pre tx vs. post tx     
   Symmetry 0.15 (0.49) -0.19 (0.91) -1.09 0.37 
   Amplitude 0.00 (0.65) 0.25 (0.68) -0.97 0.33 
   Mucosal wave -1.4 (0.82) -1.50 (0.73) -0.04 0.97 
   VF edge smoothness -0.75 (0.55) -0.50 (0.63) -1.09 0.27 
   Regularity -0.25 (0.79) -0.44 (0.73) -0.73 0.52 
   Glottal closure -0.85 (0.74) -0.50 (0.63) -1.53 0.13 
Pre tx vs. 6M post tx     
   Symmetry -0.30 (0.73) 0.25 (0.68) -2.18 0.03* 
   Amplitude 0.00 (0.56) -0.06 (0.99) -0.06 0.95 
   Mucosal wave 0.15 (0.74) 0.00 (1.15) -0.69 0.49 
   VF edge smoothness -0.50 (0.61) 0.37 (0.81) -0.42 0.67 
   Regularity -0.20 (0.69) 0.06 (0.77) -0.98 0.33 
   Glottal closure 0.55 (0.76) 0.50 (0.73) -0.59 0.55 
Post tx vs. 6M post tx     
   Symmetry 0.15 (0.489) -0.06 (0.772) -1.37 0.17 
   Amplitude 0.00 (0.459) -0.19 (0.981) -1.01 0.37 
   Mucosal wave 1.25 (0.851) 1.50 (0.730) -0.86 0.39 
   VF edge smoothness 0.25 (0.550) 0.13 (0.719) -0.09 0.93 
   Regularity 0.45 (0.759) 0.38 (0.619) -0.09 0.93 
  Glottal closure 0.30 (0.733) 0.00 (0.730) -1.12 0.26 
Note. 6M = six months; tx = treatment; VF = vocal fold; IVT = intensive voice therapy; TVT = 
traditional voice therapy; SD = standard deviation. 
 
 
4.4.3 Videostroboscopic Ratings – Comparison of Pairs 
Within group analysis 
Paired samples comparisons (baseline to post treatment, baseline to 6 months post treatment, 
or post treatment to 6 months post treatment) for vocal fold nodule size and surrounding oedema in 
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TVT and IVT groups were analysed using a series of one sample t-tests. Both TVT and IVT had 
significantly improved ratings of vocal nodule size (TVT: t = 4.333, mean diff = 0.650, p < 0.001; 
IVT: t = 9.539, mean diff = 0.867, p < 0.001) and vocal fold oedema (TVT: t = 3.559, mean diff = 
0.600, p = 0.002; IVT: t = 6.205, mean diff = 0.733, p < 0.001) immediately following treatment. 
Between baseline and 6 months both groups had significant improvement for vocal fold nodule size 
(TVT: t = 5.252, mean diff = 0.750, p < 0.001; IVT: t = 4.392, mean diff = 0.750, p = 0.001) and 
surrounding oedema (TVT: t = 4.951, mean diff = 0.650, p < 0.001; IVT: t = 3.093, mean diff = 
0.563, p = 0.007). From immediately post to 6 months post treatment, significant reduction was 
found for nodule size (t = 2.806, mean diff = 0.600, p = 0.014) but not for surrounding oedema (t = 
2.806, mean diff = 0.400, p = 0.082) in IVT group. TVT group did not show significant changes 
from post-treatment to 6 months post treatment, on either nodule size (t = 1.789, mean diff = 0.350, 
p = 0.090) or surrounding oedema (t = 0.623, mean diff = 0.100, p = 0.541).  
 
Between group analysis 
Chi-squared tests showed there were no differences between the groups in the proportion of 
patients who had improved, worsened, or had no change in their vocal fold nodule size or oedema 
(Table 4.5) at either baseline to post treatment, baseline to 6 months post treatment or post- to 6 
months post treatment. In the TVT group 75% had reduced vocal fold nodules and reduced oedema 
immediately post treatment, while 85% had reduced nodule size and 70% reduced oedema at 6 
months post treatment. In the IVT group, post treatment 87% and 73% had reduced nodule size and 
oedema, respectively. By 6 months post treatment 88% and 69% had reduced nodule size reduced 
oedema ratings, respectively. 
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Table 4.5  
Analysis of the Proportion of Change in Number of Participants in Physiological Ratings Observed 
Between the Two Groups 
Parameter/Time  TVT IVT χ2 p 
Vocal nodule size      
 Pre tx to post tx Post tx smaller 15 (75%) 13 (87%) 1.66 0.45 
 Post tx larger 2 (10%) 0 (0%)   
 No change 3 (15%) 2 (13%)   
 Pre tx to 6M post tx 6M post tx smaller 17 (85%) 14 (88%) 0.86 0.65 
 6M post tx larger 2 (10%) 2 (12%)   
 No change 1 (5%) 0 (0%)   
 Post tx to 6M post tx 6M post tx smaller 12 (60%) 12 (80%) 2.04 0.24 
 6M post tx larger 5 (25%) 3 (20%)   
 No change 3 (15%) 0 (0%)   
Surrounding oedema      
 Pre tx to post tx Post tx less 15 (75%) 11 (73%) 3.64 0.16 
 Post tx greater 3 (15%) 0 (0%)   
 No change 2 (10%) 4 (27%)   
 Pre tx to 6M post tx 6M post tx less 14 (70%) 11 (69%) 0.76 0.68 
 6M post tx greater 1 (5%) 2 (12%)   
 No change 5 (25%) 3 (19%)   
 Post tx to 6M post tx 6M post tx less 6 (30%) 9 (60%) 3.88 0.14 
 6M post tx greater 4 (20%) 3 (20%)   
 No change 10 (50%) 3 (20%)   
Note. 6M = six months; tx = treatment; IVT = intensive voice therapy; TVT = traditional voice 
therapy. 
 
 
4.4.4 Acoustic Assessment 
A series of two-factor ANOVAs (group x time) conducted for each acoustic parameter 
revealed no significant interactions between group and time for any parameters (Table 4.6). A 
significant main effect for time was observed for F0, jitter, shimmer, NHR and vocal intensity of 
prolonged /a/, with both groups showing an increase in values across the three time periods for F0 
and vocal intensity (prolonged /a/) and a reduction in values for jitter, shimmer, and NHR. There 
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was no significant main effect for vocal intensity in conversation. The between group effect was not 
significant across all acoustic parameters, suggesting no difference in the effects of the two 
interventions on acoustic measures (Table 4.6) 
Post-hoc tests were performed on the acoustic parameters which demonstrated a significant 
main effect for time. Pre- to post treatment, the TVT group had a significant increase in F0 (mean 
diff = 27.404, p < 0.001) and decrease in jitter (mean diff = -0.851, p < 0.001), shimmer (mean diff 
= -1.316, p = 0.007), and NHR (mean diff = -0.032, p = 0.038). The IVT group demonstrated 
significant reduction in F0 (mean diff = 34.985, p < 0.001) immediately post treatment only. From 
pre to 6 months post treatment, the TVT group retained the significant increase in F0 (mean diff = 
22.884, p = 0.001) and vocal intensity of prolonged /a/ (mean diff = 4.351, p = 0.026). The IVT 
group showed a significant increase in F0 (mean diff = 25.621, p = 0.005) and decreases in jitter 
(mean diff = -0.581, p = 0.006), shimmer (mean diff = -2.152, p = 0.015), and NHR (mean diff = -
0.030, p = 0.047) between pre to 6 months. When comparing immediately post treatment to 6 
months post treatment, no significant changes were observed on any acoustic parameters for either 
group. 
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Table 4.6 
Results of Acoustic Measures for Traditional Voice Therapy and Intensive Voice Therapy Groups 
 
Task/Group 
Pre tx 
Mean (SD) 
Post tx 
Mean (SD) 
6M post tx 
Mean (SD) 
Interaction effect Main effect for time Between group effect 
F P Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
F p Effect 
size 
(Partial 
eta 
squared) 
F0 (Hz)             
   TVT 203.12 (24.44) 230.53 (27.10) 226.01 (32.36) 0.69 0.51 0.04 39.15 <0.001* 0.70 0.72 0.40 0.02 
   IVT 192.31 (36.77) 227.29 (26.92) 217.93 (24.59)          
Jitter (%)             
   TVT 2.08 (1.12) 1.23 (0.93) 1.50 (1.56) 0.88 0.43 0.05 11.43 <0.001* 0.41 0.02 0.89 0.00 
   IVT 2.31 (1.01) 1.46 (0.83) 1.15 (0.79)          
Shimmer (%)             
 TVT 4.95 (1.66) 3.63 (1.62) 3.93 (2.14) 1.02 0.37 0.06 7.89 0.002* 0.32 2.53 0.12 0.07 
 IVT 6.19 (2.37) 4.34 (1.64) 4.04 (1.34)          
NHR 
   TVT 
 
0.17 (0.04) 
 
0.13 (0.04) 
 
0.15 (0.43) 
 
1.29 
 
0.29 
 
0.07 
 
4.75 
 
0.015* 
 
0.22 
 
0.18 
 
0.68 
 
0.01 
   IVT 0.16 (0.04) 0.14 (0.03) 0.13 (0.01)          
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VI of 
prolonged     
/a/ (dB) 
   TVT 74.84 (5.00) 78.57 (6.95) 78.97 (5.81) 0.27 0.77 0.02 7.11 0.003* 0.31 0.026 0.87 0.00 
   IVT 74.60 (5.29) 77.49 (5.64) 79.12 (6.00)          
VI of 
conversation 
(dB) 
            
   TVT 70.60 (4.00) 71.43 (3.98) 72.96 (4.03) 0.42 0.66 0.03 2.45 0.103 0.14 0.02 0.88 0.00 
   IVT 71.65 (3.88) 71.45 (3.16) 72.55 (3.96)          
Note. F0 = fundamental frequency; NHR = noise-to-harmonic ratio; VI = vocal intensity; IVT = intensive voice therapy; TVT = traditional voice 
therapy; SD = standard deviation; 6M = six months.  
* indicates a statistically significant difference.  
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4.4.5 Voice Handicap Index 
Mean total VHI score at pre-, post- and 6 months post treatment in the TVT group was 
41.25 (SD 18.07), 21.6 (SD 14.93) and 21.65 (SD 14.32), respectively. In the IVT group, the mean 
of the total scores was 49.69 (SD 19.02), 34.19 (SD 19.2) and 28.12 (SD 23.08) at pre-, post- and 6 
months post treatment. Two-factor ANOVA (group x time) conducted for VHI total scores revealed 
no significant interactions between group and time (F = 1.397, p = 0.262, effect size 0.078). A 
significant main effect was observed for time (F = 21.981, p < 0.001, effect size 0.571), with both 
groups showing a decrease in values between pre to post treatment. There was no significant 
between group effect (F = 3.135, p = 0.086, effect size 0.084), suggesting no difference in the 
effects of the two interventions on VHI total scores. 
Post-hoc tests revealed both groups demonstrated a significant decrease in total score (TVT: 
mean diff = 19.65, p < 0.001; IVT: mean diff = 15.50, p = 0.005) between pre- and post-treatment. 
Both groups also experienced significant decreases in total scores (TVT: mean diff = 19.65, p < 
0.001; IVT: mean diff = 15.50, p = 0.005) between pre- and 6 months post treatment. However, 
there were no significant differences in total scores between immediately post- and 6 months post 
treatment for both treatment (TVT: mean diff = -0.050, p = 1.000; IVT: mean diff = 6.063, p = 
0.268). 
 
4.5 Discussion 
The aim of the study was to examine and compare the long-term outcomes of two voice 
treatment delivery protocols. The results suggested that both groups were able to maintain most 
improvements in voice quality and vocal function at 6 months post treatment with no significant 
differences between the IVT and TVT groups with respect to degree of changes pre- to 6 months 
post treatment and immediately post treatment to 6 months post treatment. In addition, the 
individuals in both groups maintained their satisfaction with the improved vocal function at 6 
months follow-up with no significant differences between the two groups. These outcomes confirm 
our hypothesis that intensive voice treatment provides comparable long-term maintenance of vocal 
function, voice quality, and patients’ perception of quality of life when compared with traditional 
voice treatment. The evidence also supports the notion that that IVT may be considered an option 
when providing services to individuals with vocal fold nodules who have a busy lifestyle and desire 
to work on their voice issues in a more intensive manner, over a short period of time.  
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In the current investigation, between baseline to immediately post treatment both TVT and 
IVT groups had significantly improved ratings of overall voice quality, weakness and strain of 
voice. This pattern was similar to that observed in the larger cohort data previously published (Fu et 
al., 2015 – Chapters 2 & 3). However, the current data was able to confirm that by 6 months post 
treatment both groups continued to present with improvements in these perceptual parameters 
compared to pre treatment. Previous investigations have reported more than half (67 – 70%) of their 
patients with nodules, who received voice therapy without any surgical intervention, had resolution 
or improvement of their vocal symptom (including hoarseness, pain, weakness and voice loss) 
following discharge from voice therapy (Koufman & Blalock, 1989; Lancer et al., 1988). Similarly 
in the current study, over half (56%-60%) of the participants in both treatment groups were rated as 
having less severe voice impairments at 6 months. Comparison between the outcomes achieved by 
participants in both groups revealed no differences in the perceptual outcomes between the two 
groups at 6 months post treatment. Although IVT was completed within such a condensed period of 
time, the maintenance of vocal quality was not affected. Therefore, the use of intensive voice 
treatment as a means of accelerating the process of recovery was supported.  
Regarding physiological parameters, a similar pattern of positive improvements pre- to post 
treatment and pre- to 6 months post treatment was observed. Both groups had significant 
improvements in mucosal wave, vocal fold edge smoothness, and glottal closure immediately post 
treatment and significant reductions in nodules and surrounding oedema. These positive 
physiological outcomes post treatment have been reported by previous studies (Blood, 1994; Fisher 
& Logemann, 1970; Fu et al., 2015 – Chapters 2 & 3; Holmberg et al, 2001; Holmberg et al., 2003; 
Niebudek-Bogusz et al., 2008a; Niebudek-Bogusz et al., 2008b; Schneider, 1993; van der Merwe, 
2004). Specifically researchers have found vocal fold edge smoothness, regularity of vocal fold 
vibration, quality of mucosal wave and vocal fold closure to have improved with voice training; and 
elimination or marked reductions in nodules and surrounding oedema to have been dissipated post 
voice treatment (Blood, 1994; Fisher & Logemann, 1970; Holmberg et al, 2001; Holmberg et al., 
2003; Niebudek-Bogusz et al., 2008a; Niebudek-Bogusz et al., 2008b; Schneider, 1993; van der 
Merwe, 2004). At 6 months post treatment, most of these positive benefits had been maintained. 
There remained a significant improvement in glottal closure at 6 month follow-up in both groups, 
and the TVT group had maintained the improvement in vocal fold edge smoothness. However in 
both groups, the positive impact of treatment on the mucosal wave had not been maintained and had 
returned to levels comparable with pre treatment function. Our previous investigation has shown 
that mucosal wave function was improved significantly following vocal hygiene (Fu et al., 2015 – 
Chapters 2 & 3). It has also been reported by Schneider (1993) and Verdolini-Marston, Sandage, 
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and Titze (1994) that hydration improves the laryngeal appearance and function. Therefore, a 
possible explanation for the lack of maintenance of mucosal wave properties could be that the 
participants had not continued to maintain adequate hydration.   
The study also confirmed the findings of previous investigations that voice therapy reduces 
the incidence of nodule recurrence (Koufman & Blalock, 1989; Lancer et al., 1988), as participants 
from both groups had significantly reduced vocal nodule size at 6 month follow-up when compared 
with baseline. In addition, only IVT group demonstrated further reduction in nodule size at 6 
months post treatment when compared with immediately post treatment. This finding suggests that 
ongoing normalisation can continue to occur in the months post treatment. However, although 
changes in nodule sizes were observed, participants from both groups still continued to have 
nodules and oedema in situ. This indicates that it is important to reinforce to this patient group that 
instruction given in vocal hygiene session and direct vocal exercises must be continued after 
completion of treatment, for elimination of nodules and oedema to eventually occur. In contrast, if 
the patient ceases to comply with the vocal hygiene strategies and vocal exercises routines post 
treatment, exacerbation of nodule and oedema may arise. Although one study on long-term effect 
has reported that there was no recurrence vocal fold nodules 3-5 years after voice therapy based on 
a self-reported questionnaire (Lancer et al., 1988), to date, no other studies have conducted direct 
physiological assessment. Therefore, it is unclear whether or not vocal fold nodules were persistent 
in other study groups at long-term follow-up. It is also unclear as to the expected number of patients 
who would still have nodules remaining and the duration required for vocal fold nodules to 
completely resolve after voice treatment. However, from the findings in the current study, it is 
evident that at 6 months post treatment some nodules and surrounding oedema remain, therefore 
patients need ongoing compliance in order to maintain the benefits of the voice treatment. 
Our previous study found there were significant improvements on most of the investigated 
acoustic measures post treatment in both TVT and IVT groups immediately post treatment (Fu et 
al., 2015 – Chapters 2 & 3). Our current research, however, failed to yield similar results with the 
smaller cohort reported here. Although it was shown there were significant increases in F0 in both 
groups at both post treatment and 6 months, only the IVT group showed improvements in jitter, 
shimmer, NHR, and vocal intensity of prolonged vowel at 6 months compared to baseline. This 
discrepancy in outcomes between groups could be due to the significant differences with 
distribution of severity of dysphonia prior to treatment, with more patients with moderate dysphonia 
in the TVT group. The improved F0 observed in both groups which was maintained at 6 months 
may be due to a reduction in size of the vocal fold nodules and a decrease in surrounding oedema 
resulting in a decrease in the mass loading effects on the vibratory characteristics of the vocal folds 
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(Fu et al., 2015 – Chapters 2 & 3). The finding of increased F0 is consistent with findings of other 
researchers (Blood, 1994). It is recognised in the literature that the standard deviation from the 
average F0 in normal connected speech is 20-30 Hz (Boone, McFarlane, Von Berg, & Zraick, 
2010). Therefore, this statistical change in F0 obtained in this study may not represent a clinically 
perceptible change. Blood (1994) reported that the perturbation factor in percentages decreased 
from 1.4 – 1.7% (baseline) to 0.1% – 0.4% (follow-up sessions) in their two participants following 
treatment for vocal fold nodules. This trend of decrease in perturbation percentages was in line with 
significant reduction of jitter and shimmer shown in IVT group at 6 months post treatment when 
compared with baseline. Whilst there is a significant reduction in the numerical values obtained for 
jitter and shimmer the authors acknowledge that this reflects a relative change only in perturbation. 
It is acknowledged in the literature that acoustic analysis software programs track and measure short 
term perturbation signals differently and values over 1% may be invalid (Boone et al, 2010). 
However, the relative shift in these perturbation measures can be interpreted as a positive 
improvement. Furthermore, the perceptual results of a significant decrease in roughness pre to post 
treatment would support a positive clinical change in these perturbation measures. 
It has been reported that how a patient feels about his/her voice-related quality of life is one 
of the determining factors in treatment seeking, compliance, and discharge (Gillespie, Gooding, 
Rosen, & Gartner-Schmidt, 2014). With the perceptual, physiological and acoustic results 
supporting the comparable outcomes of the two groups at 6 months post treatment, it was positive 
to see both groups also had significant changes in self perception of voice post treatment which was 
maintained at 6 months post treatment. Furthermore, even though there was a higher proportion of 
participants with more moderate dysphonia in the IVT group, participants in both groups felt they 
had made comparable levels of improvement in function at post treatment and 6 months post 
treatment. By 6 months post treatment both the TVT and IVT groups reported an average VHI 
scores of less than 28 which would indicate the participants perceived their voice as normal or mild 
in severity according to Jacobson et al. (1997). Blood (1994) similarly reported that their 
participants perceived positive changes in their voices from the initiation of treatment, with 
participants rating their voices as normal at the 3 months post treatment session.  
Although this study has provided further evidence that IVT provides comparable outcomes 
which are maintained at 6 months post treatment, there were still limitations. One limitation was 
participant attrition at follow-up which reduced sample size. Therefore, a larger sample size may be 
needed to confirm the current outcomes. It is also possible that the period of follow-up may not be 
extensive enough to determine whether the treatment was able to resolve vocal fold nodules 
completely. Therefore, follow-up beyond 6 months post-treatment should be conducted to 
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determine the time required to resolve nodules with both treatments. Such data would provide 
valuable information for individuals with vocal fold nodules who are seeking voice treatment. 
Future studies should examine whether the severity of dysphonia and size of vocal fold nodules are 
determining factors in treatment prognosis. Such information would assist clinicians in determining 
the most appropriate service delivery model for their patients. Future research should also explore 
the relationship between patient compliance and outcomes following different treatment delivery 
protocols. In addition, further investigation should be conducted to explore optimal dosage of 
intervention, the effect of dysphonia severity and vocal nodule size on treatment outcome. 
 
4.6 Conclusion 
The findings of the current study revealed that IVT group was able to maintain positive 
outcomes in objective voice parameters up to 6 months post treatment which were comparable to 
TVT group. The outcomes of patient’s perception also suggested individuals were able to maintain 
satisfaction with their voice recovery and perceived improvement in voice-related quality of life 
with intensive treatment which was comparable to traditional weekly treatment. Therefore, these 
research results provide further evidence for the potential clinical value of applying intensive voice 
treatment for individuals with vocal fold nodules.  
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CHAPTER FIVE  
5 Delivery of Intensive Voice Therapy for Vocal Fold Nodules via Telepractice: A Pilot 
Feasibility and Efficacy Study 
The investigations in Chapter 2 and Chapter 3 addressed the first two sub-aims of the 
current thesis: 1) to examine the effectiveness of intensive voice therapy as compared with 
traditional voice therapy focussing specifically on the perceptual and stroboscopic ratings 
immediately following treatment (Chapter 2); and 2) to explore the differences in acoustic and 
aerodynamic changes immediately after intensive and traditional voice therapy (Chapter 3). These 
data underlined the benefits of the use of intensive voice therapy in that patients are able to 
accelerate the process of recovery and generalise learned strategies to daily usage. In Chapter 4, it 
was further recognised that participants were able to maintain positive results in objective voice 
parameters up to 6 months post intensive voice treatment which were comparable to traditional 
voice treatment. In addition, the outcomes of patient’s perception indicated individuals were able to 
maintain satisfaction with their voice recovery and perceived improvement in voice-related quality 
of life with intensive treatment which was comparable to traditional weekly treatment.  
From these three studies it is acknowledged that intensive voice therapy can be effective in 
the treatment of vocal fold nodules. Unfortunately, challenges remain regarding the clinical 
implementation of such intensive therapy services. Delivery of high intensity therapy programs in a 
conventional face-to-face (FTF) clinical model may be prohibitive for some individuals who face 
access issues. Therefore, following the succession of confirmation that intensive voice treatment 
can accelerate vocal quality and vocal fold function recovery when treating patients with vocal fold 
nodules, 10 participants were recruited in the current chapter is to examine whether an alternative 
service delivery model, telepractice, can be implemented to deliver intensive voice. Based on the 
current evidence base for telepractice services across a range of clinical areas in speech pathology, 
it is hypothesised that the provision of intensive voice therapy via telepractice will be both feasible 
and beneficial for patients. The insights gained will be instrumental in informing future service 
delivery models for the delivery of intensive treatment, potentially providing patients with vocal 
fold nodules with choice to access services in a manner (FTF or via telepractice) which is most 
conducive to their life and work commitments. 
 The content of Chapter 5 consists of the manuscript entitled “Delivery of intensive voice 
therapy for vocal fold nodules via telepractice: A pilot feasibility and efficacy study” which was 
published online in the Journal of Voice in February 2015. It is inserted as accepted, with the 
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exception of formatting and referencing changes that have been made to align with the style 
guidelines of the American Psychological Association and to maintain consistency throughout the 
thesis. References in this published manuscript which refer to published sections of this thesis have 
been clarified to assist the reader (e.g., Fu et al., 2015 – Chapters 2 & 3). The references specific to 
this chapter have been included in the overall reference list of this thesis.  
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5.1 Abstract 
Summary: Objectives. This pilot study examined voice outcomes and patient perceptions following 
intensive voice therapy for vocal fold nodules via telepractice. 
Study Design: Pilot – within-subjects experimental trial 
Methods: Participants included 10 women diagnosed with bilateral vocal fold nodules who received 
intensive voice treatment via a free videoconferencing platform Skype, (Microsoft Corp., Redmond, 
WA). All participants completed one vocal hygiene session in person, followed by eight sessions of 
therapy via telepractice over 3 weeks. Before and immediately after treatment, patients attended a 
clinic in person to complete perceptual, stroboscopic, acoustic and physiological assessments of 
vocal function. Analyses were performed by a speech-language pathologist and an otolaryngologist 
independent to and blinded to the study. Participants also completed the Voice Handicap Index and 
a telepractice satisfaction questionnaire, or an anticipated satisfaction questionnaire, before and 
after treatment.  
Results: Significant improvements were found in perceptual, vocal fold function, acoustic and 
physiological parameters as well nodule sizes and patient perceptions of voice-related quality of life 
post treatment. Participants were highly positive about their first experience with telerepractice. 
Results were similar to those from a separate study investigating the effects of an intensive voice 
therapy delivered in conventional face-to-face format. 
Conclusions: This study is consistent with possible benefits of telepractice in the delivery of 
intensive treatment for vocal fold nodules. Pending final verification with a face-to-face comparison 
group, telepractice could be recommended as an alternate treatment modality for patients with vocal 
fold nodules. 
  
Keywords: Telepractice, vocal fold nodules, perception, physiology, acoustic, aerodynamic, 
participant satisfaction 
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5.2 Introduction 
The primary etiologic factor for vocal fold nodules is proposed to be cumulative 
perpendicular impact stress between the vocal folds over time, which increases with voice use (Titz, 
1994). Certain forms of voice use, such as pressed voice, appear to increase the risk of injury (Titz, 
1994). It has been well established that the presence of vocal fold nodules can lead to lost time at 
work, reduced productivity and impaired quality of life (Kunduk & McWhorter, 2009).  
Many people with vocal fold nodules work in professions which have high vocal demands, 
therefore, it is essential that they recover their vocal function so that their ability to perform their 
jobs is not compromised (Kunduk & McWhorter, 2009). Several studies have been conducted on 
the efficacy of treatment for vocal fold nodules, with voice therapy recommended as first-line 
treatment (Blood, 1994; Holmberg, Doyle, Perkell, Hammarberg, & Hillman, 2003; Holmberg, 
Hillman, Hammarberg, Sodersten, & Doyle, 2001; Hogikyan, Appel, Guinn, & Haxer, 1999; 
Hufnagle & Hufnagle, 1984; Lancer, Syder, Jones, & Le Boutillier, 1988; Lockhart, Paton, & 
Pearson, 1997; Murry & Woodson, 1992; Verdolini-Marston, Burke, Lessac, Glze, & Caldwell, 
1995). Although it has been established that voice therapy is often effective (Blood, 1994; 
Holmberg et al., 2001; Holmberg et al., 2003; Murry & Woodson, 1992; Verdolini-Marston et al., 
1995), it has been noted that rates of therapy completion can be poor (Behrman, 2006; Hapner, 
Porton-Maira, & Johns, 2009; Portone, Johns, & Hapner, 2008; Portone-Maira, Wise, Johns, & 
Hapner, 2011). This presents a challenge for clinicians and a critical barrier for full voice recovery 
in this patient population. 
As with other behavioural intervention, it is noted that effective delivery of voice therapy is 
impacted by problems of resistance to change, therapy dropout and lack of follow-through outside 
the therapy session (Behrman, 2006; Hapner et al., 2009; Portone et al., 2008). Numerous factors 
contribute to therapy non-compliance. However, ready access to services is a key factor. In many 
settings internationally, individuals work long hours with sometimes inflexible work conditions, or 
hold occupations that do not allow them to easily take time off work, which impact their ability to 
attend regular voice treatment sessions. For others who live in more regional or rural areas, the 
travel time associated with sometimes large distances needed to access clinicians experienced in 
voice disorders also can limit therapy attendance. Ultimately issues of access can contribute to 
missed appointments and a high dropout rate in the clinical population of individuals with vocal 
fold nodules. Such non-adherence to voice therapy not only affects treatment success, but also 
results in unnecessary extensions to treatment, and repeated examinations without sufficient 
behavioural change to effect improvement which lead to excess costs to healthcare and third-party 
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payers. There is also a cost of cancellations and no-shows to healthcare (Portone et al., 2008). 
Furthermore, there may be loss of revenue or loss of employment as patients are unable to meet the 
vocal requirements of their occupations (Portone et al., 2008; Portone-Maira et al., 2011). 
Consequently, there is a need to explore ways to facilitate greater access to voice therapy to 
maximise attendance and ultimately enhance outcomes for people with vocal fold nodules and other 
conditions affecting voice.  
Recent research supports the efficacy of intensive voice therapy for vocal fold nodules (Fu, 
Theodoros, & Ward, 2015 – Chapters 2 & 3). However, the ability to undertake such high intensity 
therapy programs (total program included nine sessions over 3 weeks) in a traditional face-to-face 
(FTF) clinical model may not be possible for many patients due to the access issues previously 
discussed. Therefore, alternate modes of delivery for voice treatment need to be considered. One 
possible service delivery mode is telepractice, in which services are provided at a distance 
(American Speech-Language-Hearing Association, 2014). A growing body of evidence is available 
to support the use of telepractice in speech pathology (Keck & Doarn, 2014). Speech pathology 
services in general appear to be well-suited to telepractice delivery due to the audio-visual nature of 
the patient-clinician interaction in most consultations.  
A number of studies have explored the use of telepractice with various types of voice 
disorders. The majority of these have focussed on the assessment and treatment of voice disorders 
associated with Parkinsons Disease and revealed very positive outcomes (Constantinescu, 
Theodoros, Russell, Ward, Wilson, & Wootton, 2010; Constantinescu, Theodoros, Russell, Ward, 
Wilson, & Wootton, 2011; Theodoros, Constantinescu, Russell, Ward, Wilson, & Wootton, 2006; 
Tindall, Huebner, Stemple, & Kleinert, 2008). Only one investigation, however, has explored the 
use of telepractice with a group of patients with voice disorders of various aetiologies, including 
some patients with vocal fold nodules (Mashima, Birkmire-Peters, Syms, Holtel, Burgess, & Peters, 
2003). Participants were treated via either conventional therapy or telepractice. All of the therapy 
sessions for the remote group were delivered in adjacent rooms via a real-time audio-video 
monitoring system. The system consisted of Sony Hi-8 video cameras with remote lapel 
microphone and colour monitors. In addition, FTF contact between patient and clinician was 
minimised as much as possible during the course of the conventional treatment protocol. The study 
found that both groups demonstrated improvements in voice quality, acoustic and physiological 
parameters post voice treatment. Furthermore, no significant differences were found between the 
extent of change in either group, indicating that voice therapy delivered via telepractice was as 
effective as conventional therapy (Mashima et al., 2003). The authors suggested that the use of 
telepractice would be helpful in overcoming the barrier of geographic distance and eliminating the 
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commute time to the clinic. In a later discussion article about this service published two years later, 
Mashima et al. (2005)
 
commented on their telepractice service model and its potential to increase 
accessibility and availability for patients with voice disorders.  
Although there is preliminary evidence supporting the use of telepractice in the management 
of various voice disorders, to date, no investigations have been conducted with a cohort of patients 
with vocal fold nodules, specifically, in telepractice. In addition, no studies have been performed 
with patients with vocal fold nodules receiving telepractice at home or in the workplace. Therefore, 
the aim of this pilot study was to investigate the feasibility and efficacy of telepractice in delivering 
intensive voice therapy to individuals with vocal fold nodules in their own homes or workplace. It is 
hypothesised that telepractice will be a service delivery mode which is both feasible and effective in 
improving voice outcomes for patients with vocal fold nodules. 
 
5.3 Methods 
This study was approved by ethics committee at the Taipei Veterans General Hospital and a 
human research ethics committee at The University of Queensland.  
 
5.3.1 Participants 
Participants were recruited from the outpatient clinic at the Department of 
Otorhinolaryngology, Taipei Veterans General Hospital, Taiwan. For inclusion, participants had to 
present with bilateral vocal fold nodules, as determined by an otolaryngologist under stroboscopic 
examination, with planned behavioural management of the nodules by a speech-language 
pathologist (SLP). Participants were excluded from this study if they: 1) were not aged between 18 
years and 55 years; 2) had articulation, resonance, or language disorders; 3) had hearing impairment 
as determined by a screening test at 20 decibels hearing Level (dB HL) at 500, 1000, 2000 Hz; 4) 
had previous professional singing or speaking training; 5) had previous voice therapy or laryngeal 
surgical treatment; 6) used prescription medication which may cause changes in laryngeal function, 
mucosa or muscle activity (list provided by National Center for Voice and Speech [NCVS], 
retrieved 26 June, 2009 from http://www.ncvs.org/e-learning/rx2.html); 7) had psychiatric or 
neurologic conditions; 8) had a history of allergies, lung disease, or other concomitant vocal 
pathology (e.g., vocal polyp and vocal cyst); 9) presented with bamboo nodules (transversal cream-
yellow band lesions resembling the appearance of bamboo and its nodes at the midpoint of the 
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upper surface of vocal folds seen in patients with various autoimmune diseases or a high index of 
antinuclear antibodies [ Li et al., 2010; Murano et al., 2001]), or; 10) had no access to internet and 
Skype
TM
.  
Ten women (mean age = 33.7 years, range =19 - 49 years) with vocal fold nodules and mild-
moderate vocal impairments in perceptually evaluated voice quality were included in the study. 
Severity of dysphonia was determined from a recorded speech sample (a standard Mandarin 
passage) and rated using the “Grade” scale from the GRBAS (Grade, Roughness, Breathiness, 
Asthenia, Strain) scale (where 0 = normal, 3 = severe; Hirano, 1981). A single SLP experienced in 
the assessment and treatment of voice disorders but blind to the study purpose conducted the 
severity ratings. The participants’ occupations were categorised into non-professional voice users 
(e.g., factory worker, student, catering, clerical worker, home carer, and unemployed) and 
professional voice users (e.g., teacher, health professional, and sales personnel). The decisions on 
the extent to which various professions constituted professional voice use were made somewhat 
arbitrarily. All participants were diagnosed before treatment with bilateral broad-based nodules with 
surrounding oedema. The nodules were located at the midpoint of the membranous, vibrating vocal 
folds for all participants. None had had any previous experience with telepractice. Demographic 
information of the 10 participants is detailed in Table 5.1. 
 
 
Table 5.1  
Demographic Information of Participants 
Demographic variables  
Total number of participants 10 
Mean age (years) 33.7 
Severity of dysphonia    
   Mild-moderate 8 
   Moderate 2 
Occupations  
   Professional voice user 6 
   Non-professional voice user 4 
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5.3.2 Procedure 
Following recruitment, each individual attended the hospital clinic in person for a 
comprehensive baseline assessment of their voice and speech production. They then completed one 
vocal hygiene session in person, followed by eight sessions of intensive voice therapy delivered via 
telepractice from either their home or workplace (detailed in full below). Re-assessment at the clinic 
took place within 24 hours following completion of the final session of online therapy. 
 
5.3.2.1 Baseline and post treatment assessments. 
Auditory perceptual ratings, stroboscopic assessments, acoustic and physiological 
measurements as well as patient perception questionnaires were completed before and after therapy. 
All auditory perceptual ratings, acoustic and physiological analysis was performed by one SLP 
experienced in voice disorders and blinded to this study, while all stroboscopic ratings were 
performed by one otolaryngologist independent and blinded to this study. 
 
5.3.2.2 Auditory perceptual ratings. 
At each assessment interval, the participants were asked to read a five-sentence Mandarin 
passage. All voice samples were recorded with a Shure SM48-LC microphone (Shure, Niles, IL, 
USA) in a sound-treated room and stored in the Computerised Speech Laboratory system (CSL; 
model 4500, Kay Elemetrics Co.) at a 4.41 KHz sampling rate. The desktop microphone was placed 
in front of each participant’s mouth at a distance of 15 cm. The microphone-to-mouth distance was 
established and maintained with a 15 cm ruler taped next to the microphone. The microphone was 
moved for each participant to be level with their mouth.  
All speech samples were subsequently analysed perceptually by one SLP with 15 years 
experience assessing voice disorders. Voice quality was assessed using the GRBAS scale which 
consists of five perceptual parameters: grade (G), roughness (R), breathiness (B), asthenicity (A) 
and strain (S) (Hirano, 1981). Paired comparison ratings of GRBAS parameters were conducted 
using the Comparison Mean Opinion Score (CMOS) process (ITU-P.800, 1996). The order of the 
voice samples were randomised with respect to time points (pre versus post treatment) within each 
participant’s paired samples to reduce potential expectation bias prior to the rater listening to and 
comparing the paired speech samples. A clinician independent of the rating process created 10 pairs 
of recorded speech samples for each participant relating to the assessment time points and the five 
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GRBAS perceptual parameters (i.e., pre and post voice therapy, with a total of 20 samples or a total 
of 100 voice ratings). After listening to each pair of speech samples, the rater then rated sample 2 in 
relation to sample 1 on a scale of -3 to +3, in which 0 indicates the samples are equal. If the value is 
positive, it indicates that sample 2 is better than sample 1 (+1 mildly better; +2 better and +3 much 
better). However, if the value is negative, it indicates that sample 2 is worse than sample 1 (-1 
mildly worse; -2 worse and -3 severely worse). The SLP was able to listen and compare the speech 
samples as often as needed. Once the paired samples were rated, the principle investigator revealed 
the order of the two samples and transposed the scores to ensure data accurately reflected perceptual 
differences relative to the time of speech sample recording such that any positive score indicated an 
improvement and negative values indicated a decline in function.  
To validate the reliability of the primary rater, a second SLP with nine years experience 
assessing voice disorders listened to and rated a random set of 20 voice ratings (20% of the total 
voice ratings). Inter-rater reliability was calculated using direct calculation of the Percent Exact 
Agreement (PEA) and the Percentage of Close Agreement (PCA - where raters differed by no more 
than 1 scale point). Findings revealed an overall PEA was 80% and the PCA was 100%. Intra-rater 
reliability was calculated by having the primary rater re-rate 20% of the sample a second time, at no 
sooner than four weeks following initial assessment. The mean PEA was 80% and PCA was 100%.  
 
5.3.2.3 Stroboscopic evaluation – vocal fold function and lesion ratings. 
The stroboscopic recordings were performed during the sustained phonation of the vowel /i/ 
produced at a comfortable loudness and pitch. The examination procedure was conducted by any 
one of four otolaryngologists at any assessment point. The recorded stroboscopic samples were then 
subsequently rated by one primary otolaryngologist with 10-year experience in assessing voice 
disorders, blinded to the assessment points.  
The stroboscopic ratings were performed in two stages. The first stage was to complete 
ratings of vocal fold function and lesion including: the symmetry of vocal fold abduction and 
vibration; the regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; 
mucosal wave characteristics and glottal closure (0 = normal; 1 = mild; 2 = moderate; 3 = severe); 
nodule location (very front, front, mid, back of the vocal fold membranous portion); nodule shape 
(narrow-based, broad-based) and surrounding oedema (yes/no). The 20 samples (10 participants by 
two samples per participant) were randomized prior to presentation to the otolaryngologist for 
rating in order to reduce any potential bias. The otolaryngologist was able to review each 
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stroboscopic sample for as long as required to complete the ratings. The stroboscopic samples were 
viewed and rated without sound.   
The second stage of the stroboscopic rating process used the paired sample comparison 
process (as described previously) to rate paired samples (pre and post voice therapy) using a 
questionnaire adapted from Holmberg et al. (2001). Ratings of sample two compared to sample one 
were rated for changes in: (1) nodule size (difference between the two recordings, -1 larger; 1 
smaller; 0 no difference), and; (2) surrounding oedema (difference between the two recordings: -1 
larger; 1 smaller; 0 no difference). Once the samples were rated, the order of the samples was 
revealed to the principle investigator who then transposed the scores to ensure data accurately 
reflected differences relative to the time of videostroboscopic sample recording (pre-voice therapy 
and post-voice therapy). 
The reliability of the primary rater was determined using a second otolaryngologist with ten 
years experience assessing voice disorders who rated a random set of four samples (20% of the total 
stroboscopic samples). Inter-rater reliability of the ratings in first and second stage was calculated 
using PEA and PCA. Findings revealed PEA was 65% and PCA was 97.5% respectively for 
stroboscopic parameters. Intra-rater reliability of the ratings in first and second stage was calculated 
by having the primary rater re-rate 20% of the sample a second time, at no sooner than 4 weeks 
following initial assessment. The PEA calculated for intra-rater reliability was 92.1%, while PCA 
was 100%.  
 
5.3.2.4 Physiological assessment. 
Measures of maximum phonation time (MPT), mean airflow rate (MFR) and subglottic 
pressure were included in the aerodynamic assessment. MPT was measured with a stopwatch while 
participants were asked to produce the sustained vowel /a/ for as long as possible at a comfortable 
loudness and pitch level on a single breath, three times. The MFR and subglottic pressure were 
obtained and analysed using the Aerophone II (Model 6800, Kay Elemetrics Co., Lincoln Park, NJ). 
For MFR measurement, each participant was asked to produce a sustained vowel /a/ for as long as 
possible at a comfortable intensity and pitch level with a face mask, sealed over the nose and mouth 
connected to a pneumotachograph- based flow system, three times. The middle portions of each 
sustained vowels were used for analysis. Subglottal pressure was estimated indirectly using an 
intraoral pressure probe positioned behind the lips and resting on the tongue. The participants were 
asked to repeat at least five /ipi/ at a comfortable pitch and loudness, however with constant 
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loudness once initiated, with the face mask and probe in place at a rate of 1.5 syllables/second, three 
times. Results for each parameter were averaged to generate one single value which was used in the 
statistical analyses. 
 
5.3.2.5 Acoustic assessment. 
The participants were asked to produce a sustained vowel /a/ on one breath at a comfortable 
pitch and loudness level, three times. Vowel productions were recorded via the desktop microphone 
of the Computerized Speech Lab (CSL) (Model 5105; Kay Elemetrics, Co., Lincoln Park, NJ, 
USA). The microphone was positioned in front of the participant with a mouth-to-microphone 
distance of 15 cm. The microphone-to-mouth distance was established and maintained with a 15 cm 
ruler taped next to the microphone. The microphone was moved for each participant to be level with 
their mouth. Each participant’s production of sustained /a/ was analysed using the Multi-
Dimensional Voice Program (MDVP) software in the CSL. All acoustic recordings were conducted 
in a sound-proof room. The middle 3-second segment from each of the sustained vowels was 
selected for acoustic analysis. Detailed acoustic measures included: vocal fundamental frequency 
(F0) (Hz), mean percentage vocal jitter and shimmer, and noise-to-harmonics ratio (NHR) (dB). 
Results across the three vowel phonations were averaged to produce a single value for each 
measure. Furthermore, participants’ vocal intensity (dB) for the three prolonged vowels /a/ and 
additional conversational speech samples were simultaneously measured using Sound Level Meter 
(320 series, Center Technology Corp., Taiwan) which was also positioned in front of the participant 
with a mouth-to-microphone distance of 15 cm. Vocal intensity recorded for the prolonged vowel 
phonations and conversational speech samples were also averaged to produce a single value for 
each measure. 
 
5.3.2.6 Voice Handicap Index. 
The Chinese version of the Voice Handicap Index (VHI) was used to quantify self-
assessment of voice-related quality of life (Lam, Chan, Ho, Kwong, Yiu, & Wei, 2006). The VHI is 
a 30-item instrument consisting of three domains: emotional (VHI-E), physical (VHI-P), and 
functional (VHI-F) aspects (each 10 questions). A total score (ranging from 0 to 120) and each 
individual VHI subscale scores (ranging from 0 to 40) were generated. A lower total score 
represents less perceived voice-related quality of life problems.  
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5.3.2.7 Participant satisfaction questionnaires. 
To evaluate the patients’ perceptions of the telepractice sessions, a 16-item questionnaire 
modified from Sharma, Ward, Theodoros, and Russell (2013) was administered both immediately 
prior to and after voice therapy. In the pre-session questionnaire, the questions were worded in the 
future tense while the post-session questionnaire contained the same questions, only with 
grammatical modifications to reflect past tense (i.e., I will have/had no difficulty in seeing online 
speech pathologist). All participants responded to all questions using 5-point Likert scale (1 = 
strongly disagree, 3 = neutral/unsure, 5 = strongly agree).  
 
5.3.3 The Telepractice System 
The telepractice system used to conduct the therapy sessions consisted of two computers 
(one at clinician end and one at participant end) that were equipped with videoconferencing 
software (Skype
TM
; a peer-to-peer Internet telephony network), a web camera and microphone 
(Figure 5.1). Although it is acknowledged that Skype
TM
 may have security issues, it was 
nevertheless used as this technology was the only readily available platform for use in Taiwan for 
this population. All participants were fully informed of this limitation and gave consent to the use of 
Skype
TM
 for the voice treatment. Videoconferencing was established over a broadband internet 
connection with at least 2M/64K (download/upload) speed between the clinic and the participant’s 
home or workplace. Participants were required to have an account with Skype
TM
, and e-mail contact 
with the clinician. All aspects of treatment were delivered remotely by the principal investigator. To 
ensure there was satisfactory visual and auditory information exchanged between the participants 
and clinician, specific equipment was used. Visual information was optimised through the use of 
web cameras (5 million pixels; Ktnet Enterprise, Co., Ltd., Taichung, Taiwan). The web camera 
was clipped on the computer screen and the camera head could be moved and adjusted according to 
the participant and SLP’s position and height. There were six LED lights on the web camera which 
could be switched on if a better light source was required. To enhance the auditory signal, and 
reduce background noise, a freestanding/desktop microphone (Jazz-005; Intopic International, Co., 
Ltd., Taipei, Taiwan) was used at both the clinician and participant sites. The microphone was fixed 
on an adjustable mobile platform that allowed the participant and clinician to move and adjust the 
microphone position and height accordingly. 
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Figure 5.1. Illustration of the telepractice system equipment and setup 
 
 
5.3.4 Therapy program 
All participants completed nine sessions of intensive therapy delivered across three therapy 
sessions per week over a 3 week period. This intensive therapy model was previously reported by 
Fu et al. (2015 – Chapters 2 & 3) and found to provide comparable outcomes to a traditional non-
intensive therapy model. In week 1, for the first session participants attended in person for a session 
on vocal hygiene (adapted from Weinrich
 
(2003), Verdolini Abbott (2008), and NCVS (2009)) and 
also to receive information regarding the technology requirements and set-up for the subsequent 
eight online voice therapy sessions. The remaining two sessions in week one, and then all three 
sessions in weeks two and three were conducted via telepractice (eight telepractice sessions). In 
addition to the therapy sessions, all participants were required to complete homework activities 
using written resources provided via email. Participants were instructed to complete this homework 
practice in two 15-minutes sessions per day on a non-treatment day and in a one 15-minute session 
on a treatment day.  
The online voice therapy was provided by the principle investigator who was not involved in 
assessment of the participants. The principle investigator was trained and certified to provide the 
therapy program which was adapted from the Lessac-Madsen Resonant Voice Therapy (LMRVT) 
program developed by Verdolini Abbott (2008a, 2008b). Components of the Vocal Function 
Exercises (VFE) program developed by Stemple, Lee, D’Amico, and Pickup (1994) were also 
incorporated in the speech tasks. Full details of the therapy program are published elsewhere (Fu et 
al., 2015 – Chapters 2 & 3; provided in full in this thesis as Appendix E). In summary, it contained 
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relaxation exercises (Verdolini Abbott, 2008a) followed by basic training gestures as described by 
Verdolini Abbott (2008b) and Roy et al (2001). The sessions of direct facilitation of speech tasks 
proceeded in stages to a conversational level and real-life applications outside the therapy room. All 
resource materials used during therapy (i.e., words, phrases, sentences and reading passages for 
speech tasks) were provided via email prior to each session. 
 
5.3.5 Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., Chicago, IL) 
was used for all statistical analysis and level of significance was set at p < 0.05. Although multiple 
statistical analyses were conducted, due to the preliminary nature of the study, more stringent alpha 
levels to protect inflation was not adopted. Paired comparison ratings (between pre to post 
treatment) conducted for the perceptual parameters of grade, roughness, breathiness, asthenia, strain 
and also for the static parameters of nodule size and oedema were analysed using a series of one 
sample t-tests (one-tailed) where 0 was taken to indicate no difference between the sample pairs. 
For the vocal fold functions ratings of the symmetry of vocal fold abduction and vibration; the 
regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; mucosal wave; 
and glottal closure, analysis were conducted using Wilcoxon signed rank tests to explore extent of 
change across the two time points (baseline and post voice treatment). To determine whether 
significant changes occurred in acoustic and physiological parameters after therapy, paired sample 
t-tests were performed. 
Analysis of VHI data pre post treatment was conducted using Wilcoxon-Signed Ranks test. 
Participants’ responses to the telepractice questionnaire were collapsed from a 5-point scale to three 
groups (i.e., strongly disagree + disagree = “disagree”, unsure = “unsure”, and agree + strongly 
agree = “agree”). The Friedman test was then used to analyse the extent of change in perceptions of 
telepractice pre to post treatment.  
 
5.4 Results 
All participants completed the full telepractice voice program, with 100% attendance. One 
of the sessions had to be re-scheduled due to technical difficulties with webcam connection. This 
could not be solved during the session and the elderly participant required assistance from a family 
member. The problem was solved within 24 hours and the session continued as normal. The 
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participant completed the rest of the treatment with good attendance. Five out of the eighty sessions 
(6.25%) had delays between audio and visual images during sessions but these delays did not affect 
the integrity of the treatment. Three out of the eighty sessions (3.75%) experienced loss of 
connection but reconnected straight away. In addition, participants demonstrated high compliance 
with homework activities, reporting that they practiced at least once a day as recommended during 
the course of treatment. 
 
5.4.1 Auditory Perceptual Ratings 
Comparison between baseline and post treatment perceptual ratings demonstrated 
significantly (p < 0.05) improved ratings of overall voice quality, roughness, and weakness of voice 
(Table 5.2). Individual analysis revealed all participants were rated as having better voice post 
treatment in overall voice quality and roughness, six had reduced weakness and three had reduced 
strain post treatment. Breathiness did not change in any participant. 
 
Table 5.2  
Results of the One Sample t-tests and the Proportion of Change in Perceptual Ratings 
Parameter Rating n (%) Mean difference t Test P Value 
Grade Post-treatment better 10 (100) 1.2 9.00 <0.001* 
 No change 0 (0)    
Roughness Post-treatment better 10 (100) 1.2 9.00 <0.001* 
 No change 0 (0)    
Breathiness Post-treatment better 0 (0) N/A N/A N/A 
 No change 10 (100)    
Asthenia Post-treatment better 6 (60) 0.6 3.674 0.005* 
 No change 4 (40)    
Strain Post-treatment better 3 (30) 0.3 1.964 0.081 
 No change 7 (70)    
Note. N/A = not available. 
* Significant at P < 0.05. 
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5.4.2 Stroboscopic Ratings – Vocal Fold Function and Lesion Ratings 
Vocal fold function assessment revealed statistically significant (p < 0.05) improvements 
across the group from baseline to post treatment for ratings of mucosal wave, vocal edge 
smoothness and glottal closure (Table 5.3). No significant change was found for symmetry of vocal 
fold abduction, amplitude of vocal fold movement and regularity of vocal fold movement. 
 
 
Table 5.3  
Results of Analysis of Stroboscopic Ratings 
Parameter Pre-treatment, Mean (SD) Post-treatment,  Mean (SD) Z P Value 
Symmetry 1.3 (0.675) 1.0 (0.471) -1.732 0.83 
Amplitude 1.4 (0.699) 1.0 (0.667) -1.265 0.206 
Mucosal wave 1.8 (0.919) 1.1 (0.738) -2.111 0.035* 
VF edge smoothness 1.5 (0.527) 1.1 (0.316) -2.000 0.046* 
Regularity 1.4 (0.516) 1.2 (0.632) -0.707 0.480 
Glottal closure 1.4 (0.516) 0.8 (0.422) -2.449 0.014* 
Note. VF = vocal fold. 
* Significant at P < 0.05. 
 
 
The paired comparison ratings for nodule size and oedema (baseline and post treatment) 
were analysed using a series of one sample t-tests. Post-treatment results revealed all ten of the 
participants were rated as having smaller nodule size when compared to pre-treatment. Ratings of 
vocal fold oedema was shown to have significantly improved (t = 4, df = 9, p = 0.003, mean diff = 
0.800) following treatment.  
 
5.4.3 Physiological and Acoustic Assessments 
A series of paired sample t-tests were conducted to examine the impact of intervention on 
each physiological parameter. Results revealed significant increase in MFR, while no changes were 
found in MPT and subglottal pressure following treatment (Table 5.4). Individual analysis 
demonstrated that post treatment eight participants had an increase in MFR, five had an increase in 
MPT and seven increased their subglottic pressure.  
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Paired-samples t-tests revealed a significant increase in mean F0, and significant reductions 
were shown in jitter, shimmer and NHR following treatment (Table 5.5). Results of vocal intensity 
of prolonged vowel /a/ and conversation demonstrated no significant differences between baseline 
and post treatment. Individual analysis showed post treatment all participants had an increase in F0, 
all had reduced jitter, and nine had reduced shimmer and NHR. With regards to vocal intensity post 
treatment, eight had an increase during the prolonged vowel /a/ and five demonstrated an increase in 
vocal intensity during conversation.  
 
 
Table 5.4  
Results of Analysis of Physiological Parameters 
Parameter Pre-treatment, Mean (SD) Post-treatment, Mean (SD) t Test P Value 
MPT 6.21 (1.76) 6.63 (2.55) -0.681 0.513 
MFR 131.97 (77.16) 167.00 (80.38) -2.469 0.036* 
Subglottic pressure 9.30 (1.93) 9.81 (1.18) -0.993 0.347 
Note. MPT = maximum phonation time; MFR = mean airflow rate; SD = standard deviation.  
* Significant at P < 0.05. 
 
 
Table 5.5  
Results of Analysis of Acoustic Parameters 
Parameter Pre-treatment, Mean (SD) Post-treatment, Mean (SD) t Test P Value 
F0 186.03 (30.48) 232.01 (44.16) -7.437 <0.001* 
Jitter 1.81 (0.91) 1.09 (0.75) 3.181 0.011* 
Shimmer 4.95 (1.30) 3.74 (1.04) 3.700 0.005* 
NHR 0.17 (0.03) 0.13 (0.14) 3.246 0.010* 
VI of prolonged /a/ 72.73 (5.56) 77.74 (8.72) -1.973 0.080 
VI of conversation 69.84 (3.28) 69.96 (4.95) -0.110 0.915 
Note. F0 = fundamental frequency; NHR = noise-to-harmonic ratio; VI = vocal intensity; SD = 
standard deviation.  
* Significant at P < 0.05. 
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5.4.4 Voice Handicap Index 
Significant improvement in patient perceptions of voice function was observed following 
treatment (Table 5.6). Almost all of the participants had lower total scores after treatment (Figure 
5.2). With regard to the individual VHI subscales, results for the VHI-P showed significant 
improvement post treatment, while VHI-F and VHI-E showed no significant differences before and 
after treatment (Table 5.6). 
    
 
Table 5.6 
Summary of VHI Scores Before and After Treatment 
Subscale item Pre-treatment, 
Mean (SD) 
Post-treatment, 
Mean (SD) 
Z P Value 
VHI-F 15.3 (7.379) 12.8 (6.763) -1.011 0.312 
VHI-P 25.3 (8.233) 17.6 (6.883) -2.807 0.005* 
VHI-E 13.4 (9.559) 11.4 (0.879) -0.869 0.385 
VHI total score 54 (21.965) 41.8 (22.075) -2.199 0.028* 
Note. VHI = Voice Handicap Index; VHI-F = functional domain; VHI-P = physical domain; VHI-E 
= emotional domain; SD = standard deviation.  
* Significant at P < 0.05. 
 
 
 
Figure 5.2. Individual results of Voice Handicap Index scores pre and post-treatment. 
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5.4.5 Participant Satisfaction Questionnaires 
 Pre-treatment some of participants were uncertain about their anticipated level of comfort 
with telepractice, the visual and audio quality, comprehensiveness of instructions, sufficient time to 
execute instructions given, opportunity to clarify doubts, replacement of FTF consultation with 
telepractice consultation, accessibility to healthcare with telepractice, and preference of telepractice 
over FTF consultation (Table 5.7). However, post treatment these aspects had significantly 
improved. No significant changes were observed on Questions 3, 12, 13, 15 and 16, with post-
treatment opinions similar to pre-treatment. Even before treatment they agreed with these 
statements.  
 
148 
 
Table 5.7 
Results of Participants Perception of Telepractice Service Pre- and Post- Voice Therapy which have been Concatenated from a 5-point Likert Scale to 
a 3-point Likert Scale to Reveal Basic Groups of “disagree”, “unsure”, and “agree”.  
 Pre-treatment Post- treatment   
Questions Disagree, 
n (%) 
Unsure, 
n (%) 
Agree, 
n (%) 
Disagree, 
n (%) 
Unsure, 
n (%) 
Agree, 
n (%) 
Z P Value 
1. I will be comfortable (am 
comfortable) to use telepractice if it is 
available in the hospital or healthcare 
facility nearest to my place of 
residence. 
0 (0) 5 (50) 5 (50) 0 (0) 0 (0) 10 (100) 
 
 
 
 
-2.309 
 
 
 
 
0.021* 
 
 
 
 
2. I am (was) comfortable to undergo 
voice therapy via telepractice. 
1 (10) 4 (40) 5 (50) 0 (0) 0 (0) 10 (100) 
 
-2.640 
 
0.008* 
 
3. I would rate the online treatment as 
being equal to a treatment provided 
traditionally in the face-to-face 
method. 
1 (10) 7 (70) 2 (20) 2 (20) 1 (10) 7 (70) 
 
 
 
-1.667 
 
 
 
0.096 
 
 
 
4. The instructions given during the 
online voice therapy will be (were) 
clear and easy to follow.  
0 (0) 8 (80) 2 (20) 0 (0) 0 (0) 10 (100) 
 
 
-2.762 
 
 
0.006* 
 
 
5. I will have (had) no difficulty in 
seeing the online speech pathologist. 
0 (0) 5 (50) 5 (50) 0 (0) 0 (0) 10 (100) 
 
-3.051 
 
0.002* 
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6. I will have (had) no difficulty hearing 
the online speech pathologist. 
0 (0) 6 (60) 4 (40) 0 (0) 0 (0) 10 (100) 
 
-2.649 
 
0.008* 
 
7. I will have (had) sufficient time to 
execute the instructions given during 
the treatment. 
0 (0) 6 (60) 4 (40) 0 (0) 0 (0) 10 (100) 
 
 
-2.598 
 
 
0.009* 
 
 
8. I will have (had) opportunities to 
clarify any doubts I may have during 
the online treatment. 
0 (0) 6 (60) 4 (40) 0 (0) 0 (0) 10 (100) 
 
 
-2.972 
 
 
0.003* 
 
 
9. I will be (was) comfortable being 
online and would consider using the 
internet for the rehabilitation of my 
voice problems. 
0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 10 (100) 
 
 
 
-2.121 
 
 
 
0.034* 
 
 
 
10. Telepractice can replace a face-to-
face voice therapy. 
1 (10) 4 (40) 5 (50) 0 (0) 1 (10) 9 (90) 
 
-2.041 
 
0.041* 
 
11. Telepractice will allow easy access to 
healthcare. 
0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 10 (100) 
 -2.00 0.046* 
12. Telepractice will save me travelling 
time & money. 
0 (0) 0 (0) 10 (100) 0 (0) 0 (0) 10 (100) 
 
-1.732 
 
0.083 
 
13. Telepractice may benefit all patients 
alike. 
1 (10) 6 (60) 3 (30) 0 (0) 6 (60) 4 (40) 
 
-1.134 
 
0.257 
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14. I would prefer to have a telepractice 
consultation with the speech 
pathologist over a face-to-face 
consultation. 
0 (0) 3 (30) 7 (70) 0 (0) 0 (0) 10 (100) 
 
 
 
-2.070 
 
 
 
0.038* 
 
 
 
15. I would prefer to have a face-to face 
consultation with the speech 
pathologist over a telepractice 
consultation. 
0 (0) 7 (70) 3 (30) 5 (50) 2 (20) 3 (30) 
 
 
 
-1.027 
 
 
 
0.305 
 
 
 
16. I would prefer to have a combination 
of face-to-face and telepractice 
consultations with the speech 
pathologist. 
0 (0) 1 (10) 9 (90) 1 (10) 1 (10) 8 (80) 
 
 
 
-1.633 
 
 
 
0.102 
 
 
 
Note. The italics and brackets indicate pre-/post- wording changes between the pre- and post-therapy conditions. 
* Statistically significant difference. 
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5.5 Discussion 
The aim of the present study was to examine the feasibility and efficacy of delivering 
intensive voice therapy via telepractice. Overall the results revealed positive treatment effects which 
are quantitatively comparable to previous research on conventional FTF voice therapy for vocal 
fold nodules, and a high level of patient satisfaction (Behrman, Rutledge, Hembree, & Sheridan, 
2008; Fu et al., 2015 – Chapters 2 & 3; Niebudek-Bogusz, Kotylo, Politanski, & Sliwinska-
Kowalska, 2008a). Sessions were well attended and delivered with minimal technical difficulty. 
Consequently, this investigation provides a preliminary indication that telepractice is a viable 
service delivery mode for providing intensive voice therapy for people with vocal fold nodules.  
In the current investigation, it was found that after therapy there were significantly improved 
ratings on perceptual parameters of voice quality, specifically overall voice quality, roughness, and 
weakness of voice. These changes were parallel to positive changes in vocal fold function, with 
stroboscopic ratings showing improvements in mucosal wave, vocal fold smoothness, and glottal 
closure. In addition, positive changes in acoustic parameters were also observed. These findings are 
consistent with the patterns of the positive change observed following intensive therapy delivered in 
the traditional FTF manner (Fu et al., 2015 – Chapters 2 & 3). They were also similar to the positive 
outcomes in perceptual, vocal fold and acoustic function observed by Mashima et al. (2003) in their 
larger group of patients with voice disordered treated by telepractice.  
Unlike prior research by Fu et al. (2015 – Chapters 2 & 3) additional positive changes were 
also observed in physiological (aerodynamic) functions across the group. There was a significant 
increase in MFR post online voice therapy, which may reflect improved regulation of the mean 
resistance of the glottal airway and possibly, an overall improvement in vocal fold function in this 
cohort. This premise was supported by the fact that vocal fold function tended to improve across all 
stroboscopic parameters post-treatment, although mucosal wave, vocal fold edge smoothness, and 
glottal closure were the only parameters found to be significantly altered. A possible explanation for 
the difference in outcome between the current study and that of Fu et al. (2015 – Chapters 2 & 3) 
may be due to the individual variability in such a small cohort of participants, therefore, further 
research on a larger number of study group may be needed for clarification. Overall, the current 
findings provide further evidence to support the positive effects of delivering voice treatment via 
telepractice. 
Apart from the positive outcomes shown in perceptual, vocal fold function, acoustic and 
physiological measures, participants’ perception of changes in vocal function post treatment is an 
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important indicator of the efficacy of treatment. It is recognised that how a patient feels about 
his/her voice-related quality of life is one of the determining factors in treatment seeking, 
compliance, and discharge (Gillespie, Gooding, Rosen, & Gartner-Schmidt, 2014). The results of 
this study showed that the total VHI score decreased significantly, indicating that the participants 
had better perception of their voice-related quality of life after treatment. These results are similar 
to previous research which has reported improvements in total VHI score following voice therapy 
delivered in the traditional FTF modality (Behrman et al., 2008; Niebudek-Bogusz, 2008a). Overall 
the current results support that patients perceived a positive benefit from the therapy they received 
via telepractice. 
Exploring participant perception is an important component in the evaluation of any novel 
service delivery model. The satisfaction questionnaire conducted to explore participant perceptions 
of the telepractice service confirmed that participants were highly positive about their first 
experience with telepractice. Pre-treatment it was noted that patient expressed some concerns about 
using telepractice particularly regarding audio/visual issues, however these were resolved post-
treatment. Similar data were reported by Sharma et al. (2013) from their patient cohort who were to 
undergo dysphagia assessment remotely. As discussed by those authors, identification of any 
patient concerns pre-treatment can enable clinicians to address these concerns prior to sessions 
commencing (Sharma et al., 2013). Pre and post treatment, the majority saw telepractice as a way to 
improve access to healthcare, save time and money and believed telepractice to be a viable option to 
FTF therapy. These findings are consistent with much of the literature,
 
with patients’ perception of 
telepractice services in general to be very positive (Brennan, Georgeadis, Baron, & Barker, 2004; 
Constantinescu et al., 2010; Mashima & Doarn, 2008; Sharma et al., 2013). The results also align 
with the comments made by Mashima et al. (2005) about the benefits of delivering voice therapy 
via telepractice. 
Although the results of the current trial were generally positive, some technical difficulties 
impacted the quality of some sessions. In a few sessions occasional delays between audio and visual 
images during the therapy sessions were noted. Furthermore, in a few sessions the Skype
TM
 
connection was lost and reconnected. There was only one session where there was complete 
inability to reconnect and the session was cancelled. Contributing to technical difficulties 
experienced in this study were the sometimes low and varying bandwidth connections into the 
individual’s homes/workplace. However, these issues did not appear to have a negative impact on 
treatment outcomes in the current study. This finding is consistent with previous telepractice 
research using low bandwidth connections where outcomes were not substantially affected by audio 
and visual quality loss (Mashima et al., 2003; Ward, White, Russell, Theodoros, Kuhl, & Nelson, 
153 
 
2007). Further research is necessary however in order to establish appropriate technical standards 
and guidelines for the use of telepractice in the management of voice disorders.  
Despite evidence of therapeutic benefits, there are limitations in this study. One limitation 
was the use of Skype
TM
, the free consumer-based voice and video over the Internet Protocol (VoIP) 
software system. Whilst the participants were fully informed and gave consent to use this software 
and felt comfortable using the program for therapy, several studies have expressed concerns for 
privacy and security of the therapy sessions (Hall & McGraw, 2014; Watzlaf, Moeini, & Firouzan, 
2010; Watzlaf & Ondich, 2012). Future investigations, using more secure, low cost systems would 
enable public health privacy and security regulations to be optimised. Another limitation of the 
study was that only a small cohort was included in this pilot study. Future studies should be 
conducted on a larger number of participants to ensure the magnitude of outcome effect is not over-
estimated. Including a parallel group treated via FTF would also enhance the strength of the 
research design by enabling validation of the online treatment mode. It would also be of benefit to 
conduct long-term follow-up on the investigated measures to examine whether the treatment effects 
were maintained. Finally, it is acknowledged that the vocal hygiene session may have been a 
contributing factor to the positive outcomes observed in the cohort. In a larger study of 
conventionally delivered voice therapy no significant differences in perceptual, acoustic or 
physiological (aerodynamic) parameters were observed from pre to post vocal hygiene session (Fu 
et al., 2015 – Chapters 2 & 3). However, the therapeutic benefit of the FTF vocal hygiene session 
cannot be completely discounted.   
 
5.6 Conclusion 
This pilot study provided evidence that supports telepractice as feasible and potentially 
effective in delivering intensive voice therapy to individuals with vocal fold nodules. In this 
investigation, significant improvements were found in perceptual, vocal fold function, acoustic and 
physiological parameters post therapy. There were positive changes in participants’ perception of 
their voice and the effects of their voice on their life after voice treatment. Overall, the participants 
were satisfied with the intensive voice therapy provided through telepractice delivery. These results 
may possibly indicate the effectiveness of treatment was not reduced by the distance mode. This 
service delivery mode could be recommended as one of the treatment options for patients who are 
unable to attend conventional FTF voice therapy and have urgent need to recover their voice within 
a short period of time. There is also a need for future studies involving the management of voice 
disorders via telepractice which utilize secure standards-based technologies.  
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CHAPTER SIX 
6 Summary, Clinical Implications, Limitations and Future Directions, and Conclusion 
6.1 Summary 
Whilst there is evidence that voice treatment is effective in eliminating and reducing vocal 
fold nodules, restoring normal voice and/or improving voice quality in the majority of patients, 
there are limitations with the evidence to date. As yet there has been no exploration of the use of 
intensive therapy models for people with vocal fold nodules. Therefore, there was a need to 
examine and understand whether such intensive treatment provides effective short-term and long 
term results which may assist patients to recover and maintain their vocal quality and function. As a 
result, further systematic research in this area was conducted to provide evidence for clinical 
practice.  
The current thesis was submitted in a “thesis by partial publication” format, in which the 
content of chapters are inserted in either a slightly modified format of the published paper (i.e., 
Chapter 2 and Chapter 3, published as the pone large integrated article by Fu et al., 2015), or as 
accepted for publication format (Chapter 4 and Chapter 5). This body of work has revealed that 
intensive voice therapy not only enhanced patient’s voice quality, vocal fold condition, and acoustic 
measures immediately after therapy, patients were able to maintain positive outcomes in objective 
voice parameters up to 6 months post treatment which were comparable to traditional voice therapy. 
The outcomes also revealed that individuals with vocal fold nodules were able to maintain 
satisfaction with their voice recovery and perceived improvement in voice-related quality of life 
with intensive treatment which was comparable to traditional weekly treatment at long-term follow-
up. Further to the outcomes of intensive voice therapy delivered via face-to-face (FTF) protocol, it 
has been acknowledged in this thesis that telepractice could be considered as an option of service 
delivery modality when providing intensive treatment to individuals with vocal fold nodules.  
 
6.1.1 Main Chapter Findings 
In the present thesis, Chapter 1 described the background to the current thesis and provided 
review of literature. This synthesis of the current literature revealed that there is an existing body of 
evidence which supports the efficacy of behavioural voce therapy for vocal fold nodules. However 
a number of aspects require further validation. Firstly, much of the evidence has been determined 
from Phase 1 and Phase 2 study designs. Although early efficacy data is positive, there is an 
156 
 
absence of reported long term outcomes, and many papers lack clear description of the nature, 
intensity and duration of therapy. Furthermore, despite the reported benefits of intensive therapy 
models, such approach has not been previously applied to the remediation of vocal fold nodules. It 
was hypothesised that the benefits of massed practice may be an effective means to achieve 
successful behavioural change needed to effect vocal fold nodule remediation. Attendance and 
adherence are also important issues and have been identified as significant factors impacting on 
treatment benefit. Although there are patient factors which contribute to poor attendance and 
adherence, there are also logistical issues. As such the potential to determine new and more efficient 
ways to deliver therapy, such as intensive treatment models which can be completed in a time 
efficient manner, may help address some of these barriers. It is also possible that alternate therapy 
delivery models, such as telepractice, could be of further assistance to help patients access therapy 
in a ways that best fits with other life and work commitments.      
Based on the issues and limitations raised by the existing literature discussed in Chapter 1, 
two main research aims were formed. The primary aim of the present thesis was to compare the 
effectiveness of various forms of intensity of voice therapy in the treatment of vocal fold nodules. 
The secondary aim was to examine the potential application of an alternative service delivery 
modality when providing intensive voice therapy to individuals with vocal fold nodules. The sub-
aims relating to these were: 1) to investigate the perceptual, vocal fold functions and lesions 
outcomes of patients with vocal fold nodules following intensive voice treatment when compared to 
traditional voice therapy; 2) to explore the acoustic and physiological changes observed in cohorts 
treated via either traditional or intensive voice treatment; 3) to examine the long-term effects of 
intensive voice treatment for vocal fold nodules, and compare these effects with the long term 
outcomes for patients treated with traditional voice therapy; 4) to investigate the feasibility, efficacy 
and related patient satisfaction of a telepractice model for providing intensive voice therapy to 
individuals with vocal fold nodules. 
Four studies were then subsequently conducted to address the primary and secondary aims 
and overall thesis objectives. Firstly, Chapter 2 investigated on the perceptual and stroboscopic 
outcomes of vocal fold nodules following intensive voice therapy when compared with traditional 
weekly voice therapy. That study provided the initial evidence to support intensive voice therapy, 
finding comparable auditory perceptual and stroboscopic results were achieved following intensive 
voice therapy as compared directly to traditional voice therapy. However, these positive outcomes 
were able to be achieved over a much shorter period of time via the intensive therapy model. Whilst 
this study supported the use of intensive voice therapy model to enabled individuals with vocal fold 
nodules to achieve better vocal fold health and improve vocal quality in a condensed period of time, 
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further investigation using objective measures of voice quality were needed to validate the benefits 
of intensive voice therapy.  
Chapter 3 examined the acoustic and aerodynamic changes observed in cohorts treated via 
either traditional or intensive voice treatment. The outcomes showed significant improvements in 
acoustic parameters which supported the auditory perceptual findings in Chapter 2. No changes 
however were observed on aerodynamic measures. As no statistical differences were found between 
the treatment groups in all investigated measures in both Chapters 2 and 3, this data suggests that 
either intensive or traditional treatment durations are effective dosages in the management of vocal 
fold nodules.   
Chapter 4 explored the long-term effects of intensive voice therapy for vocal fold nodules, 
and compared these effects with the long term outcomes for patients treated with traditional voice 
therapy. Through statistical analysis, results revealed auditory perceptual, stroboscopic and acoustic 
parameters were maintained in both the intensive and traditional voice treatment groups at 6 months 
post treatment. In addition, both groups maintained satisfaction on their perception of vocal 
function. Moreover, no significant differences were found in all investigated parameters between 
the two treatment groups at 6 months. Chapter 4 provided additional evidence that individuals with 
vocal fold nodules are able to recover and maintain voice quality and vocal health through intensive 
voice treatment. Also, the investigation confirmed that intensive voice therapy was equally effective 
in assisting patients to generalise learned strategies to everyday voice use for maintenance of 
benefit.  
Finally, following the succession of confirmation that intensive voice treatment can 
accelerate vocal quality and vocal fold function recovery when treating patients with vocal fold 
nodules, an alternative service delivery was proposed to enhance patient accessibility to intensive 
voice therapy. Chapter 5 explored the voice outcomes and patient perceptions following intensive 
voice therapy for vocal fold nodules via telepractice. Findings revealed significant improvements in 
auditory perceptual, vocal fold function, acoustic and physiological parameters as well nodule sizes 
and patient perceptions of voice-related quality of life after treatment. Furthermore, patients were 
highly positive about their first experience with telerepractice and there were minimal technical 
difficulties or barriers to implementation. These results support the feasibility and efficacy of 
implementing intensive voice therapy via telepractice for patients with vocal fold nodules. 
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6.2 Implications for Clinical Practice  
Several important clinical findings have arisen from the outcomes of the current thesis. For 
clinicians treating patients with vocal fold nodules, the current evidence will assist them in selecting 
a therapy model - intensive versus traditional, FTF versus online which best suits their client's 
needs, with confidence that outcomes can be comparable. It is known that the majority of the 
individuals with vocal fold nodules work in professions which are high in voice demand, therefore, 
it is essential that therapy can help them to return to the workforce as soon as possible with an 
adequate voice. The findings from the current thesis support that intensive voice therapy is a valid 
service delivery model to help achieve this.  
The benefits of such an intensive voice treatment addressed in this thesis are that: voice 
improvement can occur in a short period of time; patients’ knowledge of tasks for home practice 
can be enhanced; it is more time efficient for both clinician and client; time between sessions is 
decreased; and the ability to carryover learnt strategies into everyday life is facilitated. Individuals 
are able to accelerate learning regulated by increasing therapy rate, increasing therapy phase 
duration, increasing variability of practice, and decreasing the rest phase duration (Patel, Bless & 
Thibeault, 2011). Intensive contact with the clinician also allows individuals with vocal fold 
nodules to resolve any queries and be provided with clinician’s feedback regarding their use of 
voice within a shorter time frame. This can help solidify patients’ awareness and carryover 
treatment tasks to daily living (Thibeault, Zelazny, & Cohen, 2009). As noted by Spielman et al. 
(2007), the downfall of a prolonged voice therapy extends the time commitment for both client and 
clinician, with no additional gains to be acknowledged. The current investigations validated the 
support for the use of intensive treatment approach which required a more compacted treatment 
time (3 weeks versus 2 months) and promotes motor learning. Furthermore, the findings of the 
effects and benefits of intensive voice therapy would ultimately help to enhance clinician’s 
knowledge of treatment decisions and improve patient’s quality of life. 
A further clinical implication relates to the use of telepractice when delivering intensive 
voice therapy to people with vocal fold nodules. Although it has been established that voice therapy 
is often effective, in some and even many caseloads, rates of therapy completion are poor and this 
presents as a challenge for clinicians (Portone-Maira, Wise, Johns, & Hapner, 2011). This would 
also be seen as a critical barrier for full voice recovery in this patient population. As with any other 
behavioural intervention, it is noted that effective delivery of voice therapy is impacted by problems 
of resistance to change, therapy dropout and lack of follow-through outside the therapy session 
(Behrman, 2006; Hapner, Portone-Maira, & Johns, 2009; Portone, Johns, & Hapner, 2008). 
Numerous factors contribute to therapy non-compliance. However, one factor is the ready access to 
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services. In many settings internationally, the long hours at work with sometimes inflexible work 
conditions, living in rural areas, and occupations that do not allow individuals to take time off work, 
have major impact on the individual’s ability to attend regular voice treatment sessions. The travel 
time associated with sometimes large distances needed to access clinicians experienced in voice 
disorders also limits therapy attendance. Ultimately issues of access can contribute to missed 
appointments and a high dropout rate in the clinical population of individuals with vocal fold 
nodules. Such non-adherence to voice therapy not only affects treatment success, but also results in 
unnecessary extensions to treatment, and repeated examinations without sufficient behavioural 
change to effect improvement. There is also a cost of cancellations and no-shows to healthcare. 
Furthermore, there may be loss of revenue or loss of employment as patients are unable to meet the 
vocal requirements of their occupations (Portone et al., 2008; Portone-Maira et al., 2011). 
Consequently, there was a need to examine the potential application of an alternative service 
delivery model. The current thesis has been able to explore ways to facilitate greater access to voice 
therapy to maximise attendance and ultimately enhance outcomes for people with vocal fold 
nodules and other conditions affecting voice. Through quantitative data analysis, it has been 
recognize that the telepractice is a feasible and effective method in delivering intensive voice 
therapy to individuals with vocal fold nodules. The findings indicate the effectiveness of intensive 
voice treatment was not reduced by the distance mode. Furthermore, patient perceptions revealed 
that individuals were keen to receive services via telepractice, could see the benefit, and would 
prefer to receive therapy via telepractice. Such evidence supports that telepractice is an accepted 
service delivery model with specific benefits for those who have a busy lifestyle and/or limited 
travel time and work restrictions.   
 
6.3 Limitations and Future Directions 
Although the studies of this thesis have provided positive outcomes supporting the 
application of intensive voice therapy using either FTF or telepractice service delivery modalities, 
there are some limitations. These have been acknowledged within each chapter and are summarised 
again here. Firstly, the primary study design reported in Chapters 2, 3 and 4 could not be a 
conventional randomised clinical trial (RCT) due to the work restrictions of participants. A 
randomisation schedule was used to allocate participants to the two groups. However, in instances 
when the participants were unable to participate in the therapy model, they were allowed to be 
reallocated to the alternate treatment. This form of pragmatic allocation of participants to treatment 
groups was necessary to minimise inter-group differences yet facilitate recruitment to the study, due 
to the specific workforce issues which exist within Taiwan. In Taiwan there is high work demand, 
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long work hours and limited sick leave allowances. As a consequence, in Taiwan and other similar 
environments, individuals face considerable issues when seeking therapy, as people rarely take sick 
leave and often do not, for fear of job loss and reduced pay. Therefore, within this context, not all 
individuals with vocal fold nodules who consented to participation in this study would have been 
able to attend intensive treatment, even if it was their allocated - or even preferred - treatment 
method. Hence using a traditional RCT recruitment model, where patients are blindly allocated to 
treatment group would have created excessively high drop-out rates and threatened the viability of 
the study. Although it is acknowledged that a conventional RCT would have provided stronger 
internal validity, a pragmatic RCT reflects the ‘real world’ scenario which provides good external 
validity (Hotopf, 2002). Future studies should adopt the use of conventional RCT if possible, to 
confirm the current findings.   
Another limitation which should be recognised is that although subjective and objective 
parameters were used to examine the short-term effects of intensive voice therapy, patient’s 
perception of the therapy was not taken into consideration into the data set reported in Chapter 2 
and 3. Patients perceptions were only explored at 6 months post treatment (Chapter 4). The reason 
for this was that it was considered more relevant to allow patients time to adjust and consider their 
“new voice”, and hence this information was only collected at 6 months post treatment. However, it 
is acknowledged that future studies would benefit from the use of standardised self-rating 
questionnaires at all time points to monitor participants’ perception of the possible changes in 
quality of life and satisfaction with voice therapy. Further insights into patient’s opinion would 
provide clinicians with knowledge to motivate patients during treatment which may enhance 
treatment compliance and attendance. In addition, future research should also explore the 
relationship between patient compliance and outcomes following different treatment delivery 
protocols. Future studies should also examine whether the severity of dysphonia and size of vocal 
fold nodules are determining factors in treatment prognosis. Such information would assist 
clinicians in determining the most appropriate service delivery model for their patients.  
Even though long-term follow-up of 6 months was conducted, it was found none of the 
vocal fold nodules had dissipated completely. It is possible that the period of follow-up may not be 
extensive enough to determine whether the treatment was able to resolve vocal fold nodules 
completely. Therefore, future investigation on follow-up beyond 6 months post-treatment should be 
conducted to determine the time required to resolve nodules with both intensive and traditional 
voice treatments. Such longitudinal monitoring was not possible within the context of a PhD study. 
However such data would provide valuable information for individuals with vocal fold nodules who 
are seeking voice treatment, as it would provide greater insight into the duration of commitment to 
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behavioural change that is required to completely eradicate vocal fold nodules, as opposed to simple 
achieve improved perceptual voice change. Furthermore, although multiple analyses were 
conducted, it should be recognised that an  alpha level adjustment was not made. Hence, there may 
be a risk of alpha inflated error. Despite of this risk, many of the outcome measures showed a 
strong sigificant statistical difference at 0.001.  
With regards to Chapter 5, which examined the application of telepractice, a limitation, 
recognised was the use of SkypeTM, the free consumer-based voice and video over the Internet 
Protocol (VoIP) software system. Whilst the participants were fully informed, gave consent to use 
this software and felt comfortable using the program for therapy, it is acknowledged that there are 
issues with the privacy and security of the therapy sessions (Hall & McGraw, 2014; Watzlaf, 
Moeini, & Firouzan, 2010; Watzlaf & Ondich, 2012). This system was specifically chosen for this 
study due to its lack of cost and ease of public use. However, future investigations, using more 
secure systems that would enable more direct translation into services which require public health 
privacy and security regulations to be met, are required. That said, it is not anticipated that the use 
of similar, but more secure, videoconferencing systems would alter the outcomes regarding efficacy 
– however they may influence data on general feasibility and patient acceptance, particularly if 
additional patient costs (to purchase software) and more complex operational systems are involved. 
Also to fully explore the efficacy of therapy delivery via telehealth, future studies should be 
conducted on a larger numbers of participants and include a parallel group treated via FTF to 
enhance the strength of the research design. Furthermore, long-term follow-up on the investigated 
measures to examine whether the treatment effects using telepractice were maintained would be 
required. Finally, another limitation that should be acknowledged is that it may be difficult to 
provide verbal biomechanical instructions through telepractice should a clinician feel there is need 
to perform manual therapy. Therefore, further studies should be performed to investigate ways to 
overcome this challenge. 
These acknowledged limitations may have implications for the current findings. They also 
provide insight into future directions for research regarding the efficacy and outcomes following 
intensive voice therapy and intensive voice therapy delivered via telepractice for patients with vocal 
fold nodules. 
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6.4 Conclusion 
Although voice therapy has been established as an effective first-line treatment for vocal 
fold nodules, there has been a diverse variation in the treatment duration and treatment intensity 
delivered. Hence, clarification to the guidelines of voice therapy for clinicians was warranted in 
order to deliver efficient and effective treatment for individuals with vocal fold nodules. This series 
of four studies provided an insight to the benefits of intensive voice therapy delivered either via 
FTF or telepractice model. The findings present evidence that individuals with vocal fold nodules 
are able to recover and maintain improved voice quality and vocal health following intensive voice 
treatment to a similar degree to traditional voice treatment. Therefore, intensive voice therapy 
should be considered as an option when providing clinical management to individuals with vocal 
fold nodules. Consequently this population would be able to regain better vocal communication and 
return to workforce in a much shorter period of time. 
While intensive voice therapy has shown to be a beneficial alternative treatment protocol 
when delivered FTF, this thesis also provided preliminary evidence that supports telepractice as 
feasible and effective method when delivering intensive voice therapy to individuals with vocal fold 
nodules. Significant improvements were found in perceptual, physiological, acoustic and 
aerodynamic parameters post therapy. There were positive changes in participants’ perception of 
their voice and the effects of their voice on their life after voice treatment. Overall, the participants 
were satisfied with the intensive voice therapy provided through telepractice delivery, which 
indicate the effectiveness of treatment was not reduced by the distance mode. This mode of service 
delivery should be one of the options provided to patients who are unable to attend conventional 
FTF voice therapy. 
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Abstract 
Summary: Objectives. To investigate the perceptual, physiological, acoustic and aerodynamic 
outcomes of patients with vocal nodules following intensive voice treatment compared to traditional 
voice treatment.  
Study Design. Pragmatic randomised clinical trial  
Methods. Fifty-three women diagnosed with bilateral vocal nodules participated in the study. Voice 
recordings, stroboscopic recordings, acoustic and aerodynamic assessments were made prior to 
voice treatment, after vocal hygiene education, and immediately postvoice treatment. All 
participants completed one session of vocal hygiene and eight sessions of direct voice therapy, 
however the delivery of the treatment between the two groups differed in treatment intensity.  
Results. Physiological improvements were observed after vocal hygiene alone, while physiological, 
perceptual, and acoustic parameters all improved to some degree in both treatment groups 
immediately posttreatment. There were no differences in the extent of change observed between the 
two groups at any time point following treatment. 
Conclusions. The investigation provided initial evidence that individuals with vocal nodules are 
able to recover voice function, vocal health and vocal communication through intensive voice 
treatment. The results suggest comparable positive perceptual, physiological and acoustic outcomes 
from intensive voice therapy compared with traditional voice therapy. Further investigation is 
required to determine the long-term effects of intensive treatment. 
Keywords: Vocal nodules-Voice treatment-Perception-Physiology-Acoustic-Aerodynamic 
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Introduction 
Vocal nodules are benign lesions of the vocal folds caused by repetitive mucosal injury leading to 
histological changes and concomitant voice mutation.
1
 Their presence causes changes to the 
vibratory pattern of the vocal cords due to an increase in vocal fold mass and can impact vocal fold 
adduction both anteriorly and posteriorly to the nodule.
2
 The resultant dysphonia is perceived as 
breathy with various degrees of turbulent noise, strained vocal quality, roughness, instability and 
vocal fry/creak, with a tendency towards a low pitch.
2-4 
 Individuals with vocal nodules constitute a large part of the client population at voice 
clinics.
5
 The voice disturbances can cause personal problems and societal losses, as individuals with 
vocal nodules in professions with high voice demands are forced to take long periods of sick leave 
and sometimes may have to change careers.
5,6
 As a consequence, extensive research has been 
conducted on the efficacy of treatment for vocal nodules, with voice therapy recommended as first-
line treatment.
5,7-14
  
 Behavioural intervention has been shown to have a positive impact on vocal nodules, with 
number of studies confirming a marked reduction or complete elimination of the nodules 
posttreatment.
5,7,8,11,15-20
 Evidence also confirms that voice quality significantly improves postvoice 
therapy.
7,8,10,19,21
 Positive outcomes have also been reported across a range of acoustic measures, 
with jitter, shimmer, signal-to-noise ratio, fundamental frequency (F0), maximum phonation time 
(MPT) and mean airflow rate positively correlated with voice improvement following treatment for 
vocal nodules.
7,8,12,19 
 Although the majority of research conducted to date has demonstrated the positive effects 
voice therapy has on vocal nodules, there is considerable variation in the duration and intensity of 
the therapy provided. In fact, no report has provided evidence or clear guidelines as to the optimal 
intensity or duration of voice therapy for clients with this vocal pathology.
5,8,11,14,16,19
 Studies have 
reported voice treatment protocols which include 2 to 16 sessions,
12
 once per week for 12 weeks,
18
 
twice weekly for 2 to 4 months,
16
 and 4 to 6 months in duration.
8 
 For voice therapy to be effective, both motor learning and cognitive processes for 
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maintenance and transfer of the new vocal behaviour should be considered. According to Schmidt 
and Lee,
22
 motor learning is a set of processes associated with practice or experience leading to 
relatively permanent changes in movement. Practice conditions include the following: amount and 
distribution of practice, the variability of practice, the scheduling of practice with several different 
tasks, and part versus whole practice. These independent variables affect the learning of motor skills. 
One variable which may have an effect on learning and has not been widely investigated, is the 
distribution of practice. Practice distribution refers to how a given amount of practice is distributed 
over time,
23
 and may be described as massed or spaced practice. In massed practice, all the practice 
periods occur very closely together with little or no rest time in between sessions. In a spaced 
practice schedule, the time interval between the practice periods is increased significantly.
24 
 Few empirical data exist on the effects of practice distribution in speech motor learning. The 
strongest evidence exists for massed practice. For example, the Lee Silverman Voice Treatment 
(LSVT® ), which incorporates principles of multiple repetition, high intensity, and high frequency 
of practice (four treatment sessions per week for four weeks), has been shown to result in long-term 
vocal improvements in the speech and voice of people with Parkinson’s disease.25,26 It is postulated 
that this treatment facilitates intensive motor relearning, maximises motor output and effort, 
increases drive and goal directed activity, and enhances sensory awareness to promote internal 
cueing, self monitoring and upscaling of motor output.
27 
 The benefits of massed, intensive practice were also noted in the treatment of functional 
dysphonia.
28,29
 In a concept article, the authors provided a framework and indications for delivery of 
intensive short-term voice therapy, referred to as “boot camp”.28 This involved concentrated 
practice, using a variety of voice therapy techniques, delivered in a concentrated time frame (1 to 4 
days with 4 to 7 hours of therapy per day). This type of therapy was reported to be tailored to the 
nature of the voice disturbance and individual specific needs, thereby maximizing the individual’s 
ability to learn and carryover targets to non-clinical environments. The authors stated that this 
approach can be successfully used with various types of dysphonia, especially those who have not 
been successful with traditional voice treatment approach, and with clients living at geographical 
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distances sufficiently far from voice centres.
28
 However, clinical trials have not yet been conducted 
on the “boot camp” treatment approach. Patel et al.28 speculated that the nature of the high-intensity 
training may better mimic cognitive, motor, and physiological requirements of activities of daily 
living than traditional therapy.  
 Potential advantages of intensive treatment are that: rigorous practice (overload) is possible; 
simultaneous interventions can be conducted for multiple components involved in voice production; 
and opportunities for specificity, individuality, and facilitating transfer of learned skills which may 
influence patient compliance are readily available.
29
 Thus in translating this evidence to the 
management of vocal nodules, it is possible that intensive voice therapy may be more beneficial 
than traditional treatment protocols, and offer greater speed and efficiency in achieving 
improvement in vocal function. To date no study has explored the relative efficacy of intensive 
treatment specifically for individuals with vocal nodules. Therefore, the aim of the present study 
was to investigate the perceptual, physiological, acoustic, and aerodynamic outcomes of patients 
with vocal nodules following intensive voice treatment when compared to traditional voice therapy. 
It is hypothesised that greater improvement in perceptual, physiological, and acoustic parameters 
will occur following intensive voice treatment for vocal nodules compared to traditional voice 
therapy. 
 
Methods 
Ethics approval for the study was obtained from the Taipei Veterans General Hospital and The 
University of Queensland Medical Research Ethics Committee.  
 
Participants 
Fifty-three women (mean age 37.5 years, range 20-54) referred from the outpatient clinic at the 
Department of Otorhinolaryngology Department, Taipei Veterans General Hospital, Taiwan, and 
diagnosed with bilateral vocal nodules were included in the study. The diagnoses of vocal nodules 
were made by one of five otolaryngologists from videostroboscopic examination, while the severity 
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of dysphonia was determined by one speech-language pathologist (SLP) experienced in the area of 
voice and blind to the study purpose. Overall severity was rated using the “Grade” scale from the 
GRABS (Grade, Roughness, Breathiness, 
Asthenia, Strain) scale
30
 (where 0 = normal, 1 = mild, 1.5 = mild-to-moderate, 2 = moderate, 2.5 = 
moderate-to-severe, and 3 = severe) and was based on evaluation of a sample of reading (a standard 
Mandarin passage). Participants were included in this study if they: 1) were aged between 18 years 
and 55 years; 2) had normal articulation, resonance, and language ability; 3) had normal hearing as 
determined by a screening test at 20 dB HL at 3 frequencies 500, 1000, 2000 Hz; 4) had no previous 
professional singing or speaking training; and 5) had no previous voice therapy or laryngeal surgical 
treatment. Exclusion criteria included: 1) use of prescription medication which may cause changes 
in laryngeal function, mucosa or muscle activity (list provided by National Center for Voice and 
Speech [NCVS]
32
); 2) current psychiatric or neurologic conditions; or 3) a history of allergies, lung 
disease, or other concomitant vocal pathology (eg, vocal polyp and vocal cyst). 
 Participants were matched in pairs according to their age, occupation, and severity of 
dysphonia. The duration of dysphonia prior to treatment was not taken into consideration. The 
participants occupations were categorised into non-professional voice users (eg, factory worker, 
students, catering, clerical worker, home carers, and unemployed) versus professional voice users 
(eg, teachers, health professional, and sales personnel). All participants were diagnosed with 
bilateral broad-based nodules before treatment. Participants in each pair were then assigned to either 
of two treatment groups according to their availability: intensive voice therapy (IVT) or traditional 
voice therapy (TVT) groups. Thirty-one participants were recruited to the intensive voice program. 
Seven withdrew or failed to complete the full program (for health, work or personal reasons), 
leaving 24 participants who completed the intensive voice therapy program. A total of 37 
participants were recruited to the traditional voice therapy program group. Eight withdrew or failed 
to complete the entire program, leaving 29 participants who completed the entire traditional voice 
therapy program. Demographic information of the 53 participants who completed both programs is 
detailed in Table 1.  
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 Comparisons of baseline characteristics between the two groups were conducted using 
independent t-tests for parametric data (age, acoustic, and aerodynamic measurements) and chi-
square tests and Mann-Whitney U tests for non-parametric data (occupation, severity of dysphonia, 
existence of vocal fold oedema and vocal nodule location). There were no statistical differences 
between the groups with regards to their age (t= -0.165, p = 0.871), severity of dysphonia (Z = -
1.861, p = 0.063), or occupation (χ2 = 0.053, p = 0.817) at presentation. With respect to pretreatment 
acoustic and aerodynamic measurements no significant differences were found between groups all 
on all parameters. There were no significant differences between the groups with respect to vocal 
nodule location (Z = -0.195, p = 0.845) or surrounding oedema of the vocal folds (χ2 = 2.511, p = 
0.113). In the TVT group, 27 (93%) had nodules located on the front 1/3 of the vocal folds while 2 
(7%) were located mid-vocal folds. In the IVT group, 22 (92%) had nodules located on the front 1/3 
of the vocal folds with 2 (8%) participants having nodules located mid-vocal fold. All of the 
participants from TVT group had surrounding oedema prior to treatment as did 92% (n = 22) of the 
IVT group.  
 
Procedure 
Participants completed assessments at three time intervals relative to therapy: 1) before the initial 
vocal hygiene session, 2) three weeks after the vocal hygiene session and immediately prior to 
IVT/TVT voice therapy, and 3) immediately following IVT or TVT. All assessments were 
performed by a SLP and otolaryngologists experienced in voice disorders who were independent to 
the study and blinded to group allocation. 
 
Auditory perceptual ratings 
At each assessment interval, the participants were asked to read a Mandarin passage consisting of 
five sentences. Samples were recorded with a Shure SM48-LC microphone and stored in the 
Computerised Speech Laboratory system (CSL; model 4500, Kay Elemetrics Co.) at a 4.41 KHz 
sampling rate in a sound-treated room. The desktop microphone was positioned in front of each 
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participant’s mouth at a mouth-to-microphone distance of 15 cm.  
 Perceptual analysis was conducted by one SLP with 15 years experience assessing voice 
disorders. Voice quality was assessed using the GRBAS scale,
 30
 which consists of five parameters: 
grade (G), roughness (R), breathiness (B), asthenicity (A) and strain (S). Ratings of the GRBAS 
parameters were conducted as paired comparisons, using the Comparison Mean Opinion Score 
(CMOS) process.
33
 This process allows the rater to detect even subtle changes in a patient’s voice 
or speech characteristic by allowing them to listen to, and compare an individual’s speech sample in 
pairs (eg, pre- and posttherapy), and rate the second sample relative to the characteristics of the first 
sample. A clinician independent of the rating process created pairs of recorded speech samples for 
each participant relating to the assessment time points (ie, prevocal hygiene and postvocal hygiene; 
prevocal hygiene and postvoice therapy; postvocal hygiene and postvoice therapy). The order of the 
two samples in each pair was randomized to reduce any potential expectation bias. After listening to 
each pair of the entire speech sample, the clinician then rated sample 2 in relation to sample 1 on a 
scale of -3 to +3, in which 0 indicates the samples are equal. If the value is negative, it indicates that 
sample 2 is worse than sample 1 (-1 mildly worse; -2 worse and -3 severely worse). However, if the 
value is positive, it indicates that sample 2 is better than sample 1 (+1 mildly better; +2 better and 
+3 much better). The SLP was able to listen and compare the speech samples as often as they 
wished. Once the paired samples were rated, the principle investigator revealed the order of the two 
samples and transposed the scores to ensure data accurately reflected perceptual differences relative 
to the time of speech sample recording such that any positive score indicated an improvement, and 
negative values, a decline in function.  
 Inter-rater reliability was explored by having a SLP with eight years experience assessing 
voice disorders rate a random set of 33 samples (20% of the total voice samples). Reliability was 
calculated using intraclass correlation coefficient (ICC) as well as direct calculation of the Percent 
Exact Agreement (PEA) and the Percentage of Close Agreement (PCA - where raters differed by no 
more than 1 scale point). The calculated results were derived from mean values of all perceptual 
parameters. Results of the ICC (0.64) revealed substantial agreement
33
 while the PEA was 74% and 
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the PCA was 93%. For intra-rater reliability the primary rater re-rated 20% of the sample a second 
time, at no sooner than four weeks following initial assessment. The ICC of 0.85 indicated almost 
perfect agreement,
33
 with the PEA 71% and PCA was 99%.  
 
Videostroboscopic evaluation – physiological ratings 
The videostroboscopic recordings were made during the sustained phonation of the vowel /i/ 
produced at a comfortable loudness and pitch. The stroboscopic assessments were conducted by any 
one of five otolaryngologists at any assessment point. The recorded videostroboscopic samples 
were then subsequently rated by one primary otolaryngologist with seven years experience 
assessing voice disorders.  
 The videostroboscopic ratings were performed in two stages. The first stage rated: the 
symmetry of vocal fold abduction and vibration; the regularity and amplitude of the vocal fold 
movement, vocal fold edge smoothness, mucosal wave characteristics and glottal closure using a 4 
point scale (0 = normal; 1 = mild; 2 = moderate; 3 = severe); Additional parameters, nodule location 
(very front, front, mid, back of the vocal fold membranous portion), nodule shape (narrow-based, 
broad-based); and surrounding oedema (yes/no) were also rated. The 159 samples (53 participants 
by three samples per participant) were randomized prior to presentation to the otolaryngologists for 
rating in order to reduce any potential bias. The otolaryngologists were able to review each 
videostroboscopic sample for as long as they wished. The ratings were completed from visual 
impression only and the videos were presented without sound.  
 The second stage of the videostroboscopic rating process, was to use the paired sample 
comparison process (as described previously) to rate paired samples (prevocal hygiene and 
postvocal hygiene; prevocal hygiene and postvoice therapy; postvocal hygiene and postvoice 
therapy) using a questionnaire adapted from Holmberg, Hillman, Hammarberg, Sodersten, and 
Doyle.
8
 Ratings of sample two compared to sample one were rated for changes in: (1) nodule size 
(difference between the two recordings, -1 larger; 1 smaller; 0 no difference), and; (2) surrounding 
oedema (difference between the two recordings: -1 larger; 1 smaller; 0 no difference). Once the 
199 
 
samples were rated, the principle investigator revealed the order of the samples and transposed the 
scores to ensure data accurately reflected differences relative to the time of videostroboscopic 
sample recording (prevocal hygiene, postvocal hygiene and postvoice therapy). 
 Inter-rater reliability of the primary rater was determined using a second otolaryngologist 
with nine years experience assessing voice disorders who rated a random set of 33 samples (20% of 
the total videostroscopic samples). The calculated results were mean values of all physiological 
parameters. The ICC revealed almost perfect agreement for inter-rater reliability (0.88), while the 
PEA was 74% and PCA was 99.6% respectively. Intra-rater reliability (based on 20% of the sample 
rated no sooner than four weeks following initial assessment) was also almost perfect (0.91), with 
PEA falling at 91.5% and PCA 97.4%.  
 
Aerodynamic assessment 
Aerodynamic assessment included measures of maximum phonation time (MPT), mean airflow rate 
(MFR) and subglottic pressure. MPT was measured with a stopwatch while participants were asked 
to produce the sustained vowel /a/ for as long as possible at a comfortable loudness and pitch level 
on a single breath, three times. The MFR and subglottic pressure were obtained and analysed using 
the Aerophone II (Model 6800, Kay Elemetrics Co., Lincoln Park, NJ). Each participant was asked 
to produce a sustained vowel /a/ for as long as possible at a comfortable intensity and pitch level 
with a face mask, sealed over the nose and mouth connected to a pneumotachograph- based flow 
system, three times. The subglottal pressure was measured indirectly using an intraoral pressure 
probe positioned behind the lips and resting on the tongue. The participants were asked to repeat 
/ipipip/ with the face mask and probe in place at a rate of 1.5 syllables/second, three times. Results 
for each parameter were averaged to produce one single value which was used in the statistical 
analyses. 
 
Acoustic assessment 
All acoustic recordings were conducted in a sound-proof room. The participants were asked to 
200 
 
produce a sustained vowel /a/ on one breath at a comfortable pitch and loudness level, three times. 
Vowel productions were recorded via the desktop microphone of the Computerized Speech Lab 
(CSL) (Model 5105, Kay Elemetrics Co.). The microphone was positioned in front of the 
participant with a mouth-to-microphone distance of 15 cm. Each participant’s production of 
sustained /a/ was analysed using the Multi-Dimensional Voice Program (MDVP) software (Kay 
Elemetrics, Lincoln Park, NJ) in the CSL. The middle 3-second segment from each of the sustained 
vowels was selected for acoustic analysis. Detailed voice stability measures included: vocal 
fundamental frequency (Fo) (Hz), mean percentage vocal jitter and shimmer, and noise-to-
harmonics ratio (NHR) (dB). Results across the three vowel phonations were averaged to produce a 
single value for each measure. In addition, participants’ vocal intensity (VI) (dB) for the three 
prolonged vowels /a/ and additional conversational speech samples were simultaneously measured 
using Sound Level Meter (320 series, Center Technology Corp., Taiwan) which was also positioned 
in front of the participant with a mouth-to-microphone distance of 15 cm. Vocal intensity recorded 
for the prolonged vowel phonations and conversational speech samples were averaged to produce a 
single value for each measure. 
 
Therapy program 
The therapy program for each treatment group consisted of both indirect and direct therapy 
treatment strategies. Both groups began voice therapy with indirect treatment strategies in which all 
participants were asked to follow general voice hygiene measures (adapted from Weinrich,
34
 
Verdolini Abbott,
35
 and NCVS
36
). Participants in each group were then scheduled to return for 
eight-sessions of direct voice therapy three weeks later. The therapy program which was followed 
over the eight sessions in both groups was identical. Only the intensity of its delivery varied 
between the groups. The TVT (control) group received one session of direct therapy per week for 
eight weeks (8 sessions of therapy). The IVT group received eight sessions delivered within a three 
week period (ie, three times per week in the first two weeks and two times in the third week). All 
sessions, regardless of group, were 45 minutes in duration.  
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 The voice therapy was provided by the principle investigator who was not involved in 
assessment of the participants. The principle investigator was trained and certified to provide the 
therapy program which was adapted from the Lessac-Madsen Resonant Voice Therapy (LMRVT) 
developed by Verdolini Abbott.
35
 Components of the Vocal Function Exercises (VFE) program 
developed by Stemple were also incorporated in the speech tasks.
37
 LMRVT focuses on the 
production of resonant voice which has been defined as a vocal quality that projects well, is easy to 
produce; involves a sensation of vibration in the mask of the face; and is characterised by ample 
harmonic content.
38
 It is generally produced with relatively complete anteroposterior vocal fold 
closure during phonation.
14
 The focus of this therapy is: (1) the production of concentrated 
vibratory sensations on the anterior palate during phonation, using an “inverted megaphone” facial 
posture, and (2) upper body relaxation, using manual manipulations to reverse any obvious head, 
neck, or shoulder tensions and to obtain good head and neck alignment.
14
 VFE represents a holistic 
approach to voice treatment designed to rebalance the three subsystems of voice, respiration, 
phonation, and resonance.
39
 These exercises are designed to build strength and endurance in the 
laryngeal muscles and in doing so improve range and control for voice production.
2,38
 The exercises 
also facilitate better control over airway valving and in so doing reduce hyperfunctional laryngeal 
behaviours.
2
  
 Therapy began with shoulder, neck, and facial muscle relaxation followed by basic training 
gestures as described by Verdolini Abbott
35
 and Roy et al.
40
 Direct facilitation of voice through 
stretch (ascending pitch glide) and contraction exercises (descending pitch glide) on the word 
“knoll”, “whoop”, or “boom” with an extreme forward focus was completed. Therapy tasks 
extended to sounds in isolation, conversation, and real-life applications outside of the therapy room, 
based on the clinician’s impression that earlier levels in the therapy hierarchy had been successfully 
mastered. All participants were asked to practice voice techniques worked on in the therapy session 
at home, in two 15-minutes sessions per day on non-therapy days, and once per day on therapy days. 
The techniques were provided in worksheets in the form of a daily checklist for participants to take 
home. 
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Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 20 (SPSS, Inc., Chicago, IL) was 
used for all statistical analysis and level of significance was set at P < 0.05. Analysis involved both 
within group and between group analyses. For within group analysis, the paired comparison ratings 
(between baseline and postvocal hygiene, baseline and posttreatment, and postvocal hygiene to 
posttreatment) conducted for the perceptual parameters of grade; roughness; breathiness; asthenia; 
strain and also for the physiological parameters of nodule size and oedema were analysed using a 
series of one sample t tests (2-tailed) where 0 was taken to indicate no difference between the 
sample pairs. 
 For the physiological parameters of the symmetry of vocal fold abduction and vibration; the 
regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; mucosal wave; 
and glottal closure were analysed using Friedman’s tests to explore extent of within group change in 
each treatment group (IVT and TVT) across the three time points (baseline, postvocal hygiene, and 
postvoice treatment). Any significant result was examined further using posthoc Wilcoxon signed 
rank tests.  
 Prior to conducting the between group analysis, data from the physiological ratings 
(symmetry of vocal fold abduction and vibration, the regularity and amplitude of the vocal fold 
movement, vocal fold edge smoothness, mucosal wave and glottal closure) were converted to 
change scores, calculated as the difference between the baseline and postvocal hygiene ratings, 
between baseline and posttreatment ratings, and between postvocal hygiene and posttreatment for 
each participant in each group. Mann-Whitney U tests were then used to determine any differences 
in the extent of change across the physiological parameters at baseline to postvocal hygiene, 
baseline to posttreatment and postvocal hygiene to posttreatment between the IVT and TVT groups.  
 To explore between group differences for the perceptual and physiological data from the 
paired comparisons ratings, the proportions of participants identified as either better, worse or no 
different at postvocal hygiene and posttreatment were calculated then compared between the groups, 
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using chi-square tests. 
 With regards to acoustic and aerodynamic measures, to identify differences between the two 
treatment groups (IVT and TVT) across time (pre-, postvocal hygiene, and after voice treatment) as 
well as any interaction occurring between treatment group and time, two-factor repeated measures 
analyses of variances (ANOVAs) were used. Where a significant (P < 0.05) effect for time was 
found, posthoc procedures were performed to determine where the significant difference occurred 
(ie, between pre- and postvocal hygiene, postvocal hygiene and posttreatment, or pre- and 
posttreatment) within each group.  
 
Results 
Perceptual ratings – paired comparisons 
Within group analysis. T tests revealed that between baseline and postvocal hygiene, there were no 
significant changes across any of the perceptual parameters except for strain, which improved 
significantly (P < 0.05) in the TVT group only (Table 2). The comparison between baseline and 
posttreatment showed that both the TVT and IVT groups were found to have significantly improved 
ratings of overall voice quality, roughness, breathiness, weakness of voice, and strain. Comparison 
between postvocal hygiene and posttreatment also demonstrated significantly improved ratings of 
overall voice quality, roughness, and strain of voice in both groups, with IVT group showing 
additional significant improvement in breathiness and weakness of voice (Table 2).  
Between group analysis. Descriptive analysis and chi-Square tests showed that there were no 
differences in the proportions of patients making positive change between the groups at either 
baseline to postvocal hygiene, baseline to postvoice treatment or post- vocal hygiene to postvoice 
treatment for all perceptual parameters (Table 3). 
 
Videostroboscopic ratings – physiological parameters 
Within group. Results of the physiological ratings over time for TVT and IVT groups are shown in 
Table 4. Friedman tests revealed a significant (P < 0.05) difference across the three time points for 
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the ratings of mucosal wave, vocal fold edge smoothness, regularity of vocal fold movement, and 
glottal closure in both the IVT and TVT groups. There were no significant differences observed for 
symmetry of vocal fold abduction or amplitude of vocal fold movement over time in either group 
(Table 4). 
 Posthoc Wilcoxon signed rank tests revealed statistically significant improvements from 
baseline to postvocal hygiene for both the TVT and IVT groups for ratings of mucosal wave (TVT: 
Z = -2.738, P = 0.006; IVT: Z = -3.441, P = 0.001), vocal fold edge smoothness (TVT: Z = -3.317, 
P = 0.001; IVT: Z = -2.887, P = 0.004) and glottal closure (TVT: Z = -2.500, P = 0.012; IVT: Z = -
1.968, P = 0.049). No significant differences were found between baseline and postvocal hygiene 
for regularity of vocal folds (TVT: Z = -0.707, P = 0.480; IVT: Z = -1.667, P = 0.096) for either 
groups.  
 Comparisons between postvocal hygiene to posttreatment revealed further significant (P < 
0.05) improvements in mucosal wave (Z = -3.625, P < 0.001), vocal fold edge smoothness (Z = -
3.464, P = 0.001), regularity of vocal movement (Z = -2.530, P = 0.011) and glottal closure (Z = -
3.500, p < 0.001) for participants in TVT group. In the IVT group only, a significant improvement 
in mucosal wave (Z = -3.477, P = 0.001) was found between postvocal hygiene and posttreatment.  
 Between baseline and immediately postvoice therapy significant (P < 0.05)  improvements 
were observed in mucosal wave (TVT: Z = -4.567, P < 0.001; IVT: Z = -4.110, P < 0.001), vocal 
fold edge smoothness (TVT: Z = -4.347, P < 0.001; IVT: Z = -3.300, P = 0.001), regularity of vocal 
fold movement (TVT: Z = -2.517, P = 0.012; IVT: Z = -2.496, P = 0.013) and glottal closure (TVT: 
Z = -4.181, P < 0.001; IVT: Z = -2.982, P = 0.003) in both the TVT and IVT groups.  
Between group analysis. Mann-Whitney U tests revealed no significant differences in the extent of 
change between the groups at either baseline to postvocal hygiene, postvocal hygiene to pos 
treatment, or baseline to posttreatment for all parameters (Table 5). 
 
Videostroboscopic ratings – comparison of pairs 
Within group analysis. One sample t tests revealed that both groups demonstrated significantly 
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improved ratings of vocal nodule size (TVT: t = 2.3, df = 26, P = 0.026, mean diff = 0.333; IVT: t = 
3.7, df = 23, p = 0.001, mean diff = 0.500) and vocal fold oedema (TVT: t = 2.6, df = 26, P = 0.015, 
mean diff = 0.370; IVT: t = 4.1, df = 23, P < 0.001, mean diff = 0.500) following vocal hygiene. 
Comparison between postvocal hygiene and posttreatment revealed significantly improved ratings 
of vocal nodule size (TVT: t = 3.808, df = 27, P = 0.001, mean diff = 0.536; IVT: t = 2.865, df = 22, 
P < 0.001, mean diff = 0.435) and vocal fold oedema (TVT: t = 4.688, df = 27, P < 0.001, mean diff 
= 0.607; IVT: t = 4.447, df = 22, P < 0.001, mean diff = 0.609). From baseline to postvocal therapy 
both groups demonstrated significantly improved ratings for vocal nodule size (TVT: t = 4.03, df = 
28, P = 0.001, mean diff = 0.552; IVT: t = 15.199, df = 22, P < 0.001, mean diff = 0.913) and vocal 
fold oedema (TVT: t = 4.04, df = 28, P < 0.001, mean diff = 0.586; IVT: t = 10.199, df = 22, P < 
0.001, mean diff = 0.826).  
Between group analysis. Descriptive analysis and chi-Square tests showed there were no significant 
differences between the groups at either baseline to postvocal hygiene, baseline to postvoice 
treatment or postvocal hygiene to postvoice treatment for all physiological paired comparisons with 
respect to the proportion of participants who had improved, declined, or had no change in vocal 
nodule size or oedema (Table 6). 
 
Aerodynamic measures 
A series of two-factor ANOVAs (group x time) conducted for each aerodynamic parameter 
revealed no significant interactions between group and time for any parameters (Table 7). There 
was also no main effect for time for any aerodynamic parameter. Furthermore, the between group 
effect was not significant for any aerodynamic parameters, suggesting no difference in the 
effectiveness of the two approaches regarding aerodynamic measures (Table 7).  
 
Acoustic measures 
Two-factor ANOVAs conducted for each acoustic parameter showed no significant interaction 
between group and time (Table 8). There was however a significant main effect for time for F0, 
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jitter, shimmer, NHR and VI for prolonged /a/, with both groups showing an increase in values 
across the three time periods for F0 and VI of prolonged /a/ and a reduction in values for jitter, NHR 
and shimmer. There was no main effect observed for VI in conversation. In addition, the between 
group effect was not significant across all acoustic parameters, suggesting no difference in the 
effects of the two interventions on acoustic measures (see Table 8).  
 Posthoc tests performed on the acoustic parameters demonstrated a significant main effect 
for time. Analysis revealed no significant differences between pre- and postvocal hygiene across all 
acoustic parameters for both treatment groups, except for VI for prolonged /a/ (P = 0.019) in IVT 
group. However, significant increases in mean F0 were found for participants in both the IVT and 
TVT groups between baseline and immediately postvoice therapy. Both groups also experienced 
significant reductions in jitter (P < 0.001 and P = 0.012), and shimmer (P = 0.001 and P = 0.03) 
following treatment. Although there was a significant main effect for time for NHR, no significant 
differences were found in the posthoc analysis between time points in both groups, though a trend 
(P = 0.099 and P = 0.381, respectively) was observed for a reduction in NHR between baseline and 
posttreatment for TVT and IVT groups. Results of VI for prolonged vowel /a/revealed a significant 
increase immediately posttreatment in TVT group (P = 0.005) but not in IVT group (P = 0.069). 
 
Discussion 
Extensive studies have been conducted to investigate the benefits of voice therapy in the 
management of vocal nodules, however there is large variation in the duration and intensity of the 
therapy reported. This study examined perceptual, physiological, acoustic, and aerodynamic 
outcomes following two treatment intensity protocols for individuals with vocal nodules. The 
results of the current investigation provide support for comparable positive perceptual, 
physiological and acoustic effects from intensive voice therapy delivered over a shorter period of 
time (three weeks), compared with the traditional model of service delivery provided over eight 
weeks. Although both treatments modalities contributed to significant improvements posttreatment 
across most variables, the efficiency of intensive practice may be better suited to some patients. 
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These findings support the benefits of massed practise as reported by other investigations.
25,26,28 
 In the current study, no significant differences were noted postvocal hygiene perceptually, 
acoustically or aerodynamically in either group, except for a perception of reduced strain in the 
TVT group. In contrast, physiological assessment showed significant positive changes to mucosal 
wave, vocal fold edge smoothness, and glottal closure nodule size and surrounding oedema 
following the vocal hygiene program in both groups. This discrepancy in findings was also 
observed by Verdolini-Marston, Sandage and Titze
41
 who found significant improvement in 
laryngeal appearance following vocal hygiene (ie, hydration), however auditory-perceptual ratings 
fell short of statistical significance. A possible explanation for the lack of change in perceptual, 
acoustic and aerodynamic parameters postvocal hygiene could be that the subtle changes identified 
under videostroboscopic examination were not yet sufficient to result in other changes.  
 Although the intensive treatment protocol used in the current study may be considered to 
increase or exacerbate vocal loading for participants with vocal nodules, the significant 
improvements in perceptual and physiological parameters identified in participants postintensive 
treatment were comparable to the results yielded posttraditional treatment. Therefore, the results 
suggest that an intensive treatment schedule did not result in an increase in vocal loading with 
subsequent exacerbation of vocal pathology in this cohort. 
 Previous case study reports have documented positive changes in vocal fold morphology 
and function following vocal hygiene counselling alone.
18
 A specific vocal hygiene target, 
hydration, has been shown to have significant benefit on the laryngeal appearance on a group of 
participants with vocal nodules and polyps.
41
 The current findings also suggest that vocal hygiene 
education remains an important part of voice therapy as the issues discussed in vocal hygiene 
session (eg, hydration, reduction in voice use, reduction in consumption of foods which may cause 
gastric reflux) may have been responsible for the development of vocal nodules in the first place. 
However several reviews of vocal hygiene training have concluded that although it is beneficial to 
include vocal hygiene program, it should be considered only as a component of a comprehensive 
vocal rehabilitation program.
42,43
 Indeed recent studies have revealed that vocal hygiene education 
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alone is ineffective for treating individuals with existing voice problems and that direct voice 
therapy is required to optimise treatment benefits.
40,44-46
 The current data would also support this 
opinion.  
 Previous investigators have reported that voice therapy is effective in restoring normal voice 
and improving voice quality in individuals with vocal nodules.
7,8,10,19-21
 Specifically, it has been 
reported that breathiness and pressed quality of voice is significantly reduced posttherapy.
8
 Our 
study also yielded a similar result, in that participants from both TVT and IVT groups had 
significantly less rough, breathy, weak, and strained voices, and overall had a better voice quality 
immediately posttherapy when compared with baseline. As implied by Holmberg et al
8
 the 
decreased breathiness may reflect a reduction in nodule size, thus making more complete glottal 
closure possible. This is consistent with our physiological findings in that our participants had 
significantly reduced nodule size and glottal closure posttherapy.  
 The reduction in strained voice identified posttherapy in both groups, may have indicated 
decreased muscle tension, and improved speech respiratory behaviour with better management of 
air supply and a more efficient relationship between subglottal pressure and glottal function.
8
 The 
decrease in strained voice may also be reflected through the improved regularity of vocal fold 
movement and mucosal wave. A combination of the improvement of all voice qualities can be seen 
as an indicator of the efficacy of the voice therapy delivered in both groups.  
 Several researchers have found regularity of vocal fold vibration, quality of mucosal wave 
and vocal fold closure to have improved with voice training; and elimination or marked reductions 
in nodules and surrounding oedema to have dissipated postvoice therapy.
5,7,8,15-18,20
 These findings 
were also demonstrated in the current study. When comparing baseline to immediately postvoice 
therapy, both the IVT and TVT groups demonstrated significant improvements in mucosal wave, 
vocal fold smoothness, regularity of vocal fold movement and glottal closure. In addition, there was 
significant reduction in nodules and surrounding oedema posttreatment for both groups. The 
improvement in mucosal wave, vocal fold smoothness, regularity of vocal fold movement and 
glottal closure may reflect an increase in effective mass of the vocal fold and a reduction in the size 
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of the vocal nodules. 
 Although significant improvements were noted by the end of treatment, for the majority of 
the participants, their vocal nodules had not completely resolved, as has been observed by other 
researchers.
5,8
 It is postulated that although the trauma to the vocal folds may have decreased after 
therapy, the impact on the vocal fold physiology might not have been significant enough to allow 
complete amelioration of the nodular lesions.
5,8
 It is also suspected that those with larger nodules 
may require a longer care period.
12
 Direct treatment periods of three weeks and eight weeks may be 
insufficient for vocal nodules to completely resolve. Therefore, further long-term observations 
should be conducted to determine whether or not the resolution of vocal nodules persists. 
 The results of the acoustic analyses revealed there were significant increases in F0, and 
decreases in jitter, and shimmer, immediately after voice treatment for both groups which is 
consistent with previous research findings.
20,47,48
 The increase in F0 may be due to a reduction in 
size of the vocal nodules and a decrease in surrounding oedema resulting in a decrease in the mass 
loading effects on the vibratory characteristics of the vocal folds.
2,8,49
 It was also noted there was a 
significant increase in vocal intensity for TVT group but not the IVT group. This increased vocal 
intensity may be attributed to the extended time provided for the TVT group to familiarise 
themselves with the use of vocal projection, which is a treatment component of LMRVT. As a 
result, participants developed a louder voice. The overall acoustic improvements found in both 
groups reflected increases in effective mass of the vocal fold, reduction in the vocal noise, and 
possibly diminishing vocal nodule size.
8,50
 This was confirmed by our physiological findings which 
showed significant improvement in mucosal wave, vocal fold edge smoothness, regularity of vocal 
fold movement, glottal closure, and significant reduction in vocal nodule size and vocal fold 
oedema immediately posttreatment. In addition, the acoustic improvement also positively correlated 
with participants' perceptual ratings in which overall voice quality, roughness, breathiness, 
weakness, and strain of voice were significantly improved. These changes indicated that the 
intensive and traditional treatment dosages used in this study were effective in the management of 
vocal nodules. As no statistical differences were found between the treatment groups, it is further 
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suggested that intensive intervention over a three week period is of sufficient duration to improve 
voice outcome for individuals with vocal nodules. 
 Similar to the aerodynamic findings yielded by Holmberg et al
5
 and Treole and Trudeau,
51
 
the current study found no significant changes in aerodynamic parameters posttreatment. It may be 
that as the participants’ aerodynamic measures were already in the normal range before voice 
treatment, significant changes were unable to be detected immediately following therapy.
52
 It may 
also be the case that as the smoothness of the vocal fold edges in the majority of the participants 
was only mildly or moderately affected at baseline, this did not impact on aerodynamic function 
through the therapy period. 
 It is known that majority of the individuals with vocal nodules work in professions which 
are high in voice demand, therefore, it is essential that they return to workforce as soon as possible 
with an adequate voice. Therefore, intensive voice therapy may be a preferable service delivery 
model as these individuals would be able to return to work with an improved voice within a shorter 
period of time. The benefits of such an intensive voice treatment include: voice improvement in a 
short period of time, increased patient compliance and understanding of home practice, more time 
efficient for both clinician and client, decreased time between sessions, and increased ability to 
carryover learned strategies into everyday life. Individuals are able to accelerate learning regulated 
by increasing therapy rate, therapy phase duration, and variability of practice, and decreasing the 
rest phase duration.
28
 Intensive contact with the clinician allows individuals with vocal nodules to 
resolve any queries and be provided with clinician’s feedback regarding their use of voice in a 
shorter time frame. This process can assist patients to consolidate their awareness and facilitates 
generalisation of treatment effects to daily living.
29
 In contrast, prolonged voice therapy as noted by 
Spielman et al.
26
 extends the time commitment for both client and clinician, with no additional 
gains to be made. 
 The overall outcome of this current investigation showed that both treatment approaches 
were able to provide improvements to vocal fold condition and vocal function. As such the data 
demonstrated that participants were able to improve voice and vocal fold health in the short period 
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of time needed for the intensive therapy approach and were able to carryover vocal strategies into 
everyday life. Thus, the intensive model may be more time efficient and beneficial for people who 
have busy work schedules as they have the need to go back to work as soon as possible with a 
satisfactory voice. 
 While the present study revealed the potential value of providing treatment to individuals 
with vocal nodules in an intensive approach, there are limitations to the study. The first issue is the 
use of a pragmatic randomized controlled trial (RCT) design, over the more conventional RCT 
method. The pragmatic allocation of participants to treatment groups was necessary to facilitate 
recruitment in the research setting of Taiwan where there is high work demands and minimal 
support for sick leave. The typical workforce in cultures such as Taiwan face considerable issues 
when seeking therapy, as people rarely take sick leave and are encouraged not to, for fear of job loss 
and reduced pay. Although a conventional RCT would have provided stronger internal validity, a 
pragmatic RCT reflects the ‘real world’ scenario which provides good external validity.53 Hence a 
pragmatic RCT approach was adopted to allow more participants to be included in the study with 
less attrition. Future studies would also benefit from the use of standardised self-rating 
questionnaires to further monitor participants’ perception of the possible changes in quality of life 
and satisfaction with voice therapy. Furthermore, long-term follow-up of both treatments should 
occur to determine whether or not there is continuous improvement or maintenance of vocal quality, 
vocal fold health and vocal communication.  
 
Conclusions 
In conclusion, the positive improvements in perceptual, physiological, and acoustic parameters of 
voice identified in this study provide evidence that intensive voice treatment is equally as beneficial 
in treating vocal nodules as a traditional voice therapy model. Intensive voice therapy should be 
considered as an option when providing clinical management to individuals with vocal nodules. 
Consequently this population would be able to regain better vocal communication and return to the 
workforce in a condensed period of time. This research warrants further investigation of the effects 
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of intensive voice treatment on the long-term follow-up and participant perception of the benefits of 
this treatment protocol. Such research will ultimately lead to better quality of life and service 
delivery for the many individuals with vocal nodules.  
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Table 1. Demographic Information of Participants 
Demographic variables TVT  Group IVT Group P 
Total number of   
   participants 
29 24  
Mean age 37.52 37.54 0.871 
Severity of dysphonia     0.063 
   Mild 2 -  
   Mild-moderate 19 12  
   Moderate 7 12  
   Moderate-severe 1 -  
Occupations   0.817 
   Professional voice user 16 14  
   Non-professional voice  
     user 
13 10 
 
Abbreviations: TVT, traditional voice therapy; IVT, intensive voice therapy. 
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Table 2. Results of the One Sample t Tests for the Perceptual Parameters Over Time for the TVT and IVT Groups 
  TVT IVT 
Time Parameter Mean difference t p Mean difference t p 
Baseline to post-VH Grade 0.310 1.877 0.071 0.042 0.196 0.846 
 Roughness 0.241 1.425 0.241 0.125 0.681 0.503 
 Breathiness 0.138 1.162 0.255 0.042 0.296 0.770 
 Asthenia 0.103 1.140 0.264 0.208 1.735 0.096 
 Strain 0.276 2.512 0.018* 0.250 1.543 0.137 
Post-VH to post-tx Grade 0.552 3.266 0.003* 0.625 3.498 0.002* 
 Roughness 0.517 2.824 0.009* 0.625 3.498 0.002* 
 Breathiness 0.241 1.885 0.070 0.292 2.290 0.032* 
 Asthenia 0.241 1.885 0.070 0.292 2.598 0.016* 
 Strain 0.241 2.045 0.050* 0.292 2.598 0.016* 
Baseline to post-tx Grade 0.897 5.363 <0.001* 0.875 4.764 <0.001* 
 Roughness 0.828 5.255 <0.001* 0.750 3.892 0.001* 
 Breathiness 0.345 2.415 0.023* 0.458 2.696 0.013* 
 Asthenia 0.483 3.524 0.001* 0.458 3.114 0.005* 
 Strain 0.586 4.308 <0.001* 0.542 2.716 0.012* 
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment. 
* Statistically significant difference. 
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Table 3. Analysis of the Proportion of Change in Perceptual Ratings at Each Time Point Observed Between the Two Groups 
Parameter/Time  TVT, n (%) IVT, n (%) χ2 P 
Grade       
 Baseline to post-VH Post-VH better 11 (38) 6 (25) 3.086 0.544 
 Post-VH worse 5 (17) 7 (29)   
 No change 13 (45) 11 (46)   
 Post-VH to post-tx Post-tx better 18 (62) 13 (54) 2.240 0.326 
 Post-tx worse 5 (17) 2 (8)   
 No change 6 (21) 9 (38)   
Baseline to post-tx Post-tx better 24 (83) 17 (71) 4.592 0.204 
 Post-tx worse 4 (14) 2 (8)   
 No change 1 (3) 5 (21)   
Roughness      
 Baseline to post-VH Post-VH better 10 (34) 5 (21) 2.613 0.241 
 Post-VH worse 6 (21) 8 (33)   
 No change 13 (45) 11 (46)   
 Post-VH to post-tx Post-tx better 18 (62) 13 (54) 2.240 0.326 
 Post-tx worse 5 (17) 2 (8)   
 No change 6 (21) 9 (38)   
 Baseline to post-tx Post-tx better 22 (76) 17 (71) 2.304 0.680 
 Post-tx worse 3 (10) 2 (8)   
 No change 4 (14) 5 (21)   
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Breathiness      
 Baseline to post-VH Post-VH better 6 (21) 5 (20) 2.192 0.700 
 Post-VH worse 3 (10) 3 (13)   
 No change 20 (69) 16 (67)   
 Post-VH to post-tx Post-tx better 9 (31) 7 (29) 0.816 0.665 
 Post-tx worse 3 (10) 1 (4)   
 No change 17 (59) 16 (67)   
 Baseline to post-tx Post-tx better 11 (38) 10 (42) 0.516 0.915 
 Post-tx worse 3 (10) 2 (8)   
 No change 15 (52) 12 (50)   
Asthenia      
 Baseline to post-VH Post-VH better 5 (17) 3 (12) 2.274 0.518 
 Post-VH worse 2 (7) 0 (0)   
 No change 22 (76) 21 (88)   
 Post-VH to post-tx Post-tx better 9 (31) 6 (25) 3.185 0.203 
 Post-tx worse 3 (10) 0 (0)   
 No change 17 (59) 18 (75)   
 Baseline to post-tx Post-tx better 14 (48) 8 (33) 4.965 0.174 
 Post-tx worse 2 (7) 0 (0)   
 No change 13 (45) 16 (67)   
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Strain      
 Baseline to post-VH Post-VH better 8 (28) 7 (29) 2.274 0.518 
 Post-VH worse 1 (3) 3 (13)   
 No change 20 (69) 14 (58)   
 Post-VH to post-tx Post-tx better 10 (35) 6 (25) 3.679 0.159 
 Post-tx worse 3 (10) 0 (0)   
 No change 16 (55) 18 (75)   
 Baseline to post-tx Post-tx better 17 (59) 11 (46) 4.915 0.178 
 Post-tx worse 2 (7) 2 (12)   
 No change 10 (34) 10 (42)   
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment. 
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Table 4. Within Group Analysis of Physiological Parameters for Both TVT and IVT Groups 
Parameter/Group Pre-VH mean (SD)           Post-VH mean (SD) Post-tx mean (SD) χ2 P 
Symmetry      
 TVT 1.22 (0.506) 1.26 (0.447) 1.26 (0.447) 0.182 0.913 
 IVT 1.28 (0.689) 1.17 (0.650) 1.04 (0.475) 1.200 0.549 
Amplitude      
 TVT 1.07 (0.550) 0.89 (0.698) 1.00 (0.679) 2.150 0.341 
 IVT 1.09 (0.733) 1.17 (0.576) 1.13 (0.694) 0.545 0.761 
Mucosal wave      
 TVT 2.00 (0.480) 1.48 (0.802) 0.63 (0.688) 32.689 <0.001* 
 IVT 1.83 (0.717) 1.22 (0.671) 0.39 (0.583) 32.747 <0.001* 
VF edge smoothness      
 TVT 1.81 (0.483) 1.41 (0.501) 0.96 (0.437) 31.524 <0.001* 
 IVT 1.74 (0.541) 1.30 (0.470) 1.13 (0.548) 16.423 <0.001* 
Regularity      
TVT 1.37 (0.492) 1.30 (0.454) 1.00 (0.555) 8.909 0.012* 
IVT 1.35 (0.573) 1.13 (0.548) 0.96 (0.475) 8.400 0.015* 
Glottal closure      
TVT 1.52 (0.509) 1.15 (0.602) 0.63 (0.565) 27.800 <0.001* 
IVT 1.65 (0.573) 1.26 (0.619) 1.09 (0.596) 10.793 0.005* 
Abbreviations: IVT, intensive voice therapy; TVT, traditional voice therapy; VH, vocal hygiene; tx, treatment; VF, vocal fold; SD, standard deviation. 
* Statistically significant difference. 
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Table 5. Between Group Analysis of Extent of Change in Physiological Parameters in Both the TVT and IVT Groups 
Time /Parameter TVT  
Mean difference (SD) 
IVT  
Mean difference (SD) 
Z P 
Pre-VH versus post-VH     
  Symmetry -0.04 (0.518) 0.08 (0.584) -0.789 0.430 
  Amplitude 0.19 (0.622) -0.08 (0.584) -1.486 0.137 
  Mucosal wave 0.52 (0.849) 0.63 (0.647) -0.536 0.592 
  VF edge smoothness 0.41 (0.501) 0.42 (0.584) -0.185 0.853 
  Regularity 0.07 (0.550) 0.21 (0.558) -0.863 0.388 
  Glottal closure 0.37 (0.688) 0.38 (0.875) -0.061 0.951 
Pre-tx versus post-tx     
  Symmetry -0.07 (0.456) 0.22 (0.795) -1.375 0.169 
  Amplitude 0.07 (0.651) -0.04 (0.562) -0.667 0.505 
  Mucosal wave 1.38 (0.775) 1.43 (0.788) -0.300 0.976 
  VF edge smoothness 0.83 (0.602) 0.61 (0.656) -1.121 0.262 
  Regularity 0.38 (0.728) 0.39 (0.656) -0.114 0.909 
  Glottal closure 0.86 (0.693) 0.57 (0.728) -1.458 0.145 
Post-VH versus post-tx     
  Symmetry 0.00 (0.602) 0.13 (0.757) -0.371 0.711 
  Amplitude -0.11 (0.506) 0.04 (0.562) -1.013 0.311 
  Mucosal wave 0.85 (0.864) 0.83 (0.778) 0.020 0.841 
  VF edge smoothness 0.44 (0.506) 0.17 (0.576) -1.632 0.103 
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  Regularity 0.30 (0.542) 0.17 (0.576) -1.080 0.280 
  Glottal closure 0.52 (0.580) 0.17 (0.778) -1.757 0.079 
Abbreviations: VH, vocal hygiene; tx, treatment; VF, vocal fold; IVT, intensive voice therapy; TVT, traditional voice therapy; SD, standard deviation. 
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Table 6. Physiological Paired Comparison Ratings 
Parameter/Time  TVT, n (%) IVT, n (%) χ2 P 
Vocal nodule size      
 Baseline to post-VH Post-VH smaller 13 (48) 14 (58) 0.752 0.687 
 Post-VH larger 4 (15) 2 (8)   
 No change 10 (37) 8 (33)   
 Post-VH to post-tx Post-tx smaller 19 (68) 13 (57) 1.122 0.571 
 Post-tx larger 4 (14) 3 (13)   
 No change 5 (18) 7 (30)   
 Baseline to post-tx Post-tx smaller 20 (69) 21 (91) 4.680 0.096 
 Post-tx larger 4 (14) 0 (0)   
 No change 5 (17) 2 (9)   
Surrounding oedema      
 Baseline to post-VH Post-VH smaller 14 (52) 13 (54) 1.719 0.423 
 Post-VH larger 4 (15) 1 (4 )   
 No change 9 (33) 10 (42)   
 Post-VH to post-tx Post-tx smaller 20 (71) 16 (69) 0.156 0.925 
 Post-tx larger 3 (11) 2 (9)   
 No change 5 (18) 5 (22)   
 Baseline to post-tx Post-tx smaller 22 (76) 19 (83) 5.264 0.072 
 Post-tx larger 5 (17) 0 (0)   
 No change 2 (7) 4 (17)   
Abbreviations: VH, vocal hygiene; tx, treatment; IVT, intensive voice therapy; TVT, traditional voice therapy. 
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Table 7. Results – MPT, MFR, and Subglottic Pressure for TVT and IVT Groups 
 
Task/Group 
 
Pre-VH              
Mean (SD)           
 
Post-VH               
Mean (SD) 
 
Post-tx              
Mean (SD) 
Interaction Effect Main Effect Between Group Effect 
F p Effect 
Size 
(Partial 
eta 
Squared) 
F p Effect 
Size 
(Partial 
eta 
Squared) 
F p Effect 
Size 
(Partial 
eta 
Squared) 
MPT (s)             
 TVT 8.53 (3.59) 8.81 (3.14) 9.57 (3.64) 0.972 0.385 0.037 0.227 0.798 0.009 0.001 0.974 <0.005 
 IVT 9.04 (4.35) 9.07 (3.24) 8.72 (2.79)          
             
MFR (mL/s)             
 TVT 139.60 
(60.65) 
143.65 
(71.00) 
140.34 
(65.02) 
0.634 0.530 0.005 0.165 0.848 0.007 0.959 0.332 0.018 
 IVT 163.35 
(65.07) 
150.68 
(75.52) 
159.09 
(81.21) 
         
             
Subglottic 
pressure 
(cmH2O) 
            
 TVT 10.10 
(3.08) 
9.64 (2.92) 10.68 
(3.04) 
1.886 0.162 0.070 0.762 0.472 0.030 2.478 0.122 0.046 
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 IVT 11.32 
(2.80) 
11.41 
(3.09) 
11.18 
(3.37) 
 
 
        
Abbreviations: VH, vocal hygiene; tx, treatment; MPT, maximum phonation time; MFR, mean airflow rate; IVT, intensive voice therapy; TVT, 
traditional voice therapy; SD, standard deviation.  
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Table 8. Results – F0, jitter, shimmer, NHR, VI of Prolonged Vowel /a/ and VI of Conversational Speech Sample for TVT and IVT Groups 
 
Task/Group 
 
Pre-VH              
Mean 
(SD)           
 
Post-VH               
Mean 
(SD) 
 
Post-tx              
Mean (SD) 
Interaction Effect Main Effect for Time Between Group Effect 
F p Effect Size 
(Partial eta 
Squared) 
F p Effect Size 
(Partial eta 
Squared) 
F P Effect Size 
(Partial eta 
Squared) 
F0 (Hz)             
 TVT 205.75 
(29.28) 
205.03 
(27.27) 
233.92 
(29.56) 
0.637 0.533 0.025 60.303 <0.001* 0.707 0.342 0.561 0.007 
 IVT 197.88 
(33.56) 
203.79 
(23.89) 
230.67 
(25.65) 
         
Jitter (%)             
 TVT 2.03 
(1.18) 
1.65 
(0.96) 
1.20 (0.92) 0.515 0.600 0.020 18.537 <0.001* 0.426 0.275 0.602 0.005 
 IVT 2.08 
(1.06) 
1.92 
(0.89) 
1.21 (0.84)          
Shimmer (%)             
 TVT 5.17 
(1.90) 
4.59 
(1.82) 
3.87 (2.10) 0.495 0.613 0.019 10.231 <0.001* 0.290 1.158 0.287 0.022 
 IVT 5.83 
(2.43) 
5.24 
(2.21) 
3.96 (1.83)          
NHR             
 TVT 0.16 0.15 0.14 (0.05) 0.089 0.915 0.004 3.508 0.038* 0.123 0.046 0.831 0.001 
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(0.04) (0.03) 
 IVT 0.16 
(0.04) 
0.15 
(0.03) 
0.14 (0.04)          
VI of 
prolonged     
/a/  
(dB) 
            
 TVT 75.73 
(5.53) 
76.43 
(5.34) 
79.92 
(6.51) 
0.196 0.823 0.008 9.931 <0.001* 0.293 0.541 0.465 0.011 
 IVT 75.28 
(5.79) 
75.15 
(4.33) 
78.70 
(6.97) 
         
VI of 
conversation 
(dB) 
            
 TVT 71.50 
(3.81) 
71.85 
(2.75) 
72.27 
(3.79) 
1.184 0.315 0.047 1.122 0.334 0.045 0.097 0.757 0.002 
 IVT 72.19 
(3.52) 
70.84 
(3.11) 
71.91 
(3.99) 
         
Abbreviations: F0, fundamental frequency; NHR, noise-to-harmonic ratio; VI, vocal intensity; IVT, intensive voice therapy; TVT, traditional voice 
therapy; SD, standard deviation. 
* Statistically significant difference.  
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APPENDIX D 
Supplementary Material: Demographic Information of Participants 
Demographic variables TVT  Group IVT Group 
Total number of participants 20 16 
Mean age 36.40 38.50 
Severity of dysphonia     
   Mild 2 - 
   Mild-moderate 14 7 
   Moderate 4 9 
Occupations   
   Professional voice user 14 11 
   Non-professional voice  
   user 
6 5 
Note. TVT = traditional voice therapy; IVT = intensive voice therapy. 
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APPENDIX E 
Supplementary material: Therapy program 
 The therapy program which consisted of one session of vocal hygiene (adapted from NCVS, 
2009, Verdolini Abbott, 2008 & Weinrich, 2003) followed by eight sessions of direct voice therapy 
was identical in both groups. All sessions, regardless of group, were 45 minutes in duration. 
Components of the Vocal Function Exercises (VFE) program developed by Stemple were also 
incorporated in the speech tasks (Stemple, Lee, D’Amico, & Pickup, 1994). Therapy procedures 
commenced with stretches of shoulders and neck and relaxation of facial muscles adapted from 
Verdolini Abbott (2008b) followed by basic training gestures as described by Verdolini Abbott 
(2008a) and Roy et al. (2001). A series of basic body stretches was chosen from Verdolini Abbott 
(2008a) according to each participant’s ability to execute them. Following the relaxation exercises, 
participants were taught direct facilitation of speech tasks which started with stretching (ascending 
pitch glide) and contracting exercises (descending pitch glide) on the word “knoll”, “whoop” or 
“boom”, all with “extreme forward focus”, then working on sounds in isolation (containing both 
consonants and vowels) while feeling the vibration along the anterior alveolar ridge, and 
maintaining easy phonation. The sessions of direct facilitation of speech tasks proceeded in stages 
to a conversational level and real-life applications outside the therapy room.  
 
In addition, participants were guided in applying resonant voice to louder phonation and other 
challenging situations specific to their lifestyle. Detailed individual session speech tasks were given 
in stages as described by Verdolini Abbott (2008a, 2008b). These series of speech tasks aimed to 
achieve  optimal  glottal closure, eliminate compensatory behaviours, and increase the flexibility of 
the laryngeal muscles, thus improving vocal fold function. In addition, all participants were asked to 
practice voice techniques worked on in the therapy session at home, in two 15-minutes sessions per 
day on non-therapy days, and once per day on therapy days. The techniques taught during sessions 
were provided in worksheets in the form of a daily checklist for participants to take home. The 
participants were asked to bring back the worksheets on their next therapy session for clinician to 
monitor their home program completion. During the final therapy session, the clinician and 
participant devised a self-treatment schedule to facilitate the participant’s continued progress 
following therapy as suggested by Verdolini Abbott (2008a). 
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APPENDIX F 
Supplementary material: Procedures of stroboscopic ratings 
 The stroboscopic ratings were performed in two stages. The first stage was to complete 
ratings of physiological parameters including: presence or absence of vocal nodule (yes/no), 
presence or absence of surrounding oedema (yes/no), the symmetry of vocal fold abduction and 
vibration; the regularity and amplitude of the vocal fold movement; vocal fold edge smoothness; 
mucosal wave characteristics and glottal closure all rated on a 3 point scale (0 = normal; 1 = mild; 2 
= moderate; 3 = severe). An operational definition for rating the physiological parameters were 
provided to the raters (see Supplementary Appendix D). The otolaryngologist was able to review 
each stroboscopic sample for as many times as they required. The ratings were performed through 
visual impression only and were presented without sound.  
 
 The second stage of the stroboscopic rating process, was to use the paired sample 
comparison process as discussed above to rate paired samples (pre- vs. 6 months post voice therapy 
and post vs. 6 months post voice therapy) presented in random order. Comparisons of the paired 
samples were rated for changes in nodule size and surrounding oedema on a 3 point scale (1 = 
larger, 0 = no change, -1 = smaller) as per Holmberg et al. (2003). Once rated, the principle 
investigator revealed the order of the samples and transposed the scores to reflect changes over time. 
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APPENDIX G 
Supplementary material: Operational definition of stroboscopic ratings – Physiological 
parameters 
Physiological parameters Definition 
Symmetry Degree to which the two vocal folds mirror each other during 
vibration 
Amplitude Horizontal excursion away from mid-line 
Mucosal wave Traveling wave moving across the superior surface of the 
vocal folds in the medial to lateral direction 
Vocal fold edge smoothness Degree of smoothness of vocal fold edge 
Regularity Degree of consistency from one vibratory cycle to the next 
Glottal closure Predominant mucosal closure pattern  
   Hourglass 
   Spindle 
   Posterior glottic chink 
   Anterior glottis chink 
   Complete closure 
   Complete non-closure 
 
